1. health and fitness
2. disease

Program PDF
Updated: 2-23-15
Non-Certified Industry Events
Session #4501
Latest Insights from the CoreValve Clinical Experience
Monday, March 16, 2015, 6 a.m. - 7:30 a.m.
Omni San Diego
CME Hours: /CNE Hours:
6:30 a.m.
Latest Insights from the CoreValve Clinical Experience
Jeffrey J. Popma
Newton, MA
6:30 a.m.
Sustainability of the TAVR Advantage
Michael J. Reardon
Houston, TX
Jason Neil Katz
Morrisville, NC
8:00 a.m.
Legend
Keith A. A. Fox
Edinburgh, Scotland, United Kingdom
8:00 a.m.
Legend
Eugene Braunwald
Boston, MA
8:00 a.m.
Legend
Anthony N. DeMaria
San Diego, CA
6:30 a.m.
Understanding Clinical Drivers of Outcome
James Bernard Hermiller
Indianapolis, IN
6:30 a.m.
Global Perspectives
Stephan Windecker
Bern, Switzerland
8:00 a.m.
Legend
Robert M. Califf
Durham, NC
Acute Coronary Syndromes (including MOC)
Session #818
Core Curriculum: Landmark Trials in CAD
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 20C
CME Hours: 1.5 /CNE Hours: 1.5
6:30 a.m.
Advancing TAVR Therapy
G. Michael Deeb
Ann Arbor, MI
Chair: James A. de Lemos
Acute Coronary Syndromes - Scientific Session
Session #676
Evolution of ACS Concepts and Management: A Conversation With
the Legends
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 6F
CME Hours: 1.5 /CNE Hours: 1.5
Chair: Jeffrey S. Berger
8:00 a.m.
FIT Interviewer
Sandy Charles
New York, NY
Monday, March 16, 2015
8:00 a.m.
Landmark Trials in NSTEMI-ACS
Glenn A. Hirsch
Baltimore, MD
8:25 a.m.
Landmark Trials in STEMI
Henry E. Kim
Detroit, MI
8:50 a.m.
Landmark Trials in the Management of the Stable Ischemic Heart Patient
Tracy Wang
Durham, NC
8:00 a.m.
Interviewer
Jeffrey S. Berger
New York, NY
9:15 a.m.
Audience Question and Answer/Discussion
8:00 a.m.
Interviewer
Jay S. Giri
Princeton Junction, NJ
Arrhythmias and Clinical EP - Scientific Session
Session #677
Can Registries Improve the Quality of Arrhythmia Care?
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 1B
CME Hours: 1.5 /CNE Hours: 1.5
8:00 a.m.
Interviewer
Co-Chair: Sana M. Al-Khatib
Co-Chair: Mark S. Kremers
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 1 of 64
Program PDF
Updated: 2-23-15
Panelist: Amy Leigh Miller
Panelist: Matthew R. Reynolds
8:00 a.m.
Anticoagulation for Atrial Fibrillation in the Clinic: Promises and Pitfalls.
Insights From the PINNACLE Registry
Joseph P. Drozda
Saint Louis, MO
8:12 a.m.
Can Remote Monitoring of Implanted Devices Improve Outcome?
Joseph Akar
New Haven, CT
8:24 a.m.
Device System Malfunction: Can Registries Help? Where Do We Need to go?
Robert G. Hauser
Minneapolis, MN
8:36 a.m.
Complications After ICD Implantation: A Benchmark for Public Reporting
Jeptha P. Curtis
New Haven, CT
8:48 a.m.
Outcomes of Cardiac Resynchronization Defibrillators in the Real World: Do
the Trials Hold up in Practice?
Pamela Peterson
Denver, CO
9:00 a.m.
Obtaining Maintenance of Certification Part IV Credit Using an ICD Registry
Paul D. Varosy
Denver, CO
9:12 a.m.
Panel Discussion
Arrhythmias and Clinical EP (including MOC)
Session #819
ACCF Study Session for Maintenance of Certification: ABIM
Recertification Made Easy: Electrophysiology Module 1
Monday, March 16, 2015, 8 a.m. - 10:30 a.m.
29B
CME Hours: 2.5 /CNE Hours: 0
Co-Chair: Peter N. Smith
MOC Faculty: Peter A. Brady
MOC Faculty: Mintu Turakhia
Monday, March 16, 2015
Co-Chair: Thomas L. Spray
Co-Chair: Evan M. Zahn
Panelist: David Bichell
Panelist: Christopher Caldarone
Panelist: Andrew Pelech
Panelist: Abraham Rothman
8:00 a.m.
Pre-debate Vote: Catheter Based vs Surgical
8:02 a.m.
Catheter Based Device Closure of Perimembranous VSD (3 minute video; 4
minute presentation)
Thomas K. Jones
Seattle, WA
8:10 a.m.
Surgical Closure of Perimembranous VSD (3 minute video; 4 minute
presentation)
Jennifer Hirsch-Romano
Ann Arbor, MI
8:18 a.m.
Post-debate Vote:
8:20 a.m.
Directed Questions from Panelists
8:30 a.m.
Pre-debate Vote: Catheter Based vs Surgical
8:32 a.m.
Catheter Based Treatment of Native Aortic Coarctation in Children (3 minute
video; 4 minute presentation)
Darren P. Berman
Columbus, OH
8:40 a.m.
Surgical Treatment of Native Aortic Coarctation in Children (3 minute video;
4 minute presentation)
Michael E. Mitchell
Milwaukee, WI
8:48 a.m.
Post-debate Vote:
8:50 a.m.
Directed Questions from Panelists
Congenital Heart Disease - Scientific Session
Session #678
Head to Head: Surgery vs. Intervention: Joint Symposium of the
American Association for Thoracic Surgeons and the American
College of Cardiology
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 31C
CME Hours: 1.5 /CNE Hours: 1.5
9:00 a.m.
Pre-debate Vote: Catheter Based vs Surgical
9:02 a.m.
Surgical Replacement of the Pulmonary Valve (3 minute video; 4 minute
presentation)
Christopher Caldarone
Toronto, Canada
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 2 of 64
Program PDF
Updated: 2-23-15
9:10 a.m.
Catheter Based Device Replacement of the Pulmonary Valve (3 min video; 4
min presentation)
Joshua Kanter
Washington, DC
Co-Chair: Thomas Force
9:18 a.m.
Post-debate Vote:
8:15 a.m.
Obesity Paradox
Stefan D. Anker
London, United Kingdom
9:20 a.m.
Directed Questions from Panelists
Heart Failure and Cardiomyopathies - Scientific Session
Session #679
New Devices for Cardiogenic Shock
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 6C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: James M. McCabe
Co-Chair: Holger Thiele
Monday, March 16, 2015
8:00 a.m.
Glucose, Obesity, Metabolic Syndrome, and Diabetes
Tamara Horwich
8:30 a.m.
Diabetes as a Risk Factor for Heart Failure
Kevin D. O'Brien
Seattle, WA
8:45 a.m.
Heart Failure as a Risk Factor for Diabetes
Maya E. Guglin
Tampa, FL
8:00 a.m.
Is There Still a Role for IABP Support in Shock?
James Revenaugh
8:30 a.m.
Sleep Apnea and Heart Failure
John S. Floras
Toronto, Canada
8:15 a.m.
When Is ECMO Indicated?
Ehrin J. Armstrong
Denver, CO
9:15 a.m.
Hypertension and Heart Failure
David Aguilar
Houston, TX
8:30 a.m.
Circulite: A Bridge to Durable Therapy?
Daniel Burkhoff
New York, NY
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #681
Nuclear Cardiology: Applications in Clinical Practice
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 2
CME Hours: 1.5 /CNE Hours: 1.5
8:45 a.m.
Impella for Acute Hemodynamic Support
J. Dawn Abbott
Providence, RI
8:00 a.m.
CAD and Myocardial Infarction
John J. Mahmarian
9:00 a.m.
The Next Generation of PVADs
Biswajit Kar
Houston, TX
9:15 a.m.
Defining Futility: Is There Such a Thing as Too Sick for Percutaneous Support?
Frederic S. Resnic
Burlington, MA
Heart Failure and Cardiomyopathies - Scientific Session
Session #680
Diabetes, Metabolism, Hypertension, and Heart Failure
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 5A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Javed Butler
Co-Chair: James E. Udelson
Co-Chair: L. Samuel Wann
8:15 a.m.
Cardiomyopathies and Heart Failure
Prem Soman
Pittsburgh, PA
8:30 a.m.
Myocardial Viability
Vasken Dilsizian
Baltimore, MD
8:45 a.m.
Special Patient Populations
Jennifer H. Mieres
Lake Success, NY
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 3 of 64
Program PDF
Updated: 2-23-15
9:00 a.m.
Stress Protocols and Tracers: Present and Future
Brian G. Abbott
East Greenwich, RI
9:15 a.m.
The Prognostic Power of Nuclear Cardiology: Pondering the Evidence
Leslee J. Shaw
Atlanta, GA
Prevention - Scientific Session
Session #682
Genes, Your Cholesterol and Your Jeans!
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 6B
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Raul Santos
Co-Chair: Michael D. Shapiro
8:00 a.m.
Severe Hypercholesterolemia - Monogenic Vs Polygenic - Does It Matter?
Allan D. Sniderman
8:15 a.m.
What's New in Familial Hypercholesterolemia?
Joshua Knowles
Stanford, CA
Monday, March 16, 2015
8:00 a.m.
Program Co-Chair: Bonnie Ky
8:00 a.m.
Welcome & Introduction
Ana Barac
8:00 a.m.
Welcome & Introduction
Bonnie Ky
Philadelphia, PA
8:05 a.m.
ACC Talk: Cardio-Oncology - Why is it Important Now? The Cardiologist's
Perspective
Pamela S. Douglas
Durham, NC
8:15 a.m.
ACC Talk: Cardio-Oncology - Why is it Important Now? The Oncologist's
Perspective
Susan Dent
Ottawa, Canada
8:25 a.m.
Part One: Expert Consensus in the Cardiovascular Care of Cancer Patients
8:25 a.m.
Pre-Case Presentation Vote
8:30 a.m.
Lifelong low LDL - Genetic Insights Into Atherosclerotic Risk
Brian A. Ference
Detroit, MI
8:26 a.m.
CASE PRESENTATION 1 : How Do You Identify the High Risk Patient?
Tochukwu Okwuosa
Chicago, IL
8:45 a.m.
Beyond LDL: APOC3 and Other Emerging Genetic Targets
Sotirios Tsimikas
La Jolla, CA
8:31 a.m.
Expert Discussion - Risk Stratification
9:00 a.m.
Living With FH- A Patient Perspective
Katherine Wilemon
South Pasadena, CA
Panelist (CMR Imaging)
W. Gregory Hundley
Winston Salem, NC
9:15 a.m.
Question and Answer
Special Topics - Intensive
Session #52
Cardio-Oncology Intensive
Monday, March 16, 2015, 8 a.m. - 1:45 p.m.
Room 7B
CME Hours: 4.25 /CNE Hours: 4.25
8:00 a.m.
Program Co-Chair: Ana Barac
Panelist (Risk Scores)
Jersey Chen
Rockville, MD
Panelist (Biomarkers)
Daniel J. Lenihan
Nashville, TN
Panelist (Echo Imaging)
Thomas H. Marwick
Hobart, Australia
Panelist (Oncology)
Erica L. Mayer
Boston, MA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 4 of 64
Program PDF
Updated: 2-23-15
8:58 a.m.
Post-Case Presentation Vote
Monday, March 16, 2015
Panelist: Anecita Fadol
11:15 a.m.
Part Two: B -What's Next? New Cardiotoxic Regimens And Advances In
Cardio-Oncology
8:59 a.m.
Pre-Case Presentation Vote
9:00 a.m.
CASE PRESENTATION 2: What Can We Do to "Protect the Heart?"
Gillian Murtagh
Chicago, IL
11:15 a.m.
VEGF Signaling Pathway Inhibitors - Management of Hypertension, LV
Dysfunction, and Ischemia
Co-Chair: Thomas Force
9:05 a.m.
Expert Discussion - Cardioprotective Strategies
Panelist (Oncology)
Susan Dent
Ottawa, Canada
11:20 a.m.
What Guidelines Do we Use and What is the Best Anti-hypertensive
Regimen?
Raymond Townsend
Philadelphia, PA
Panelist (Cardiology)
Jean-Bernard Durand
Houston, TX
Panelist (Exercise)
Lee Jones
New York, NY
11:30 a.m.
Should Every Patient get an Echo and/or Cardiac Ischemia Evaluation?
Javid Moslehi
Nashville, TN
Panelist (Cardiology and Survivorship)
Anju Nohria
Boston, MA
11:40 a.m.
Audience Question and Answer
9:29 a.m.
Post-Case Presentation Vote
11:45 a.m.
Part 2: C -Cardiotoxicity of Radiation Therapy (Relevance, Promises of New
Agents, Cardioprotective Strategies)
9:30 a.m.
Break
10:45 a.m.
Part Two - A. The Impact of Collaborative Care
Co-Chair: Justin Bekelman
Co-Chair: Joseph Carver
11:45 a.m.
Questions Posed to Attendees; Pre-Debate Vote
Co-Chair: Michael J. Fisch
Co-Chair: Joann Lindenfeld
10:45 a.m.
CASE PRESENTATION 3: How Do We Deliver Comprehensive Care to our
Patients?
Michael J. Fisch
10:50 a.m.
CASE PRESENTATION 3: How Do We Deliver Comprehensive Care to our
Patients?
Joann Lindenfeld
Aurora, CO
10:55 a.m.
Expert Discussion Across Oncology, Cardiology, Survivorship, Exercise
Panelist: Saro Armenian
Panelist: Ming Hui Chen
Panelist: Louis S. Constine
11:15 a.m.
CASE PRESENTATION 4: How Do We Care for the Patient Being Treated with
VEGF Signaling Pathway Inhibitors?
Rupal P. O'Quinn
11:50 a.m.
DEBATE: Cardiotoxicity of Radiation Therapy Should be a Problem of the Past
Reshma Jagsi
12:00 p.m.
DEBATE: Cardiotoxicity of Radiation Therapy Remains a Current and Future
Problem
Oren Cahlon
New York, NY
12:10 p.m.
Questions Posed to Attendees; Post-Debate Vote
12:15 p.m.
Break
12:30 p.m.
Part Three: How to Build A Program: Practice Changers and Tips
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 5 of 64
Program PDF
Updated: 2-23-15
Co-Chair: Richard M. Steingart
12:30 p.m.
ACC Talk: How to Build a Clinical Practice?
Monika J. Leja
12:40 p.m.
Audience Question & Answer
12:50 p.m.
ACC Talk: How to Build a Cardio-Oncology Imaging Practice?
Juan Carlos Plana
Houston, TX
1:00 p.m.
Audience Question & Answer
1:10 p.m.
ACC Talk: How to Build a Survivorship Practice?
Kevin C. Oeffinger
New York, NY
1:20 p.m.
Audience Question & Answer
1:30 p.m.
Summary of Practice Changers
Richard M. Steingart
New York, NY
Monday, March 16, 2015
Patients With Congestive Heart Failure and an Implanted device: Results
from the AATAC Multicenter Randomized Trial
Luigi Di Biase, Prasant Mohanty, Sanghamitra Mohanty, Pasquale Santangeli,
Chintan Trivedi, Dhanunjaya Lakkireddy, Madhu Reddy, Pierre Jais, Sakis
Themistoclakis, Antonio Dello Russo, Michela Casella, Gemma Pelargonio,
Maria Narducci, Robert Schweikert, Petr Neuzil, Javier Sanchez, Rodney
Horton, Salwa Beheiry, Richard Hongo, Steven Hao, Giovanni Forleo, Claudio
Tondo, John Burkhardt, Michael Haissaguerre, Andrea Natale, Texas Cardiac
Arrhythmia Institute at St Davids Medical Center, Austin, TX, USA
8:10 a.m.
Panel Discussion
8:15 a.m.
Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve
Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials
Network
A. Gillinov, Annetine Gelijns, Michael K. Parides, Joseph DeRose, Alan
Moskowitz, Pierre Voisine, Gorav Ailawadi, Denis Bouchard, Peter Smith,
Michael Mack, Michael Acker, John Mullen, Helena L Chang, John Puskas,
David Adams, Keith A. Horvath, Steven Bolling, Robert Michler, Nancy Geller,
Ellen Moquete, Wendy Taddei-Peters, Patrick O'Gara, Eugene Blackstone,
Michael Argenziano, for the CTSN Investigators, Icahn School of Medicine at
Mount Sinai, New York, NY, USA
8:25 a.m.
Panel Discussion
1:35 p.m.
Session Feedback and Post-Meeting Discussion
Ana Barac
Washington, DC
8:30 a.m.
Long-Term Effect of Goal Directed Weight Management on an Atrial
Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
Rajeev K. Pathak, Melissa E. Middeldorp, Megan Meredith, Abhinav Mehta,
Rajiv Mahajan, Walter Abhayaratna, Dennis Lau, Prashanthan Sanders,
Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide,
Australia, Australian National University, Canberra, Australia
1:35 p.m.
Session Feedback and Post-Meeting Discussion
Bonnie Ky
Philadelphia, PA
8:40 a.m.
Panel Discussion
Special Topics - Special Session
Session #408
Joint Session of the American College of Cardiology/New England
Journal of Medicine Late-Breaking Clinical Trials
Monday, March 16, 2015, 8 a.m. - 9:15 a.m.
Hall H (Main Tent)
CME Hours: 1.5 /CNE Hours: 1.5
8:45 a.m.
Everolimus-Eluting Stents versus Bypass Surgery for Multivessel Coronary
Artery Disease
Seung-Jung Park, Jung-Min Ahn, Young-Hak Kim, Duk-Woo Park, Sung-Cheol
Yun, Jong-Young Lee, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee,
Seong-Wook Park, Suk Jung Choo, Cheol-Hyun Chung, Jae-Won Lee, David
Cohen, Alan Yeung, Seung-Ho Hur, Ki-Bae Seung, Taehoon Ahn, Hyuck Moon
Kwon, Do-Sun Lim, Seung-Woon Rha, Myung Ho Jeong, Bong-Ki Lee, Damras
Tresukosol, Guosheng Fu, Asan Medical Center, Seoul, South Korea
Co-Chair: John A. Jarcho
Co-Chair: Prediman K. Shah
Panelist: Eric R. Bates
Panelist: Richard I. Fogel
Panelist: Bernard J. Gersh
Panelist: Alice K. Jacobs
Panelist: Andrea M. Russo
8:55 a.m.
Panel Discussion
8:00 a.m.
Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in
9:00 a.m.
Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients
Undergoing Coronary Artery Bypass Graft Surgery: A Multi-Center
Randomized Controlled Clinical Trial
Derek J. Hausenloy, Luciano Candilio, Richard Evans, David P. Jenkins, Shyam
Kolvekar, Rosemary Knight, Gudrun Kunst, Christopher Laing, Jennifer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 6 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Nicholas, John Pepper, Andrew Ritchie, Steven Robertson, Maria Xenou, Tim
Clayton, Derek Yellon, University College London, London, United Kingdom
Rhonda M. Cooper-DeHoff
Gainesville, FL
9:10 a.m.
Panel Discussion
8:55 a.m.
Investigator Initiated Projects
Darcy DiFede
Miami, FL
Special Topics - Scientific Session
Session #683
State Legislatures: New Battlegrounds for Medical Malpractice
Liability Reform
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 6A
CME Hours: 1.5 /CNE Hours:
9:15 a.m.
Industry Sponsored Trials
Dana Leach
Gainesville, FL
8:00 a.m.
Health Policy Hot Topics
Tbd
Hal Dasinger
Napa, CA
9:25 a.m.
Question and Answer
Tbd
Joseph S. Wilson
Atlanta, GA
Special Topics - Scientific Session
Session #684
What Do I Want to Be When I Grow Up? - CVT Session II
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 10
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: John Baker
8:00 a.m.
What Does It Take to Be CEO?
8:00 a.m.
Changing Landscape of Hospital/System Administration-Insight from the ACC
CV Summit
Howard T. Walpole, Jr.
Nashville, TN
8:30 a.m.
The Road to Executive Leadership
Kevin Fitzpatrick
Washington, DC
Special Topics - Scientific Session
Session #685
MOC Part IV The Easy Way: No Registries, No Problem
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
30B
CME Hours: 1.5 /CNE Hours: 0
8:00 a.m.
Group Moderator
Andrew M. Freeman
Denver, CO
8:00 a.m.
Group Moderator
Sunil V. Rao
Durham, NC
Co-Chair: Janet Fredal Wyman
8:15 a.m.
The Road to the C Suite
Cathleen D. Biga
9:05 a.m.
NIH Cell Therapy Network
Rachel Olson
Minneapolis, MN
8:00 a.m.
Radiation Exposure
Kalon K. L. Ho
Boston, MA
8:00 a.m.
Coronaries/Catheterization
James E. Tcheng
Durham, NC
8:00 a.m.
Beta Blockers/ACE-I/Statins
Kim Allan Williams, Sr.
Chicago, IL
8:45 a.m.
Clinical Research As A Career
8:45 a.m.
Independent Investigator-Pharmacist
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 7 of 64
Program PDF
Updated: 2-23-15
Special Topics - Future of CV Medicine
Session #1008
Future of Medical Education: Future of Cardiovascular Medicine IX
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 20D
CME Hours: 1.5 /CNE Hours: 1.5
Chair: John A. McPherson
8:00 a.m.
Pre-session Assessment
8:05 a.m.
ACC Talk: The Burning Platform in Medical Education
John A. McPherson
Nashville, TN
8:10 a.m.
Game Changing Ideas to Promote Life-long Learning Among Trainees and
Early Career Cardiologists
John M. Mandrola
Louisville, KY
8:30 a.m.
Evaluating the Adult Learner
Julie Damp
Nashville, TN
Monday, March 16, 2015
9:09 a.m.
Innovations in Medical Education: Social Media-based Learning
(demonstration)
Anjan Gupta
Milwuakee, WI
9:17 a.m.
Innovations in Medical Education: ACC Initiatives
Janice Sibley
Washington, DC
9:25 a.m.
Wrap-up and Post-session Assessment
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2632
Controversies in Antithrombotic Strategies After Stenting
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 6D
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Paul A. Gurbel
Co-Chair: Deepak L. Bhatt
8:00 a.m.
Platelet Function Testing Still has a Role in 2014
Paul A. Gurbel
8:10 a.m.
Discussion
8:35 a.m.
Evaluating the Adult Learner
Lisa A. Mendes
Brentwood, TN
8:40 a.m.
Panel Discussion: Observations
8:15 a.m.
Platelet Function Testing Remains a Research Tool and Should not be used
Clinically
Sanjay Kaul
Los Angeles, CA
8:45 a.m.
Tools/Innovations to Teach and Evaluate Adult Learners
8:25 a.m.
Discussion
8:45 a.m.
Innovations in Medical Education: Simulation, Team-based Training
(demonstration)
Kathryn L. Berlacher
Pittsburgh, PA
8:30 a.m.
There is a Role for Genetic Testing in Antiplatelet Therapy
Jessica L. Mega
Boston, MA
8:53 a.m.
Innovations in Medical Education: Feedback App (demonstration)
Chittur A. Sivaram
Oklahoma City, OK
9:01 a.m.
Innovations in Medical Education: Easy Access Digital Learning
(demonstration)
Thomas Ben Morrison
Chesterfield, MO
8:40 a.m.
Discussion
8:45 a.m.
There is No Good Reason to do Genetic Testing in Deciding Antiplatelet
Therapy
Dirk Sibbing
Muenchen, Germany
8:55 a.m.
Discussion
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 8 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
9:00 a.m.
Patients with Atrial Fibrillation and PCI or ACS Need Triple Therapy - Practical
Guidance
Christopher P. Cannon
Boston, MA
Jonathan Afilalo
Montreal, Canada
9:10 a.m.
Discussion
9:14 a.m.
Panel Discussion
9:15 a.m.
Avoid Triple Therapy - It Causes Bleeding, but Does Not Reduce Events
C. Michael Gibson
Boston, MA
9:20 a.m.
Complex Patient Case Presentation 2
Scott M. Lilly
Columbus, OH
9:25 a.m.
Discussion
9:24 a.m.
Panel Discussion
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2633
Complex Patient Selection for TAVR
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 9
CME Hours: 1.5 /CNE Hours: 1.5
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2903
Challenging Cases II
Monday, March 16, 2015, 8 a.m. - 9:30 a.m.
Room 8
CME Hours: /CNE Hours:
Co-Chair: Zachary Gertz
Co-Chair: Nimesh Desai
8:00 a.m.
Left Main Coronary Artery Thrombosis with Acute Myocardial Infarction: A
Management Dilemma
Natasha Purai Arora, Omar Kashlan, Mouhammed Joumaa, Saint John
Hospital & Medical Center, Detroit, MI, USA
8:00 a.m.
Low Flow, Low Gradient, Low EF - Predictors of Risk
Crochan John O'Sullivan
8:10 a.m.
Role of MR in Decision Making and Results
Luis Nombela-Franco
Quebec, Canada
8:20 a.m.
Impact of Renal Disease on Evaluation and Outcomes
Molly Szerlip
Tucson, AZ
8:30 a.m.
How to Assess Pulmonary Disease and Effect on Outcome
Danny Dvir
Rockville, MD
8:40 a.m.
Role of Vascular Disease in Outcomes and Access
Mitul B. Kadakia
Philadelphia, PA
8:50 a.m.
Impact of AF and Conduction Disease in Decision Making
Susheel K. Kodali
New York, NY
9:00 a.m.
Fraility and Dementia in TAVR Evaluation
9:10 a.m.
Complex Patient Case Presentation 1
8:08 a.m.
Discussion
8:12 a.m.
Transesophageal Pericardiocentesis: A Novel Approach to Treat Loculated
Hemopericardium
Tiffany Chen, Creighton Don, University of Washington, Seattle, WA, USA
8:20 a.m.
Discussion
8:24 a.m.
Trans-Catheter Aortic Valve Implantation Patient: Late (8 Months) AorticRight Ventricle Fistula Due to Annulus Aortic Rupture
Gennaro Sardella, Massimo Mancone, Simone Calcagno, Manuela Reali,
Sapienza University of Rome, Rome, Italy
8:32 a.m.
Discussion
8:36 a.m.
Clarity via Intravascular Imaging
Marysia S. Tweet, Sharonne Hayes, Patricia Best, Rajiv Gulati, Mayo Clinic,
Rochester, MN, USA
8:44 a.m.
Discussion
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 9 of 64
Program PDF
Updated: 2-23-15
8:48 a.m.
Retrograde Left Main Chronic Total Occlusion PCI in the setting of Acute
Coronary Syndrome
Wael ElMallah, Khaled Ziada, Texas Tech University Health Science Center, El
Pasp, USA, Gill Heart Institute, Lexington, KY, USA
Monday, March 16, 2015
Massimiliano Gnecchi, Maurizio Ferrario, Dept. of Cardiology Fondazione
IRCCS Policlinico San Matteo, Pavia, Italy, University of Pavia, Pavia, Italy
8:56 a.m.
Discussion
054 - Low Platelet Count and Fatal Myocardial Infarction: A Population Based
Analysis
Venkat Vuddanda, Abhishek Goyal, Marjan Mujib, Sahil Khera, Dhaval Kolte,
Wilbert Aronow, Sachin Sule, William Frishman, Howard Cooper, Julio Panza,
Westchester Medical Center, Valhalla, NY, USA
9:00 a.m.
Aortic Intramural Hematoma Mimicking ST-segment Elevation Myocardial
Infarction By Sequential Compression Of Coronary Artery - Successful
Treatment With Percutaneous Coronary Intervention.
Nelson Chavarria, Gregory Gustafson, Chong Park, Emmanuel Moustakakis,
New York Hospital Queens, Flushing, NY, USA
055 - Comparison Between a New Grading Scale Including Platelet Function
Test and the Current Bleeding Scales in Patients with Acute Coronary
Syndrome Using Prasugrel
Yongwhi Park, Jong-Hwa Ahn, Jin-Sin Koh, Jeong Rang Park, Seok Jae Hwang,
Young-Hoon Jeong, Choong Hwan Kwak, Jinyong Hwang, Gyeongsang
National University Hospital, Jinju, South Korea
9:08 a.m.
Discussion
056 - Higher Platelet Inhibition with Thienopyridine Therapy, Rather than
Serum Fibrinogen Level, Is Associated with Periprocedural Bleeding After
Percutaneous Coronary Intervention
Khushboo Kaushal, Lawrence Ang, Felice Lin, Samhita Palakodeti, Andrew
Huynh, Kelly Enright, Mattheus Ramsis, Shiqian Li, Phildrich Teh, Mitul Patel,
Ryan Reeves, Ehtisham Mahmud, Sulpizio Cardiovascular Center - University
of California, San Diego, La Jolla, CA, USA
9:12 a.m.
Percutaneous First-in-Human Tricuspid Valve Annuloplasty Using the
Mitralign System
Joachim Schofer, Rebecca Hahn, Medical Care Center Prof. Mathey Prof.
Schofer, Hamburg, Germany, Columbia University Medical Center/New York
Presbyterian Hospital, New York, NY, USA
9:20 a.m.
Discussion
9:24 a.m.
Audience Q & A
Valvular Heart Disease - Self-Directed Learning Session
Session #1502
Heart Songs at ACC.15: A Self-Paced Multimedia Learning Experience
Monday, March 16, 2015, 9 a.m. - 5 p.m.
Ballroom 20 Lobby
CME Hours: 2 /CNE Hours: 2
Co-Chair: Michael J. Barrett
Co-Chair: Carolyn S. Lacey
Co-Chair: Matthew Schumaecker
Co-Chair: Sarah Luther
Co-Chair: Adrian C. Bell
Co-Chair: Michael J. Barrett
Co-Chair: Matthew W. Martinez
057 - P2y12 Receptor Inhibition According to Prehospital Administration of
Ticagrelor in Primary PCI for St Elevation Myocardial Infarction: The PrivateAtlantic Study
Johanne Silvain, Robert Storey, Guillaume Cayla, Jean-Baptiste Esteve, JeanGuillaume Dillinger, Eric Vicat, Jean-Philippe Collet, Anne Tsatsaris, Caroline
Baradat, Néjoua Salhi, Frederic Lapostolle, Jens Lassen, Christian Hamm,
Arnoud Van't Hof, Gilles Montalescot, ACTION Coeur Research Group, Paris,
France
058 - Temporal Trend in the Incidence of Stent Thrombosis: Impact of
Improved Antiplatelet Regimen and Evolving Coronary Stent Technology
Pranav Kansara, Wasif Qureshi, Usman Choudhry, James Hopkins, Claudine
Jurkovitz, James Laughery, Ehsanur Rahman, Sandra Weiss, William S.
Weintraub, Christiana Care Health System, Newark, DE, USA
059 - Platelet Function Testing and Heart-Type Fatty Acid Binding Protein
Levels for Risk Stratification in Patients with Acute Coronary Syndrome Who
Undergo Percutaneous Coronary Intervention
Ian Pearson, Alistair Hall, Chris Gale, Mohan Sivananthan, Leeds Teaching
Hospitals NHS Trust, Leeds, United Kingdom
Acute Coronary Syndromes - Poster Contributions
Session #1244
Conquering the Platelet and More for Better Outcomes
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
053 - Neutrophil to Platelet Ratio: A Novel Prognostic Biomarker in STEMI
Patients Undergoing Primary Percutaneous Coronary Intervention
Gaetano M. De Ferrari, Alberto Somaschini, Stefano Cornara, Antonella Pepe,
Claudia Pavesi, Rita Camporotondo, Alessandra Repetto, Antonella Potenza,
060 - Definite Stent Thrombosis: Does High Density Lipoprotein Cholesterol
Level Matter?
Pranav Kansara, Wasif Qureshi, Claudine Jurkovitz, James Hopkins, Usman
Choudhry, James Laughery, Paul Kolm, Ehsanur Rahman, Sandra Weiss,
William S. Weintraub, Christiana Care Health System, Newark, DE, USA
061 - Impact of Proton Pump Inhibitor Use on the Comparative Safety and
Effectiveness of Prasugrel versus Clopidogrel: Insights from TRANSLATE-ACS
Larry R. Jackson, Eric Peterson, Lisa McCoy, Christine Ju, Marjorie Zettler,
Brian Baker, John Messenger, Douglas Faries, Mark Effron, David Cohen,
Tracy Wang, Duke Clinical Research Institute, Durham, NC, USA
062 - Usefulness of Mean Platelet Volume as a Biomarker for Angiographic
Thrombus Burden and Short-Term Mortality in Patients with ST-Segment
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 10 of 64
Program PDF
Updated: 2-23-15
Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary
Intervention
Yi-Ning Yang, Hong-Mei Lai, Rui Xu, Yi Ma, Xiao-Mei Li, Qian Zhao, Qing-Jie
Chen, Hui Zhai, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi,
People's Republic of China
063 - Association of Circulating Levels of Neopterin with Plaque Vulnerability
in Patients with Coronary Artery Disease an Angiogram, Optical Coherent
Tomography and Intravascular Ultrasound Study
Jieqiong He, Jinwei Tian, Bo Yu, Department of Cardiology,The Second
Affiliated Hospital of Harbin Medical University, Harbin, MA, People's
Republic of China
064 - Does Statin Therapy Prevent Neoatherosclerosis?
Sining Hu, Haibo Jia, Rocco Vergallo, Jinwei Tian, Tsunenari Soeda, Yoshiyasu
Minami, Lei Gao, Daniel Ong, Hang Lee, Shaosong Zhang, Bo Yu, Ik-Kyung
Jang, Cardiology Division, Massachusetts General Hospital, Harvard Medical
School, Boston, MA, USA, Department of Cardiology, The Second Affiliated
Hospital of Harbin Medical University, Key Laborator, Harbin, People's
Republic of China
065 - Culprit Lesions of Acute Coronary Syndrome Are Characterized by The
Presence of Stenosis and High-Risk Plaque, But Not Higher Segmental
Coronary Artery Calcium Score: Results from the ROMICAT II Trial
Maros Ferencik, Stefan B. Puchner, Thomas Mayrhofer, Michael T. Lu, Ting
Liu, Pal Maurovich-Horvat, Khristine Ghemigian, Jerome Fleg, James Udelson,
Udo Hoffmann, Oregon Health and Science University, Portland, OR, USA,
Massachusetts General Hospital and Harvard Medical School, Boston, MA,
USA
066 - Elevated Serum Fibrinogen Level Is Associated with Long-Term Major
Adverse Cardiac Events Following Percutaneous Coronary Intervention
Felice Lin, Lawrence Ang, Samhita Palakodeti, Khushboo Kaushal, Andrew
Huynh, Kelly Enright, Mattheus Ramsis, Shiqian Li, Phildrich Teh, Mitul Patel,
Ryan Reeves, Ehtisham Mahmud, Sulpizio Cardiovascular Center - University
of California, San Diego, La Jolla, CA, USA
067 - Activated Leukocyte Cell Adhesion Molecule (ALCAM) and Outcomes in
Acute Coronary Syndromes: A PLATO Biomarker Substudy
Lars Wallentin, Annika E. Michelsen, Pål Aukrust, Richard Becker, Maria
Bertilsson, Andrzej Budaj, Jan Cornel, Anders Himmelmann, Steen Husted,
Agneta Siegbahn, Robert Storey, Frederic Kontny, Thor Ueland, Department
of Medical Sciences, Cardiology, and Uppsala Clinical Research Center,
Uppsala University, Uppsala, Sweden
068 - Comprehensive Plaque Distribution in Native Coronary Arteries: A
Three-Vessel Optical Coherence Tomography Analysis
Lei Gao, Rocco Vergallo, Yoshiyasu Minami, Haibo Jia, Daniel Ong, Tsunenari
Soeda, Jinwei Tian, Hang Lee, Bo Yu, Shiro Uemura, Ik-Kyung Jang, Cardiology
Division, Massachusetts General Hospital, Harvard Medical School, Boston,
MA, USA
069 - Fractional Flow Reserve (FFR) versus Angiography in Guiding
Management to Optimize Outcomes in Non-ST Elevation Myocardial
Infarction (FAMOUS - NSTEMI) Health Economic Analysis
Julian Nam, Andrew Briggs, Jamie Layland, Keith Oldroyd, Nick Curzen, Arvind
Sood, Kanarath Balachandran, Rajiv Das, Shahid Junejo, Hany Eteiba, Mark
Petrie, Stuart Watkins, Simon Corbett, Brian O'Rourke, Anna O'Donnell, Alex
Monday, March 16, 2015
McConnachie, Robert Henderson, Mitchell Lindsay, Colin Berry, University of
Glasgow, Glasgow, United Kingdom
070 - Natural History of Coronary Arterial Remodeling in Patients with Acute
Coronary Syndrome: A Serial Intravascular Ultrasound Study
Jinwei Tian, Haibo Jia, Yoshiyasu Minami, Lei Gao, Hang Lee, Bo Yu, Ik-Kyung
Jang, the 2nd Affiliated Hospital of Harbin Medical University, Harbin,
People's Republic of China, Massachusetts General Hospital, Boston, MA,
People's Republic of China
071 - Intravascular Ultrasound, but not Optical Coherence Tomography,
Predicts No Reflow Phenomenon after Primary Percutaneous Coronary
Intervention in Patients with ST-segment Elevation Myocardial Infarction
Caused by Plaque Rupture
Tsunenari Soeda, Takumi Higuma, Naoki Abe, Masahiro Yamada, Hiroaki
Yokoyama, Shuji Shibutani, Haibo Jia, Jinwei Tian, Rocco Vergallo, Yoshiyasu
Minami, Hang Lee, Ken Okumura, Ik-Kyung Jang, Massachusetts General
Hospital, Boston, MA, USA
072 - Incidence and Predictors of Multiple Coronary Plaque Ruptures: A 3Vessel Optical Coherence Tomography Study
Rocco Vergallo, Tomonori Itoh, Jack W. Tan, Chong-Jin Kim, Shiro Uemura, Bo
Yu, Yoshiyasu Minami, Tsunenari Soeda, Haibo Jia, Ik-Kyung Jang,
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
073 - Acute Coronary Syndrome Caused by Non-Critical Coronary Stenosis:
Insight from an In Vivo Optical Coherence Tomography Study
Haibo Jia, Sining Hu, Amir Lerman, Catalin Toma, Harold Dauerman, Daniel
Ong, Rocco Vergallo, Jinwei Tian, Tsunenari Soeda, Yoshiyasu Minami, Lei
Gao, Hang Lee, Shaosong Zhang, Jingbo Hou, Bo Yu, Ik-Kyung Jang,
Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical
University, Harbin, People's Republic of China, Massachusetts General
Hospital, Harvard Medical School, Boston, MA, USA
074 - Effect of Atorvastatin Therapy on Macrophages Accumulation in
Coronary Atherosclerotic Plaques as Assessed by Optical Coherence
Tomography
Tsuyoshi Nishiguchi, Takashi Kubo, Kenichi Komukai, Yasutsugu Shiono,
Makoto Orii, Takashi Yamano, Yoshiki Matsuo, Yasushi Ino, Tomoyuki
Yamaguchi, Hironori Kitabata, Kumiko Hirata, Atsushi Tanaka, Takashi
Akasaka, Department of Cardiovascular Medicine, Wakayama Medical
University, Wakayama, Japan
075 - Long Term Variation of High on Treatment Platelet Reactivity After an
Acute Myocardial Infarction
Joakim Alfredsson, Tomas Lindahl, Kerstin M. Gustafsson, Magnus Janzon,
Lena Jonasson, Elisabeth Logander, Lennart Nilsson, Eva Swahn, Department
of Cardiology and Department of Medical and Health Sciences, Linköping,
Sweden
076 - Aspirin Use During Hospital Stay Is Associated with Improved Survival in
Type 2 Myocardial Infarction
Bashar Al Jayyousi, Musab Alqasrawi, Belal Al Khiami, Ravinder Kumar,
Gardar Sigurdsson, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
077 - Personalised Antiplatelet Treatment Strategy and Outcomes Following
Primary PCI for Stemi (Pastor Study)
Jussi Mikkelsson, Tuomas Paana, Aino Lepantalo, Pasi Karjalainen, Satakunta
Central Hospital, PORI, Finland
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 11 of 64
Program PDF
Updated: 2-23-15
078 - Platelet Reactivity in Older Patients Undergoing Invasive Management
of Non-ST Elevation Acute Coronary Syndrome
Jonathan Adam Batty, Murugapathy Veerasamy, Hannah Sinclair,
Vijayalakshmi Kunadian, Institute of Cellular Medicine, Newcastle University,
Newcastle upon Tyne, United Kingdom, Freeman Hospital, Newcastle upon
Tyne, United Kingdom
079 - Real-world Incidence Rates of Bleeding in Asian patients on Prasugrel
and Ticagrelor
Doreen Tan, Khoo Teck Puat Hospital, Singapore, Singapore
080 - How Soon Can Off-Pump Coronary Artery Bypass Graft Surgery Be
Performed After Clopidogrel Discontinuation to Minimize Bleeding Risk?
Wei Liu, Yujie Zhou, An Zhen hospital Capital Medical University, Beijing,
People's Republic of China
081 - Intraoperative Bleeding Risk in Patients Undergoing Coronary Artery
Bypass Grafting with Prior Exposure to Clopidogrel
Jalaj Garg, Kevin Chen, Ramin Malekan, David Spielvogel, Hasan Ahmad,
Lehigh Valley Health Network, Allentown, PA, USA, Westchester Medical
Center, New York Medical College, Valhalla, NY, USA
082 - Predicting the Likelihood for Coronary Artery Bypass Grafting in Non St
Elevation Myocardial Infarction Patients
Ali Shafiq, Faraz Kureshi, Jae-Sik Jang, Timothy Fendler, Kensey Gosch, Philip
Jones, Richard Bach, David Cohen, John Spertus, St Luke's Mid America Heart
Institute and UMKC, Kansas City, MO, USA, Barnes-Jewish Hospital,
Washington University School of Medicine, St. Louis, MO, USA
083 - Platelet to Lymphocyte Ratio Is an Independent Risk Factor of Contrast
Induced Nephropathy in Patients with ST Elevation Myocardial Infarction
Undergoing Primary Percutaneous Coronary Intervention
Gaetano M. De Ferrari, Stefano Cornara, Alberto Somaschini, Raniero Covi,
Andrea Baldo, Rita Camporotondo, Gabriele Crimi, Marco Ferlini, Silvia Pica,
Maurizio Ferrario, Dept. of Cardiology Fondazione IRCCS Policlinico San
Matteo, Pavia, Italy, University of Pavia, Pavia, Italy
084 - Long-Term Outcomes of Thrombus Aspiration During Primary
Percutaneous Coronary Intervention
Ji-Young Yoon, Jeikeon Chae, Sookyeong Song, Lae Young Jung, YISIK KIM,
Sun Hwa Lee, Sang-Rok Lee, Kyoung-Suk Rhee, Wonho Kim, Jaeki Ko,
Chonbuk National University hospital, Jeonju, South Korea
085 - Simultaneous Double Coronary Thrombosis in ST Elevation Myocardial
Infarction: A Systematic Review of Literature
Ahmed Mahmoud, Marwan Saad, Islam Elgendy, University of Florida,
Gainesville, FL, USA, Trinitas Regional Medical Center-Seton Hall University,
NJ, USA
086 - Time to Discovery of Left Ventricular Thrombus After Anterior Wall ST
Elevation Myocardial Infarction with Reduced Ejection Fraction Treated with
Percutaneous Coronary Intervention and Dual Antiplatelet Therapy
Kipp Slicker, Ola Oyetayo, Wesley Lane, Dane Langsjoen, Ryan Mack, Lisa De
La Rosa, Chhaya Patel, Christopher Chiles, Baylor Scott & White Healthcare
Texas A&M Health Science Center, Temple, TX, USA
Monday, March 16, 2015
087 - Elevated Red Blood Cell Distribution Width was Associated with
Attenuated Endothelial Function in Patients with ST-Segment Elevation
Myocardial Infarction
Hiroyuki Suzuki, Yasushi Matsuzawa, Eiichi Akiyama, Masaaki Konishi, Naoki
Nakayama, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Satoshi Umemura,
Kazuo Kimura, Yokohama City University Medical Center, Yokohama, Japan
088 - High Red Blood Cell Distribution Width Is Associated with the Presence
of Acute Coronary Syndrome
Ryo Nishio, Satoru Kawasaki, Takeo Tanaka, Hiroyuki Kawamori, Toshimitsu
Ishii, Hozuka Akita, Hyogo Prefectural Kaibara Hospital, Hyogo, Japan
Acute Coronary Syndromes - Poster Contributions
Session #1245
Emerging Targets of Therapy for ACS
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
089 - A Specific Antidote for Ticagrelor
Sven Nylander, Susanne Pehrsson, Tord Inghardt, Thomas Antonsson, Peder
Svensson, Tove Sjögren, Linda Öster, Annika Janefeldt, Ann-Sofie Sandinge,
Phil Newton, Feenagh Keyes, Mark Austin, Andrew Buchanan, AstraZeneca
R&D, Mölndal, Sweden, MedImmune, Cambridge, United Kingdom
090 - Compound 21, a Selective AngiotensinII Type 2 Receptor Agonist,
Downregulates Lipopolysaccharide-stimulated Tissue Factor Expression in
Human Peripheral Blood Mononuclear Cells Activated by Exposure to High
Glucose
Cristina Balia, Valentina Scalise, Silvia Petrini, Tommaso Neri, Silvana
Cianchetti, Alessandro Celi, Roberto Pedrinelli, University of Pisa, Pisa, Italy
091 - Sequential Repeat Dosing of Allogeneic Cardiosphere-Derived Cells Is a
Viable Paradigm for Treating Myocardial Ischemic Injury in
Immunocompetent Rats
Heidi J. Reich, Eleni Tseliou, Geoffrey de Couto, Jackelyn Valle, Daniel
Luthringer, Baiming Sun, Linda Marban, Eduardo Marban, Cedars-Sinai Heart
Institute, Los Angeles, CA, USA
092 - The Sphingosine-1-Phosphate Receptor Agonist Fingolimod Reduces
Ischemia-Reperfusion Injury by Decreasing Cardiomyocyte Apoptosis
Mediated by activation of the RISK pathway
Carlos G. Santos-Gallego, Belen Picatoste, Ida U Njerve, Torsten Vahl,
Kiyotake Ishikawa, Roger Hajjar, Valentin Fuster, Juan Badimon, Icahn School
of Medicine at Mount Sinai, New York City, NY, USA
093 - Photoluminescent Mesoporous Silicon Nanoparticles with siRNA
Benefit Mesenchymal Stromal Cells Transplantation After Acute Myocardial
Infarction
Wenbin Lu, Zhuoying Xie, Ling Bai, Genshan Ma, Southeast University,
Nanjing, People's Republic of China
094 - RVX-208 the First Selective Bromodomain Extra-Terminal Protein
Inhibitor Being Developed for Patients with High Residual Risks of
Cardiovascular Disease
Norman Cw Wong, Jan Johansson, Kenneth Lebioda, Christopher Halliday,
Ewelina Kulikowski, Resverlogix Corporation, Calgary, Canada, Resverlogix
Corporation, San Francisco, CA, USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 12 of 64
Program PDF
Updated: 2-23-15
095 - Ticagrelor Potentiates Neutrophil Phagocytosis via Inhibition of
Adenosine Reuptake by Erythrocytes
Mark R. Thomas, Khalaf F. Alsharif, Lynne R. Prince, Victoria C. Ridger,
Heather M. Judge, David H. Dockrell, Ian Sabroe, Robert F. Storey, University
of Sheffield, Sheffield, United Kingdom
Monday, March 16, 2015
Bhupendar Tayal, Antonia Delgado Montero, Akiko Goda, Stephanie Holt,
Samir Saba, David Schwartzman, Peter Søgaard, John Gorcsan, University of
Pittsburgh Medical Center, Pittsburgh, PA, USA
096 - Rotigaptide and the Effects of Remote Ischemic Preconditioning
Rasha Salman, Jacob Johnsen, Michael R. Schmidt, Thomas R. Lassen, Rie
Hansen, Hans Erik Boetker, Department of Cardiology, Aarhus N, Denmark,
Institute of Clinical Medicine, Aarhus N, Denmark
234 - Transient Responder of Cardiac Resynchronization Therapy: Their
Proportion, Predictors and Prognosis
Takafumi Oka, Koichi Inoue, Koji Tanaka, Yuko Toyoshima, Takaaki Isshiki,
Takeshi Kimura, Masakiyo Nobuyoshi, Kenji Ando, Satoshi Shizuta, Takeshi
Arita, Satoki Fujii, Katsuomi Iwakura, Kenshi Fujii, Sakurabashi Watanabe
Hospital, Osaka, Japan, Osaka, Japan
097 - Interferon Regulatory Factor-1 Is Responsible for Cardiac Protective
Effect of 5-Azacytidine
Young Keun Ahn, Yong Sook Kim, Hye-yun Jeong, Mi Ra Kim, Hae Chang
Jeong, Myung Ho Jeong, Chonnam National University Hospital, Gwangju,
South Korea
235 - The Acute Response to Cardiac Resynchronization Therapy Is Not
Related to Left Ventricular Lead Position or Electrical Separation Time
Stian Ross, Erik Kongsgaard, Thor Edvardsen, Trine Haland, Rita Skaardal,
Gammelsrud Lars Ove, Trent Fischer, Richard Cornelussen, Hans Henrik
Odland, Oslo University Hospital, Departement of Cardiology, Oslo, Norway
098 - Gamma-Glutamyltransferase Stimulates Tissue Factor Expression
Independent of its Enzymatic Activity in Human Mononuclear Cells
Valentina Scalise, Cristina Balia, Silvana Cianchetti, Maria Franzini, Vittoria
Carnicelli, Silvia Petrini, Tommaso Neri, Riccardo Zucchi, Alessandro Celi,
Alessandro Corti, Roberto Pedrinelli, University of Pisa, Pisa, Italy, Scuola
Superiore Sant'Anna, Pisa, Italy
236 - The Acute Effects of Selective Site Right Ventricular Pacing on Left and
Right Ventricular Hemodynamic Function in a Normal Heart Population
Stuart Cheng-Yuen Tan, James Hampton-Till, Paul White, Richard Axell, David
Farwell, Stuart Harris, Essex Cardiothoracic Centre, Basildon, United
Kingdom, Postgraduate Medical Institute, Anglia Ruskin University,
Chelmsford, United Kingdom
099 - Microrna-34c Hampers Angiogenesis of Mesenchymal Stem Cells
Young Keun Ahn, Yong Sook Kim, Hea Jin Kang, Mi Ra Kim, Dong Im Cho,
Myung Ho Jeong, Chonnam National University Hospital, Gwangju, South
Korea
237 - Benefits of ICD Therapy: Connecting Treatment Decisions to
Individualized SCD Risk Estimates within MADIT-II Using the Seattle
Proportional Risk Model
Wayne C. Levy, Ilan Goldenberg, Arthur Moss, University of Washington,
Seattle, WA, USA, University of Rochester, Rochester, NY, USA
100 - Circulating Monocyte-Platelet Aggregates Are Higher in Acute Coronary
Syndrome
Nicole Allen, Liza Karotkin, Gabriel Lerner, Yu Guo, Jeffrey Berger, New York
University Medical Center, New York City, NY, USA
Arrhythmias and Clinical EP - Poster Contributions
Session #1253
Outcomes and Cardiac Device Therapy
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
231 - Echocardiographic Predictors of Long Term Outcomes in Patients
Undergoing Cardiac Resynchronization Therapy: What is the Optimal Metric?
John Rickard, Ryan Tedford, Mark Niebauer, Mohamed Bassiouny, David
Spragg, Bryan Baranowski, Bruce Wilkoff, Niraj Varma, Johns Hopkins,
Baltimore, MD, USA, Cleveland Clinic, Cleveland, OH, USA
232 - Impaired Baseline Global Circumferential Strain Is a Marker for
Ventricular Arrhythmias After Resynchronization Therapy in Patients with
Ischemic Cardiomyopathy
Antonia Delgado-Montero, Bhupendar Tayal, Akiko Goda, Stephanie Holt,
David Schwartzman, Samir Saba, John Gorcsan, University of Pittsburgh
Medical Center, Pittsburgh, PA, USA
233 - Incidence of Ventricular Arrhythmias after Cardiac Resynchronization
Defibrillator Therapy in Patients with Right Ventricular Pacing versus Intrinsic
QRS Widening
238 - Outcomes After Implantable Cardiac Defibrillator Placement in Patients
with End-Stage Renal Disease
Ashok Krishnaswami, Mary Lou Kiley, Faith Anthony, Yuexin Chen, Jason
Chen, Sumanth Rajagopal, Taylor Liu, Charlie Young, Elizabeth W. Paxton,
Kaiser Permanente- San Jose Medical Center, San Jose, CA, USA, Kaiser
Permanente Surgical Outcomes and Analysis, San Diego, CA, USA
239 - Comparative Effectiveness of Cardiac Resynchronization Therapy with
Defibrillator versus Defibrillator Alone in Heart Failure Patients with
Moderate to Severe Chronic Kidney Disease
Daniel Friedman, Jagmeet Singh, Jeptha Curtis, Wai Hong Tang, Haikun Bao,
Erica Spatz, Adrian Hernandez, Uptal Patel, Sana Al-Khatib, Duke University
Hospital, Durham, NC, USA
240 - Reassessment of Cardiac Function and Implantable CardioverterDefibrillator Use Among Medicare Patients with Low Ejection Fraction After
Myocardial Infarction
Sean Pokorney, Amy Leigh Miller, Anita Chen, Laine Thomas, Gregg Fonarow,
James de Lemos, Sana Al-Khatib, Eric Peterson, Tracy Wang, Duke Clinical
Research Institute, Durham, NC, USA
241 - Are There Differences in Implantable Cardioverter-Defibrillator
Counseling Rates Among Eligible Patients Hospitalized for Heart Failure?
National Results from the American Heart Association’s Get with the
Guidelines- Heart Failure Program
Paul L. Hess, Adrian F. Hernandez, Deepak L. Bhatt, Anne S. Hellkamp, Clyde
W. Yancy, Lee H. Schwamm, Eric D. Peterson, Philip J. Schulte, Gregg C.
Fonarow, Sana M. Al-Khatib, Duke Clinical Research Institute, Durham, NC,
USA, Durham, NC, USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 13 of 64
Program PDF
Updated: 2-23-15
242 - Temporal Trends and Clinical Correlates of ICD Implantation Amongst
Patients Actively Listed for Heart Transplantation
Kairav Vakil, Kashan S. Abidi, M Chadi Alraies, Sue Duval, Monica ColvinAdams, Ziad Taimeh, Selcuk Adabag, University of Minnesota, Minneapolis,
MN, USA, Veterans Affairs Medical Center, Minneapolis, MN, USA
243 - The Post-Implantation Electrocardiogram Predicts Clinical Response to
Cardiac Resynchronization Therapy
Edward Coverstone, Justin Sheehy, Robert Kleiger, Timothy Smith,
Washington University, Saint Louis, MO, USA
244 - Association of Air Pollution with Increased Incidence of Ventricular
Tachyarrhythmias Recorded by Implantable Cardioverter Defibrillators
In-Soo Kim, Jungwoo Sohn, Seung-joon Lee, Jin-Kyu Park, Jae-Sun Uhm, HuiNam Pak, Moon-Hyoung Lee, Chang-Soo Kim, Boyoung Joung, Yonsei
University College of Medicine, Seoul, South Korea
245 - Healthcare Resource Utilization and Impact on Cost with Use of Remote
Monitoring Strategy Compared to Conventional Follow-up for Implantable
Cardioverter Defibrillators: A Meta-Analysis of Randomized Controlled Trials
Saurabh Aggarwal, Navdeep Gupta, Rohit Loomba, Anushree Agarwal, Imtiaz
Ismail, Nawfal Al-Khafaji, Venkata Alla, Hussam Abuissa, Rohit Arora, Aryan
Mooss, Creighton University School of Medicine, Omaha, NE, USA, Medical
College of Wisconsin, Milwaukee, WI, USA
246 - Variations in Use of Remote Monitoring of Implantable Defibrillators
Relative to the Introduction of Billing Codes Specific to Remote Monitoring
Faseeha Altaf, Joseph Akar, Judith Lichtman, Haikun Bao, Paul Jones, Paul
Varosy, Frederick Masoudi, Kenneth Stein, Leslie Saxon, Jeptha Curtis, Yale
University School of Medicine, New Haven, CT, USA, Boston Scientific
Corporation, St. Paul, MN, USA
247 - Left Ventricular Regional Time Correlation by Echocardiographic Strain
Analysis Is Predictive of Survival Free from Arrhythmias in Non-Left Bundle
Branch Patients After Cardiac Resynchronization Therapy
Stephanie C. Holt, Bhupendar Tayal, Antonia Delgado-Montero, Sanjeev
Shroff, David Schwartzman, Samir Saba, John Gorcsan, Heart and Vascular
Institute at the University of Pittsburgh, Pittsburgh, PA, USA
248 - Comparison of Upgraded versus De-Novo Cardiac Resynchronisation
Therapy (CRT) Devices on Cardiovascular Outcomes and Response: A 5 Year
Registry
Christopher James McAloon, Domonic P. Heining, Jethro J. Barker, Benjamin
Anderson, Gavin Atherton, Faizel Osman, University Hospital Coventry and
Warwickshire NHS Trust, Coventry, United Kingdom, Warwick Medical
School, University of Warwick, Coventry, Coventry, United Kingdom
Arrhythmias and Clinical EP - Poster Contributions
Session #1254
Risks for Atrial Fibrillation: Where Do We Look?
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
249 - Racial/Ethnic Differences in Atrial Fibrillation Symptoms, Treatment
Patterns, and Outcomes: Insights from Outcomes Registry for Better
Informed Treatment for Atrial Fibrillation (ORBIT-AF) Registry
Monday, March 16, 2015
Harsh Golwala, Larry Jackson, DaJuanicia Simon, Gregg Fonarow, Paul Chang,
Bernard Gersh, Alan Go, Elaine Hylek, Peter Kowey, Kenneth Mahaffey, Laine
Thomas, Eric Peterson, Jonathan Piccini, Kevin Thomas, University of
Louisville School of Medicine, Louisville, KY, USA, Duke Clinical Research
Institute, Durham, NC, USA
250 - Utilization and Predictors of Electrical Cardioversion for Atrial
Fibrillation
Yogita M. Rochlani, Nishi Shah, Naga Venkata Pothineni, Hakan Paydak,
University of Arkansas for Medical Sciences, Little Rock, AR, USA
251 - The Minimum Left Atrium Volume Is a Superior Predictor of Future
Atrial Fibrillation in a Low Risk General Population: The Copenhagen City
Heart Study
Tor Biering-Sørensen, Rasmus Mogelvang, Peter Schnohr, Jan Jensen,
Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
252 - Atrial Fibrillation, Prevalence and Risk for Mortality in Very Old Men
and Women
Bodil Lernfelt, Gustaf Lernfelt, Per O. Hansson, Department of Internal
Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
253 - Circulating Intermediate CD14++CD16+ Monocytes Are Increased in
Patients with Atrial Fibrillation and Reflect Functional Remodeling of Left
Atrium
Atsushi Suzuki, Koji Fukuzawa, Tomoya Yamashita, Akihiro Yoshida, Naoto
Sasaki, Takuo Emoto, Asumi Takei, Ryudo Fujiwara, Tomoyuki Nakanishi,
Soichiro Yamashita, Akinori Matsumoto, Hiroki Konishi, Hirotoshi Ichibori,
Nobutaka Inoue, Ken-ichi Hirata, Kobe University Graduate School of
Medicine, Kobe, Japan, Kobe Rosai Hospital, Kobe, Japan
254 - Community Screening for Atrial Fibrillation in a Chinese Population
Using a Smartphone-Based Wireless Single-Lead ECG
Ngai-Yin Chan, Chi-Chung Choy, Princess Margaret Hospital, Kowloon, Hong
Kong
255 - Novel Association of Polymorphic Genetic Variants with Predictors of
Outcome of Catheter Ablation in Atrial Fibrillation: New Directions from a
Prospective Study (DECAF)
Sanghamitra Mohanty, Amelia W. Hall, Prasant Mohanty, Sameer Prakash,
Chintan Trivedi, Luigi Di Biase, Pasquale Santangeli, Carola Gianni, Rong Bai,
John Burkhardt, Joe Gallinghouse, Rodney Horton, Javier Sanchez, Patrick
Hranitzky, Amin Al-Ahmad, Viswanath R. Iyer, Andrea Natale, Texas Cardiac
Arrhythmia Institute, Austin, TX, USA, UT at Austin, Austin, TX, USA
256 - Are There Gender-Related Differences in Management, and Outcome
of Patients with Atrial Fibrillation? A Prospective National Study
Yoav Arnson, Moti Haim, Meir Medical Center, Cardiology Department, Kfar
Sava, Israel, Clalit Health Services Research Institute, Tel Aviv, Israel
257 - Addition of Atrial Ectopy and NT-proBNP to Framingham Atrial
Fibrillation Risk Algorithm Improves Risk Prediction
Preman Kumarathurai, Mette R. Mouridsen, Nick Mattsson, Bjorn Larsen,
Olav Nielsen, Thomas Gerds, Ahmad Sajadieh, Copenhagen University
Hosptial of Bispebjerg, Copenhagen, Denmark
258 - Socioeconomic Status and Predictors of Survival in Patients Admitted
with Atrial Fibrillation
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 14 of 64
Program PDF
Updated: 2-23-15
Faraj Kargoli, Eric Shulman, Philip Aagaard, Ethan Hoch, Luigi Di Biase, Kevin
Ferrick, Andrew Krumerman, Montefiore Medical Center/Albert Einstein
College of Medicine, Bronx, NY, USA
259 - Age and Gender Differences in Atrial Fibrosis in Patients with Atrial
Fibrillation
Nazem Akoum, Christian Mahnkopf, Gagandeep Kaur, Eugene Kholmovski,
Nassir Marrouche, Comprehensive Arrhythmia Research and Management
(CARMA) Center-University of Utah, Salt Lake City, UT, USA
260 - Cumulative and Individual Effects of Single Nucleotide Polymorphisms
for Atrial Fibrillation by Meta-Analysis of Genome-Wide Association Studies
in Patients with Heart Failure
Akira Fujii, Akiyoshi Ogimoto, Takayuki Nagai, Hiroshi Kawakami, Jun Suzuki,
Katsuji Inoue, Kazuhisa Nishimura, Teruyoshi Uetani, Jun-ichi Funada,
Yasuharu Tabara, Takafumi Okura, Jitsuo Higaki, Ehime University Graduate
School of Medicine, Toon, Japan
261 - Efficacy and Safety Outcomes of Various Rate Control Strategies for
Patients with Acute Decompensated Heart Failure with Reduced Ejection
Fraction and Atrial Fibrillation or Flutter with Rapid Ventricular Response
Siva Krothapalli, Lee Joseph, Omer Iqbal, Olurotimi Mesubi, Hardik Doshi,
Nicole Worden, Jayasheel Eshcol, Musab Alqasrawi, Prashant Bhave, Michael
Giudici, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
262 - Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the
United States
Mintu Turakhia, Jason Shafrin, Katalin Bognar, Jeffrey Trocio, Younos
Abdulsattar, Daniel Wiederkehr, Dana Goldman, Stanford University,
Stanford, CA, USA, Precision Health Economics, Los Angeles, CA, USA
263 - Prevalence and Outcomes of Recurrent Hospital Admissions in Patients
with Atrial Fibrillation: Insights from the Gulf Survey of Atrial Fibrillation
Events (Gulf SAFE) Registry
Nidal Asaad, Mohammad Zubaid, Mohammed Mohsen, Jassim Al-suwaidi,
Rajvir Singh, Jassim Zaheen, Alawi Alsheikh-Ali, Wael Almahmeed, Wafa
Rashed, Haitham Amin, Ahmed Al Qudaimi, Christian Bollensdorff, Magdi
Yacoub, Hamad Medical Corporation, Doha, Qatar
264 - The Impact of Atrial Fibrillation on Endothelial Dysfunction
Gerasimos Siasos, Savvas Mazaris, Konstantinos Zisimos, Evangelos
Oikonomou, Eleni Kokkou, Theodosia Konsola, Konstantinos Mourouzis,
Manolis Vavuranakis, Theodoros Zografos, Marina Zaromitidou, George
Lazaros, Christine Chrysohoou, Athanasios Papavassiliou, Christodoulos I
Stefanadis, Dimitris Tousoulis, University of Athens Medical School, 1st
Cardiology Department, “Hippokration” Hospital, Athens, Greece
265 - The Role of Systemic Inflammation in Paroxysmal and Chronic Atrial
Fibrillation
Gerasimos Siasos, Savvas Mazaris, Konstantinos Zisimos, Evangelos
Oikonomou, Eleni Kokkou, Theodosia Konsola, Konstantinos Mourouzis,
Manolis Vavuranakis, Theodoros Zografos, Marina Zaromitidou, George
Lazaros, Christine Chrysohoou, Athanasios Papavassiliou, Christodoulos I
Stefanadis, Dimitris Tousoulis, University of Athens Medical School, 1st
Cardiology Department, “Hippokration” Hospital, Athens, Greece
Monday, March 16, 2015
Konstantinos Siontis, Bernard Gersh, Pamela McCabe, Veronique Roger,
Alanna M. Chamberlain, Mayo Clinic, Rochester, MN, USA
267 - Trends in Atrial Fibrillation Hospitalization in Young Patients
Abhishek Deshmukh, Achint Patel, Shantanu Solanki, Samir Patel,
Nileshkumar Patel, Badal Thakkar, Nilay Patel, Shilpkumar Arora, Nikhil
Nalluri, Peter Noseworthy, Suraj Kapa, Chance Witt, Sadip Pant, Apurva
Badheka, Paul Friedman, Samuel Asirvatham, Mayo Clinic, Rochester, MN,
USA, Rochester, MN
268 - The Incidence of Atrial Fibrillation Post Atrial Flutter Amongst Different
Races
Matthew Pierce, Evan Klein, Chethan Gangireddy, Jeffrey Arkles, Temple
University Hospital, Philadelphia, PA, USA, Temple University School of
Medicine, Philadelphia, PA, USA
Congenital Heart Disease - Poster Contributions
Session #1255
The Right Heart in Congenital Heart Disease
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
317 - Three-Dimensional Evaluation of Regional Right Ventricular Curvature
in Repaired Tetralogy of Fallot
Waseem Cossor, Francesco Maffessanti, Karima Addetia, Victor Mor-Avi,
Keigo Kawaji, David Roberson, Karin Dill, Peter Varga, Roberto Lang, Amit
Patel, University of Chicago, Chicago, IL, USA, Advocate Children's Hospital,
Oak Lawn, IL, USA
319 - Wide Complex Tachycardia in a Patient with Epstein’s Anomaly and an
Underlying Epsilon Wave
Shane Paul Prejean, Charles Smith, Louisiana State University Internal
Medicine Residency, Baton Rouge, LA, USA, Louisiana Cardiology Associates,
Baton Rouge, LA, USA
320 - Poor Right Ventricular Exercise Reserve Predicts Heart Failure and
Arrhythmia in Adults with Congenital Right Heart Disease
Ada Stefanescu, Ami Bhatt, John Serfas, Sara Tabtabai, Joshua Ruff, Doreen
Yeh, Massachusetts General Hospital, Boston, MA, USA
321 - New Treatment Opportunities in Pulmonary Hypertension and
Congenital Heart Disease
Ilja Mark Blok, Annelieke van Riel, Mark J. Schuuring, Arie Van Dijk, Barbara
Mulder, Berto Bouma, Academical Medical Center, Amsterdam, The
Netherlands, University Medical Center Nijmegen, Nijmegen, The
Netherlands
322 - Regional Right Ventricular Ejection Fraction and Cardiac Output in
Repaired Tetralogy of Fallot
Waseem J. Cossor, Francesco Maffessanti, Karima Addetia, Victor Mor-Avi,
Keigo Kawaji, David Roberson, Karin Dill, Roberto Lang, Amit Patel, University
of Chicago, Chicago, IL, USA, Advocate Children's Hospital, Oak Lawn, IL, USA
266 - Characteristics and Prognostic Implications of Clinical Presentations of
New-Onset Atrial Fibrillation
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 15 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Congenital Heart Disease - Poster Contributions
Session #1256
Pediatric Congenital Heart Disease: Interventional
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
Heart Failure and Cardiomyopathies - Poster Contributions
Session #1250
Energy Metabolism in Heart Failure
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
323 - Elective Balloon Pulmonary Valvuloplasty in the Newborn with
Tetralogy of Fallot
Mohamed Leye, Nagib Dahdah, Joaquim Miro, CHU Sainte Justine, Montréal,
Canada
177 - Adiponectin Rescues Lipotoxic Cardiomyopathy by Promoting
Sphingosine-1-Phosphate and Ceramidase Expression
Geoffrey Weiting Cho, Yukiko Miyauchi, Joshua Johnson, William L. Holland,
Joseph Hill, UT Southwestern Medical Center, Dallas, TX, USA
324 - Contemporary Transcatheter Patent Ductus Arteriosus Closure: Results
of the Largest Retrospective Study to Date
Manish Bansal, Candice Li, Charles Mullins, Henri Justino, Texas Children's
Hospital/Baylor College of Medicine, Houston, TX, USA
178 - Myostatin Inhibition Improves Cardiac Glucose Metabolism in a Murine
Model of Obesity
Estibaliz Castillero, Hirokazu Akashi, Ruiping Ji, Catherine Wang, Ziad Ali, H
Lee Sweeney, P. Christian Schulze, Isaac George, College of Physicians and
Surgeons of Columbia University, New York, NY, USA, University of
Pennsylvania School of Medicine, Philadelphia, PA, USA
325 - Percutaneous Pulmonary Valve Implantation: a Systematic Review of
Safety Outcomes
Rhanderson Cardoso, Mohammad Ansari, Daniel Garcia, Carlos Alfonso,
Eduardo De Marchena, University of Miami, Miami, FL, USA
326 - Impact of Persistent Right to Left Shunt in Device-Occluded Atrial Septal
Defects
Michael Zdradzinski, Abraham Abernethy, Kathryn Stackhouse, Rachel Elkin,
Mohamed Halane, Wael ElMallah, Richard Krasuski, The Cleveland Clinic,
Cleveland, OH, USA
327 - Complications from Ultrasound Guided Femoral Arterial Access in
Pediatric Cardiac Catheterization: A Prospective Single Center Cohort Study
John Alexander, Benjamin Waller, Thomas Yohannan, Agrawal Vijaykumar,
Hannah Lloyd, Marsha Stewert-Sellers, Shyam Sathanandam, University of
Tennessee, Memphis, TN, USA, Le Bonheur Children's Hospital, Memphis, TN,
USA
328 - Impact of Pulmonary Hypertension on Right Heart Remodeling
Following Device Closure of Atrial Septal Defects
Michael John Zdradzinski, Abraham Abernethy, Rachel Elkin, Kathryn
Stackhouse, Mohammed Halane, Wael ElMallah, Richard Krasuski, The
Cleveland Clinic, Cleveland, OH, USA
329 - Patient-Specific Simulation of Right Ventricle Outflow Tract Conduit
Balloon Angioplasty Using Cardiac MRI-Derived 3D Virtual Models to Assess
the Risk of Coronary Artery Compression During Transcatheter Pulmonary
Valve Replacement
Puneet Bhatla, Sujata Chakravarti, Achiau Ludomirsky, Michael Argilla, Phillip
Berman, Doff McElhinney, Vittoria Flamini, New York University Medical
Center, NY, NY, USA
330 - Candidacy for Device Closure of Complex Muscular Ventricular Septal
Defects: Novel Application of Rapid Prototyping and Virtual 3D Models
Derived from Cardiac CT and MRI
Puneet Bhatla, Sujata Chakravarti, Shi-Joon Yoo, Omar Thabit, Doff
McElhinney, Achiau Ludomirsky, New York University Medical Center, New
York, NY, USA
179 - Foxo3a Modulates Cardiac Remodeling via Inhibition of Myofibroblast
Differentiation in Acute Myocardial Infarction
Luise Holzhauser, Alexander Jenke, Konstantinos Savvatis, Mathias Grueger,
Robert Schur, Dirk Westermann, Diana Lindner, Wolfgang Poller, Heinz-Peter
Schultheiss, Carsten Skurk, Charite Berlin, Campus Benjamin Franklin,
Department of Cardiology and Pulmonology, Berlin, Germany, Albert Einstein
College of Medicine, Jacobi Medical Center, Department of Medicine, Bronx,
NY, USA
180 - Dysfunctional Iron Homeostasis in Mitochondria from Left Ventricular
Myocardium of Dogs with Advanced Heart Failure
Vinita Singh-Gupta, Ramesh Gupta, Hani N. Sabbah, Henry Ford Hospital,
Detroit, MI, USA
181 - Mitochondrial Function Is Abnormal in Circulating Blood Monocytes of
Dogs with Advanced Heart Failure
Hani N. Sabbah, Vinita Singh-Gupta, Ramesh Gupta, Henry Ford Hospital,
Detroit, MI, USA
Heart Failure and Cardiomyopathies - Poster Contributions
Session #1251
The Hospitalized Heart Failure Patient
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
183 - Tailoring Therapy in Acute Heart Failure: Can Biomarkers Distinguish
Responders from Non-Responders?
Licette Liu, Mattia A.E. Valente, Douwe Postmus, Christopher O'Connor,
Marco Metra, Piotr Ponikowski, John Teerlink, Gad Cotter, Beth Davison,
John Cleland, Michael Givertz, Daniel Bloomfield, Dirk van Veldhuisen, Hans
Hillege, Peter van der Meer, Adriaan Voors, University Medical Center
Groningen, Groningen, The Netherlands
184 - Temporal Trends in Cardiac Rehabilitation Referral Among Patients
Hospitalized with Heart Failure: Analysis from American Heart Association
Get With The Guidelines-Heart Failure Registry
Harsh Golwala, Ambarish Pandey, Christine Ju, Javed Butler, Clyde Yancy,
Deepak Bhatt, Adrian Hernandez, Gregg Fonarow, University of Louisville
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 16 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
School of Medicine, Louisville, KY, USA, Duke Clinical Research Institute,
Durham, NC, USA
Adrian M. Kielhorn, Harshali Patel, Juan Maya, Rui Song, Henry Henk, Amgen
Inc, Thousand Oaks, CA, USA
185 - Improved Case Mix Index due to Embedding Clinical Documentation
Improvement Specialists on an Inpatient Cardiology Service at a Tertiary
Medical Center
James C. Blankenship, William A. Vandermark, John Pfeifer, Susan M. Krex,
TyAnn A. Schneider, Peter Berger, Geisinger Medical Center, Danville, PA,
USA
194 - Anti-Hyperglycemic Medication Use Among Medicare Beneficiaries with
Heart Failure, Diabetes, and Chronic Kidney Disease
Priyesh Ashok Patel, Li Liang, Prateeti Khazanie, Bradley Hammill, Gregg
Fonarow, Paul Heidenreich, Clyde Yancy, Deepak Bhatt, Lesley Curtis, Adrian
Hernandez, Duke Clinical Research Institute, Durham, NC, USA, Duke
University Medical Center, Durham, NC, USA
186 - In-Hospital Use of Potentially Harmful Drugs in Heart Failure: Impact on
Length of Stay and Mortality
Paulino Alvarez, David Putney, Kevin Donahue, Ajit Appari, Craig Pratt, Jerry
Estep, Houston Methodist Hospital, Houston, TX, USA
Heart Failure and Cardiomyopathies - Poster Contributions
Session #1252
Moving Towards Better Management of Heart Failure
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
187 - Adherence, Hospitalizations and Treatment Modifications Among Heart
Failure Patients: A Retrospective US Claims Database Analysis
Celine Deschaseaux, Martin McSharry, Eibhlin Hudson, Stuart Turner,
Novartis Pharma AG, Basel, Switzerland
188 - In Patients with Severe Advanced Heart Failure, Non Response to
Decrease LV Filling Pressure Is Not Associated with Worse Survival and
Outcomes: Insights from the ESCAPE (Evaluation Study of Congestive Heart
Failure and Pulmonary Artery Catheterization Effectiveness) Trial
Francisco Y. Macedo, Wenyaw Chan, Anita Deswal, Kumudha Ramasubbu,
Andrew Civitello, Biykem Bozkurt, Baylor College of Medicine and Michael
DeBakey VA Medical Center, Houston, TX, USA, Texas Heart Institute,
Houston, TX, USA
189 - High Risk Heart Failure Patient Multidisciplinary Care Pathway:
Improving Care and Outcomes
Kismet Rasmusson, Jose Benuzillo, Deborah Budge, Benjamin Horne, Colleen
Roberts, Jennifer Nixon, Norma Geer, Lynette Penrod, Jason Buckway,
Donald Lappe, Intermountain Healthcare, Salt Lake City, UT, USA
190 - Diuretic Response in Acute Heart Failure: An Analysis from ASCEND-HF
Jozine Ter Maaten, Allison Dunning, Mattia A.E. Valente, Kevin Damman,
Justin Ezekowitz, Robert Califf, Randall Starling, Christopher O'Connor, Phillip
Schulte, Jeffrey Testani, Adrian Hernandez, Wai Hong Tang, Adriaan Voors,
Department of Cardiology, University of Groningen, University Medical
Center Groningen, Groningen, The Netherlands, Duke Clinical Research
Institute, Durham, NC, USA
191 - Gender Differences in Risk Profiles and Management of Patients with
Heart Failure Rehospitalizations: Observations from the Gulf CARE Study
Amar Salam, Kadhim Sulaiman, Jassim Al Suwaidi, Nidal Asaad, Khalid
AlHabib, Wael Almahmeed, Alawi Alsheikh-Ali, Ahmed AL-Motarreb,
Prashanth Panduranga, Hussam AlFaleh, Abdulfatah Elasfar, Nooshin
Bazargani, Mohammad Al Jarallah, Haitham Amin, Mustafa Ridha, Awad
Alqahtani, Rajvir Singh, Robert Bonow, Magdi Yacoub, Hamad Medical
Corporation, Doha, Qatar
192 - Current Heart Failure Management Patterns in Medicare Advantage
Patients: A Contemporary United States Claims Database Analysis
Harshali Patel, Adrian Kielhorn, Juan Maya, Rui Song, Henry Henk, Amgen Inc,
Thousand Oaks, CA, USA
195 - The Nutritional Index ‘CONUT’ Is Useful for Predicting Prognosis of
Acute Decompensated Heart Failure
Kenji Harada, Hiroyuki Fujinaga, Takanobu Okumura, Tokushima Prefectural
Central Hospital, Tokushima, Japan
196 - Precipitating Factors for Hospitalization with Heart Failure and Clinical
Outcomes: Results from the Gulf CARE Study
Amar Salam, Kadhim Sulaiman, Jassim Al Suwaidi, Nidal Asaad, Khalid
AlHabib, Wael Almahmeed, Alawi Alsheikh-Ali, Ahmed AL-Motarreb, Haitham
Amin, Nooshin Bazargani, Prashanth Panduranga, Hussam AlFaleh,
Abdulfatah Elasfar, Mohammad Al Jarallah, Mustafa Ridha, Awad Alqahtani,
Rajvir Singh, Robert Bonow, Magdi Yacoub, Hamad Medical Corporation,
Doha, Qatar
197 - Resource Use One Year Following Hospitalization for Acute Heart
Failure: A Comparison of Patients with Preserved versus Reduced Ejection
Fraction
Gregory A. Nichols, Kristi Reynolds, Teresa M. Kimes, Wing Chan, Kaiser
Permanente Center for Health Research, Portland, OR, USA
198 - Echocardiographic Assessment of Right Ventricular Function in a
Routine Practice: Which Parameters Are Useful to Predict One-Year Outcome
in Advanced Heart Failure Patients With Dilated Cardiomyopathy?
Takayuki Kawata, Masao Daimon, Koichi Kimura, Tomoko Nakao, Seitetsu
Lee, Megumi Hirokawa, Masafumi Watanabe, Yutaka Yatomi, Issei Komuro,
University of Tokyo, Tokyo, Japan
199 - Absolute Discharge Level or Relative Reduction in NT-proBNP During
Hospitalisation for Acute Decompensated Heart Failure as a Target to Reduce
6-Month Mortality?
Susan Stienen, Khibar Salah, Luc Eurlings, Paulo Bettencourt, Marco Metra,
Antoni Bayes-Genis, Luca Bettari, Jan Tijssen, Yigal Pinto, Wouter Kok,
Academic Medical Center, Amsterdam, The Netherlands
200 - Which Patients? Which Devices? mHealth Monitoring with Wearable
and Implantable Devices in Heart Failure: Meta Analyses of Randomized
Trials
Sanjeev Bhavnani, Jill Waalen, Ajay Srivastava, J. Thomas Heywood, Scripps
Translational Science Institute, La Jolla, CA, USA, Scripps Clinic, La Jolla, CA,
USA
193 - Heart Failure Management Patterns in a Large United States
Commercial Claims Database
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 17 of 64
Program PDF
Updated: 2-23-15
201 - The Certainty of Uncertainty: Heart Failure Risk Models Can Rarely
Identify Patients Who Will Die in the Next Year
Larry A. Allen, Dan Matlock, Susan Shetterly, Xu Stanley, Wayne Levy, Jerry
Gurwitz, David Smith, David Magid, University of Colorado Anschutz Medical
Campus, Aurora, CO, USA, Kaiser Permanente Institute for Health Research,
Denver, CO, USA
202 - Preventable Precipitating Factors of Hospitalizations with Heart Failure
and Prolonged Hospital Length of Stay: Observations from the Gulf CARE
Study
Amar Salam, Kadhim Sulaiman, Jassim Al Suwaidi, Nidal Asaad, Khalid
AlHabib, Wael Almahmeed, Alawi Alsheikh-Ali, Haitham Amin, Ahmed ALMotarreb, Prashanth Panduranga, Hussam AlFaleh, Abdulfatah Elasfar,
Nooshin Bazargani, Mohammad Al Jarallah, Mustafa Ridha, Awad Alqahtani,
Rajvir Singh, Robert Bonow, Magdi Yacoub, Hamad Medical Corporation,
Doha, Qatar
203 - Living Alone or Living Only with an Elderly Spouse Is an Independent
Predictor of Hospital Readmission in Elderly Patients with Decompensated
Heart Failure
Eisaku Nakane, Nozomi Tanaka, Yuki Kimura, Takayuki Sekihara, Hideyuki
Hayashi, Mitsumasa Okano, Kanae Su, Masahiro Kimura, Moritoshi Funasako,
Takao Kato, Shoichi Miyamoto, Toshiaki Izumi, Tetsuya Haruna, Moriaki
Inoko, Kitano Hospital, Osaka, Japan
204 - Response to Exercise Training and Outcomes in Heart Failure Patients
with Diabetes Mellitus: Insights from HF-ACTION
Adam Z. Banks, Robert Mentz, Amanda Stebbins, Catherine Mikus, Phillip
Schulte, Jerome Fleg, Lawton Cooper, Steven Keteyian, Ileana Pina, Dalane
Kitzman, Mona Fiuzat, David Whellan, William Kraus, Christopher O'Connor,
Duke University, Durham, NC, USA, Duke Clinical Research Institute, Durham,
NC, USA
205 - Sex Differences in Cardiac Stiffness: The Importance of Accounting for
Fitness
Satyam Sarma, Erin Howden, William Cornwell, Mildred Opondo, Kara Boyd,
Mitchel Samels, Sheryl Livingston, Dean Palmer, Benjamin Levine, Institute
for Exercise and Environmental Medicine, Dallas, TX, USA, University of Texas
Southwestern Medical Center, Dallas, TX, USA
206 - Risk of Overt Heart Failure in Stage A and B Heart Failure: Association
with Symptoms, Physiology and Expected Outcome
Hong Yang, Kazuaki Negishi, Mark Nolan, Ying Wang, Makoto Saito, Leah
Wright, Thomas Marwick, Menzies Research Institute Tasmania, Hobart,
Australia
207 - Population Attributable Risk for 30-Day Readmission Following Heart
Failure Hospitalization from a Large Multi-State Healthcare Cost and
Utilization Project State Inpatient Database
Jonathan D. Davis, Margaret A. Olsen, Kerry Bommarito, Justin M. Vader,
Shane LaRue, Washington University School of Medicine, Saint Louis, MO,
USA, Barnes Jewish Hospital, Saint Louis, MO, USA
208 - Prognostic Value of Hemoconcentration in Acute Decompensated Heart
Failure with Preserved and Reduced Ejection Fraction: Data from the Korean
Heart Failure (KorHF) Registry
Jaewon Oh, Seok-Min Kang, Namki Hong, Jong-Chan Youn, Sungha Park,
Sang-Hak Lee, Donghoon Choi, Severance Cardiovascular Hospital Yonsei
University College of Medicine, Seoul, South Korea
Monday, March 16, 2015
209 - Additional Prognostic Impact of Post-Admission Respiratory Condition
and Resting Heart Rate on 30-Day Mortality in Acute Decompensated Heart
Failure
Takeshi Yagyu, Toyonaka Municipal Hospital, Osaka, Japan
210 - The Prognostic Significance of Electrocardiographic Parameters for New
Onset Heart Failure in the General Population
Niek Verweij, Frank P. Brouwers, Rudolf A. De Boer, Hans J. Hillege, Dirk J.
van Veldhuisen, Wiek H. van Gilst, Pim van der Harst, Department of
Cardiology, University Medical Center Groningen, University of Groningen,
Groningen, The Netherlands
211 - Heart Failure Patients Evaluated in the Emergency Department:
Personalization of Care Using the Intermountain HF Readmission Risk Score
Deborah Budge, Jose Benuzillo, Kismet Rasmusson, Jennifer Nixon, Benjamin
Horne, Michael M. Woodruff, Robert J. Bunnell, Donald Lappe,
Intermountain Healthcare, Salt Lake City, UT, USA
212 - Prevalence and Predictors of Sleep-Disordered Breathing in Patients
with Stable Chronic Heart Failure: Final Data of the SchlaHF Registry
Holger Woehrle, Michael Arzt, Olaf Oldenburg, Andrea Graml, Anna Drabik,
Helmut Teschler, Erland Erdmann, Karl Wegscheider, Sleep and Ventilation
Center Blaubeuren, Lung Center Ulm, Ulm, Germany, ResMed Science
Center, Martinsried, Germany
213 - Is Mode Presentation Affecting the Mortality of Patients Presenting
with Acute Heart Failure?
Ahmad Shoaib, Joseph John, Kenneth Wong, John Cleland, Andrew Clark,
Academic Cardiology University of Hull, Hull, United Kingdom
214 - Prolonged Lung to Finger Oxygen Circulation Time Predicts Low Cardiac
Output State
Jeremy Van't Hof, Younghoon Kwon, Cho Yoonsik, Dean Krueger, Conrad
Iber, Gladwin Das, University of Minnesota, Minneapolis, MN, USA,
University of Southern California, Los Angeles, CA, USA
215 - Hepatic Dysfunction in Patients with Heart Failure Undergoing Cardiac
Surgery- Application of the MELD Scoring System for Outcome Prediction
Kishio Kuroda, Tomoko Kato, Kenji Kuwaki, Atsushi Amano, Mai Murata,
Juntendo University, Tokyo, Japan
216 - Single-Beat Pressure-Volume Parameters Predict Heart Failure Events In
a Catheterization Referral Population
Aarthi Sabanayagam, Rupinder Kaur, Victoria Gutgarts, Faraj Kargoli, Ayesha
Salahuddin, Daniel Spevack, Montefiore Medical Center for Heart and
Vascular Care, The Albert Einstein College of Medicine, New York, NY, USA
217 - Nutritional Assessment by Prognostic Nutritional Index Provides the
Additional Long-Term Prognostic Information to Body Mass Index in Patients
Admitted with Acute Decompensated Heart Failure
Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Shunsuke Tamaki,
Yusuke Iwasaki, Masato Kawasaki, Atsushi Kikuchi, Takumi Kondo, Tsutomu
Kawai, Satoshi Takahashi, Masashi Ishimi, Hideyuki Hakui, Tatsuhisa Ozaki,
Yoshihiro Satoh, Masahiro Seo, Masatake Fukunami, Osaka General Medical
Center, Osaka, Japan
218 - Temporal Trends in Acute Decompensated Heart Failure
Hospitalizations in the U.S., 1998-2011
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 18 of 64
Program PDF
Updated: 2-23-15
Sunil K. Agarwal, Lisa Wruck, Pedro M. Quibrera, Kunihiro Matsushita, Laura
Loehr, Patricia Chang, Wayne Rosamond, Jacqueline Wright, Gerardo Heiss,
Josef Coresh, Johns Hopkins University, Baltimore, MD, USA
219 - Healthcare Costs and Resource Utilization in Heart Failure: Differences
Based on Heart Failure History
Jason Swindle, Stuart J. Turner, Engels N. Obi, Cori Blauer-Peterson, Lynn A.
Wacha, Aylin Altan, Optum, Eden Prairie, MN, USA, Novartis Pharmaceuticals
Corporation, East Hanover, NJ, USA
220 - Prognostic Value of Peak Oxygen Consumption In Chronic Heart Failure
Patients Failing to Achieve Respiratory Exchange Ratio > 1,0
Ilya Giverts, Maria Poltavskaya, Oxana Dikur, Artem Doletsky, Denis Andreev,
Ekaterina Yakubovskaya, Abram Syrkin, First Moscow State Medical
University, Moscow, Russian Federation
Monday, March 16, 2015
228 - Independent Factors Associated with Emergency Department
Utilization in Non-Elderly Patients with Heart Failure
Heather A. Jaynes, James Tisdale, Alan Zillich, Purdue University, West
Lafayette, IN, USA
229 - Revisiting Intravenous Inotropes: Are They as Bad as We Thought in
REMATCH
Ahmed Harhash, Marshall Rovner, Audrey Kleet, Jacqueline Fearon-Clarke,
Kathleen Hollasch, David Baran, Mark Zucker, Marc Goldschmidt, Morristown
Medical Center, Morristown, NJ, USA, Newark Beth Israel Medical Center,
Newark, NJ, USA
230 - Effect of Left Ventricular Systolic Dysfunction on Warfarin Dose
Sameer Ather, Aditi D. Shendre, Sumanth Prabhu, Nita Limdi, University of
Alabama at Birmingham, Birmingham, AL, USA
221 - Exercise Ventilatory Power in Heart Failure Patients: Functional
Phenotypes Definition by Combining Cardiopulmonary Exercise Testing with
Stress Echocardiography
Valentina Labate, Francesco Bandera, Greta Generati, Marta Pellegrino,
Valeria Donghi, Eleonora Alfonzetti, Marco Guazzi, IRCCS Policlinico San
Donato, San Donato Milanese, Italy
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Poster Contributions - Session #1241
CMR Potpourri
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
222 - The Road to Recovery: The Role of Marital Status and Living Condition
on the Outcomes of African Americans with Heart Failure
Marvin Louis Roy Yap Lu, Mahek Shah, Carlos Davila, Albert Einstein Medical
Center, Philadelphia, PA, USA
001 - Kinetic Energy Ejection Fraction: A Better Marker of Cardiac Function in
the Single Ventricle Circulation
James Wong, Radomir Chabiniok, Kuberan Pushparajah, Eva Sammut, Shane
M. Tibby, David Celermajer, Daniel Giese, Tarique Hussain, Gerald Greil,
Tobias Schaeffter, Reza Razavi, King's College London, London, United
Kingdom
223 - Racial Disparities in Left Ventricular Remodeling among Patients with
Systolic Heart Failure
Yulanka Castro Dominguez, Shashank Jain, Atish Mathur, Adam Raskin, Frank
Wang, Carlos Osorio, Monali Patel, Vivek Joseph, Pallavi Solanki, Marc
Klapholz, Rutgers - New Jersey Medical School, Newark, NJ, USA
224 - Relationship Between Heart Failure Therapy and Cost Burden of Heart
Failure in a Managed Care Population
Jason Swindle, Engels N. Obi, Stuart J. Turner, Cori Blauer-Peterson, Lynn A.
Wacha, Aylin Altan, Optum, Eden Prairie, MN, USA, Novartis Pharmaceuticals
Corporation, East Hanover, NJ
225 - Readmissions in Heart Failure and Myocardial Infarctions: A Paradoxical
Improvement in Quality of Care
Sheeva Rajaei, John Teerlink, Mary Whooley, Anju Sahay, Paul Heidenreich,
Stanford University, Stanford, CA, USA
226 - One-Minute Post-Exercise Heart Rate Recovery Independently Predicts
Clinical Outcome in Patients with Acute Decompensated Heart Failure
Jong-Chan Youn, Jaewon Oh, Sungha Park, Sang-Hak Lee, Donghoon Choi,
Seok-Min Kang, Severance Cardiovascular Hospital, Yonsei University College
of Medicine, Seoul, South Korea
227 - Prognostic Impact of Urinary Sodium Concentration in Patients with
Acute Heart Failure
Satoshi Honda, Toshiyuki Nagai, Yasuo Sugano, Tatsuhiro Shibata, Yasuhide
Asaumi, Takeshi Aiba, Teruo Noguchi, Kengo Kusano, Hisao Ogawa, Satoshi
Yasuda, Toshihisa Anzai, National Cerebral and Cardiovascular Center, Suita,
Japan
002 - Assessment of Ventriculo-Vascular Properties in Repaired Coarctation
Using Cardiac MRI Derived Aortic, Left Atrial and Left Ventricular Strain
Quanliang Shang, Shivani Patel, Phalla Ou, David Danford, Andreas Schuster,
Phillip Beerbaum, Samir Sarikouch, Shelby Kutty, University of Nebraska
Medical Center, Chiildren's Hospital and Medical Center, Omaha, NE, USA
003 - Abnormal Right Atrial Performance in Surgically Repaired Tetralogy of
Fallot: German Competence Network for Congenital Heart Defects
Investigators
Shelby Kutty, Quanliang Shang, Shivani Patel, David Danford, Michael
Steinmetz, Andreas Schuster, Titus Kuehne, Philipp Beerbaum, Samir
Sarikouch, Hannover Medical University, Hannover, Germany, University of
Nebraska College of Medicine, Children’s Hospital & Medical Center
004 - Is Cardiac MRI a Cost-Saving Strategy for New Cardiac Patients?
Julianne Matthews, Nicholas Boniface, Brandon Mikolich, John Lisko, J.
Ronald Mikolich, Northeast Ohio Medical University, Rootstown, OH, USA,
Sharon Regional Health System, Sharon, PA, USA
005 - Left Atrial Shape Predicts Recurrence After Atrial Fibrillation Ablation
Erik Bieging, Alan Morris, Joshua Cates, Nassir Marrouche, Christopher
McGann, University of Utah, Salt Lake City, UT, USA
006 - Plaque Analysis with Cardiac Magnetic Resonance Imaging for Chronic
Total Occlusion and Strategy of Intervention
Koichiro Asawa, Kojiro Yoshimura, Hiroshi Ueda, Seiji Matsuhisa, Naohiro
Yoshida, Hidetoshi Yoshitani, Yukiko Kuga, Kazuya Ueda, Yasunori Nishida,
Koseikai Takai Hospital, Nara, Japan
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 19 of 64
Program PDF
Updated: 2-23-15
007 - Effective Orifice Area by Cardiac Magnetic Resonance for the Functional
Assessment of Bioprosthetic Aortic Valves
Dimitrios Maragiannis, Matthew Jackson, Jose Flores-Arrendondo, Paulino
Alvarez, Autry Kyle, William Zoghbi, Dipan Shah, Stephen Little, Stephen
Little, Houston Methodist Hospital, Houston, TX, USA
008 - Characterization of High Intensity Plaques on Noncontrast T1 Weighted
Magnetic Resonance Imaging by Intravascular Modalities
Akira Oshita, Hideo Kawakami, Fumiyasu Seike, Hiroshi Matsuoka, Ehime
Prefectural Imabari Hospital, Imabari, Japan
009 - Chest Pain in Patients Under Age 40: Are We Getting It Right?
Daniel Morgenstern, Julian Kley, John Lisko, Luke Shivers, Brandon Mikolich,
J. Ronald Mikolich, Sharon Regional Health System, Sharon, PA, USA,
Northeast Ohio Medical University, Rootstown, OH, USA
010 - Dynamic Fractional Flow Reserve Measurement: Potential Implications
for Dynamic First-Pass Myocardial Perfusion Imaging
David Barmby, Andrew Davies, Amber Gislason-Lee, Mohan Sivananthan,
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, University of
Leeds, Leeds, United Kingdom
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Poster Contributions - Session #1242
Exercise Capacity in Disease/Screening and Diagnosis
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
011 - Cardiac Output Reserve: A Novel Marker of Symptoms and Exercise
Capacity in Aortic Stenosis
Matthew Lumley, Rupert Williams, Satpal Arri, Kaleab Asrress, Michael
Marber, Ronak Rajani, John Chambers, Divaka Perera, Kings College London,
London, United Kingdom
013 - Significance of Impaired Heart Rate Response to Exercise in Obesity
Nóra Sydó, Tibor Sydó, Sahar Abdelmoneim, Sharon Mulvagh, Joseph
Murphy, Bela Merkely, Todd Miller, Thomas Allison, Mayo Clinic, Rochester,
MN, USA, Semmelweis University, Heart and Vascular Center, Budapest,
Hungary
014 - Spontaneous Coronary Artery Dissection Patients Significantly More Fit
than the Average Patient Referred for Exercise Stress Testing
Sahar Naderi, Ido Weinberg, Mark Lindsay, Malissa Wood, Massachusetts
General Hospital, Boston, MA, USA
015 - Diagnostic Accuracy of CT Angiography (CTA) for Critical Pathologic
Features in Anomalous Aortic Origin of the Coronary Arteries (AAOCA) in
Children: A Comparative Study with Surgery in a Single Center
Rajesh Krishnamurthy, Prakash Masand, Siddharth Jadhav, Wei Zhang,
Silvana Molossi, Kristen Sexson, Dean McKenzie, Charles Fraser, Carlos Mery,
Texas Children's Hospital, Houston, TX, USA, Baylor College of Medicine,
Houston, TX, USA
016 - Results of Systematic MRI-Based Pre-Participation Screening of School
Children: The Sample Size Issue
Paolo Angelini, Benjamin Cheong, Carlo Uribe, Syed W. Ali, MacArthur
Elayda, James Willerson, Texas Heart Institute, Houston, TX, USA, Baylor
College of Medicine, Houston, TX, USA
Monday, March 16, 2015
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Poster Contributions - Session #1243
Non Invasive Imaging: Advances in Clinical Non-Invasive Imaging
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
017 - Combined Assessment of Carotid Intima-Media Thickness and Left
Ventricular Concentric Hypertrophy Predict Cardiovascular Death in
Hemodialysis Patients
Hisao Yoshikawa, Suzuki Makoto, Go Hashimoto, Masato Nakamura, Kaoru
Sugi, Yoshikawa Hospital, Tokyo, Japan
018 - Three Dimensional Echocardiographic Anatomic Intelligence Approach
for Fully Automated Simultaneous Quantification of Left Ventricular and
Atrial Volumes
Diego Medvedofsky, Wendy Tsang, Masaaki Takeuchi, Lynn Weinert, Megan
Yamat, Amit Patel, Ivan Salgo, David Prater, Victor Mor-Avi, Roberto Lang,
University of Chicago Medical Center, Chicago, IL, USA
019 - Is Late Gadolinium Enhancement Magnetic Resonance Imaging
Necessary for Detection of Transmural Scar Tissue in Chronic Coronary Artery
Disease Patients with Nearly Normal Global Left Ventricular Function?
Assami Roesner, Derk Avenarius, Siri Malm, Amjid Iqbal, Bart Bijnens, Henrik
Schirmer, Universityhospital of North Norway, Tromsoe, Norway, University
of Tromsoe, Tromsoe, Norway
020 - Transesophageal Echocardiographic Findings After Left Atrial and Left
Atrial Appendage Modification
Sena Kilic, Donna Chelle Morales, Lane Duvall, David Silverman, Matthew
Parker, Hartford Hospital, Hartford, CT, USA, University of Connecticut,
Farmington, CT, USA
021 - Prediction of Intraventricular Thrombosis by Quantitative Imaging of
Stasis: A Pilot Color-Doppler Study in Patients with Acute Myocardial
Infarction
Carolina Devesa Cordero, Lorenzo Rossini, Pablo Martinez-Legazpi, Candelas
Perez Del Villar, Yolanda Benito, Alicia Barrio, Francisco Fernandez-Aviles,
Raquel Yotti, Juan Carlos del Alamo, Javier Bermejo, Hospital General
Universitario Gregorio Marañon, Madrid, Spain, Mechanical and Aerospace
Engineering Department, University of California San Diego, La Jolla, CA, USA
022 - Aortic Annulus Sizing for Transapical Heart Valve Implantation: An
Agreement Analisys of Different Three-Dimensional Transoesophageal
Echocardiographic Modalities and Cardiac Computed Tomography Scan
Vincenzo Polizzi, Pino Paolo Giuseppe, Giampaolo Luzi, Diego Bellavia,
Rosario Fiorilli, Claudia Chialastri, Andrea Madeo, Myriam Lo Presti, Joseph
Malouf, Vitaliano Buffa, Francesco Musumeci, Azienda Ospedaliera San
Camillo-Forlanini, Roma, Italy
023 - Effect of Aldosterone Antagonists on Diastolic Function Measured by
Echocardiography: A Meta-Analysis of Randomized Controlled Trials
Shivang Shah, Enrique Jimenez, Pratap Reddy, Nuri Akkus, LSUHSC
Shreveport, Shreveport, LA, USA, Shreveport, LA, USA
024 - Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion
Echocardiography in Type 2 Diabetes Mellitus
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 20 of 64
Program PDF
Updated: 2-23-15
Runqing Huang, Sahar S. Abdelmoneim, Lara F. Nhola, Amy L. Dichak, Susan J.
Eifert Rain, Sharon L. Mulvagh, Mayo Clinic, Rochester, MN, USA
025 - Screening for Abdominal Aortic Aneurysm During Transthoracic
Echocardiography: A Prospective Study in a Japanese Population
Yoshihisa Matsumura, Hiroaki Kitaoka, Tetsuro Sugiura, Kochi Medical
School, Nankoku-shi, Japan
026 - Right Ventricular Dilatation Post Pericardiectomy Causes Tricuspid
Regurgitation
Muhammad Umer Tariq, Wahaj Aman, Abhishek Karwa, Rudolfo Benatti,
Allan Klein, Cleveland Clinic, Cleveland, OH, USA
027 - Transient Ischemic Dilation: A New Perspective Utilizing Cardiac MRI
John Cyril Lisko, Nicola Nicoloff, Brandon Mikolich, Amitha Dhingra, J. Ronald
Mikolich, Northeast Ohio Medical University, Rootstown, OH, USA, Sharon
Regional Health System, Sharon, PA, USA
028 - Prognostic Value of Dobutamine Stress Echocardiography in Renal
Transplant Candidates: A Meta-Analysis
Yugandhar R. Manda, Jamshid Shirani, St. Luke's University Health Network,
Bethlehem, PA, USA
029 - Feasibility and Diagnostic Potential of Regadenoson Stress 2D-Speckle
Tracking Echocardiography for Detection of Inducible Ischemia: Initial Results
of the Single Center, Prospective, Randomized, Comparative, Same-Setting
Study of Regadenoson Stress SPECT versus 2D Speckle Tracking Echo (LexiECHO Trial)
Aiden Abidov, Ahmed Pasha, Arun Kannan, Nisreen Yaghmour, Evbu
Enakpene, Vincent Sorrell, The University of Arizona, Tucson, AZ, USA, The
University of Kentucky, Lexington, KY, USA
030 - Incremental Value of the Novel Marker, “Echocardiographic PulmonaryLeft Atrial Ratio” for Non-Invasive Determination of the Aetiology in
Pulmonary Hypertension
David Platts, Jonathan Hunter, Ryan Maxwell, Jilani Latona, Darryl Burstow,
Gregory Scalia, The Prince Charles Hospital, Brisbane, Australia
031 - Prospective Comparison of Ventricular Function by Echocardiography
and MRI Comparison of Normal to Asymptomatic Single Right and Single Left
Ventricular Morphology
Kristen Sexson, Cory Noel, Peng Chen, Ramkumar Krishnamurthy, Rajesh
Krishnamurthy, Feagin Douglas, M. Regina Lantin-Hermoso, Ricardo
Pignatelli, Baylor College of Medicine/Texas Children's Hospital, Houston, TX,
USA
032 - Effect of Nitric Oxide Inhibition on Skeletal Muscle Microvascular Flow
in Acute Peripheral Artery Thromboembolism Treated with High Mechanical
Index Pulses and Systemic Microbubbles
Thomas Porter, Feng Xie, John Lof, University of Nebraska Medical Center,
Omaha, NE, USA
033 - Calculation of Left Ventricular Stroke Volume by Doppler
Echocardiography: Is One Method Better Than the Other?
Olivia N. Gilbert, Natalie Bradford, Sujethra Vasu, Bharathi Upadhya, Min Pu,
Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
034 - Echocardiography Core Lab Reproducibility of Cardiac Safety
Assessments in Cardio-Oncology
Monday, March 16, 2015
Michel Georges Khouri, Bonnie Ky, Gary Dunn, Theodore Plappert, Virginia
Englefield, Eric Yow, Huiman X. Barnhart, Martin St. John Sutton, Pamela
Douglas, Duke University, Durham, NC, USA, University of Pennsylvania,
Philadelphia, PA, USA
035 - Educational Intervention Reduced the Rate of “Rarely Appropriate”
Outpatient Transthoracic Echocardiograms Ordered by Attending
Cardiologists: A Randomized Controlled Trial
David M. Dudzinski, Eric Isselbacher, Rajan Bhatia, Michael Picard, Rory
Weiner, Massachusetts General Hospital, Boston, MA, USA
036 - Oximetry Paradoxus: Superiority Over Pulsus Paradoxus in the Clinical
Diagnosis of Cardiac Tamponade
Michael J. Shih, Briana T. Costello, Gabriel Improvola, Juan M. Munoz-Pena,
Bosko Margeta, Charlotte Bai, Rami Doukky, Rush University Medical Center,
Chicago, IL, USA, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL,
USA
038 - Rest Flow Rate, Not Stroke Volume, Is a Better Discriminator of True
Versus Pseudosevere Severe Aortic Stenosis: Implications for Stress
Echocardiography and for the Routine Assessment of Aortic Stenosis Severity
Navtej S. Chahal, Maria Drakopoulou, Ana Gonzalez, Alison Duncan, Rajdeep
S. Khattar, Roxy Senior, Royal Brompton Hospital, London, United Kingdom
039 - Characterization of Regional Differences in Pathological LV Remodeling:
Insights from 3D Echocardiographic Analysis
Yong Hyun Park, Mark Handschumacher, Xin Zeng, Timothy Tan, Romain
Capoulade, Judy Hung, Massachusetts General Hospital, Boston, MA, USA
040 - Accuracy of Right Heart Echocardiographic Parameters in Post-Surgical
Tetralogy of Fallot Patients: An Echocardiographic and Cardiac MRI
Comparative Study
Tasnim Vira, Anne Alvarez, David Patton, Patricia Campbell, University of
Calgary, Calgary, Canada
041 - Automated Quantification of Right Ventricular Size and Systolic
Function by Real-Time Volume Trans-Thoracic Echocardiography:
Comparison with Cardiac Magnetic Resonance Imaging
Xiao Zhou, Zhen Qian, Shizhen Liu, Theresa Green, Scott Edwards, Sarah
Rinehart, Venkateshwar Polsani, Mani Vannan, Piedmont Heart Institute,
Atlanta, GA, USA
042 - Lack of Cardiac Events During Trastuzumab and Pertuzumab Therapy in
Patients with Her2-Positive Metastatic Breast Cancer: Implications for
Cardiac Monitoring
Anthony F. Yu, Carlos Manrique, Jennifer Liu, Clifford A. Hudis, Richard
Steingart, Chau Dang, Memorial Sloan Kettering Cancer Center, New York,
NY, USA
043 - Mitral Valve Index: A Simple and Robust Parameter for Detecting
Prosthetic Mitral Valve Regurgitation
Sushil Allen Luis, Lori Blauwet, Ramila Mehta, Himabindu Samardhi, Cathy
West, Chris Luis, Gregory Scalia, Fletcher Miller, Darryl Burstow, Mayo Clinic,
Rochester, MN, USA, The Prince Charles Hospital, Brisbane, Australia
044 - Noninvasive Estimation of Pulmonary Capillary Wedge Pressure: A
Study Using Left Atrial Volume, Function and Deformation Property Assessed
by Speckle Tracking Echocardiography
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 21 of 64
Program PDF
Updated: 2-23-15
Yoshie Fujii, Yoshiaki Kawase, Nozomi Nomura, Keiko Ogawa, Ryuhei Tanaka,
Hidemaro Sato, Hiroki Kondo, Jun Kikuchi, Tatsuya Saigusa, Takayoshi Kato,
Taiji Miyake, Tomohiro Tsunekawa, Munenori Okubo, Kunihiko Tsuchiya,
Shinji Tomita, Hitoshi Matsuo, Masanori Kawasaki, Shinya Minatoguchi, Gifu
Heart Center, Gifu, Japan, Gifu University Graduate School of Medicine, Gifu,
Japan
045 - Importance of Stress Perfusion and Diastolic Function in Predicting
Outcome of Contemporary End Stage Liver Disease Patients Undergoing
Transplantation
Bipul Baibhav, Mohammed Chamsi-Pasha, Feng Xie, Timothy Mccashland,
Thomas Porter, University of Nebraska Medical Center, Omaha, NE, USA
046 - Gender Difference in Regression of Myocardial Hypertrophy After
Aortic Valve Replacement
Kumiko Hirata, Makoto Orii, Yasutsugu Shiono, Takashi Yamano, Yoshiki
Matsuo, Yasushi Ino, Tomoyuki Yamaguchi, Takashi Kubo, Atsushi Tanaka,
Takashi Akasaka, Wakayma Medical University, Wakayama, Japan
047 - Validity of Real-Time Single-Beat versus Multi-Beat Full-Volume Capture
Three-Dimensional Echocardiography for Quantification of Right Ventricular
Volume: Validated by Cardiac MRI
Eiichi Hyodo, Takafumi Nagaura, Kohei Moribayashi, Koichi Tamita, Atsushi
Yamamuro, Junichi Yoshikawa, Nishinomiya Watanabe Cardiovascular
Center, Nishinomiya, Japan
048 - Prediction of Clinical Outcome in Patients with Pericardial Effusion and
Malignancies: Stratified by Post-Pericardiocentesis Constrictive Physiology
In-Jeong Cho, Hyuk-Jae Chang, Hyemoon Chung, Chi Young Shim, Geu-Ru
Hong, Jong-Won Ha, Namsik Chung, Severance Cardiovascular Hospital,
Seoul, South Korea
049 - Pulmonary Artery Acceleration Time, an Accurate Non-Invasive
Measure of Pulmonary Hemodynamics in Children
Philip Thaler Levy, Georgeann Groh, Joshua Murphy, Timothy Sekarski, Mark
Holland, Gautam Singh, Washingon University School of Medicine, Saint
Louis, MO, USA
050 - Comprehensive Hemodynamic Assessment of 295 Small Mechanical
Aortic Valve Prostheses Early Post-Implantation
Aravind Raghavan, Lori Blauwet, Rakesh Suri, Ramila Mehta, David Hodge,
Fletcher Miller, Mayo Clinic, Rochester, MN, USA
051 - Cardiovascular Complications in Sickle Cell Disease
Emmanuel Ako, John B. Porter, John M. Walker, The Hatter Cardiovascaular
Institiute, University College London, London, United Kingdom
052 - Noninvasive Estimation of Pulmonary Capillary Wedge Pressure in
Patients with Mitral Regurgitation by Speckle Tracking Echocardiography
Nozomi Nomura, Yoshiaki Kawase, Yoshie Fujii, Keiko Ogawa, Ryuhei Tanaka,
Hidemaro Sato, Hiroki Kondo, Jun Kikuchi, Tatsuya Saigusa, Takayoshi Kato,
Taiji Miyake, Tomohiro Tsunekawa, Munenori Okubo, Kunihiko Tsuchiya,
Shinji Tomita, Hitoshi Matsuo, Masanori Kawasaki, Shinya Minatoguchi, Gifu
Heart Center, Gifu, Japan, Gifu University Graduate School of Medicine, Gifu,
Japan
Monday, March 16, 2015
Prevention - Poster Contributions
Session #1246
Risk Assessment, Exercise and Atrial Fibrillation
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
101 - Urbanization Is an Independent Predictor of Insulin Resistance in a
South Asian Population
Mohan Thanikachalam, Jahnavi Sunderarajan, Kevin Lane, Hari Vanzan, Kwan
HK Chui, Ragavendra Baliga, Sadagopan Thanikachalam, Tufts University
School of Medicine, Boston, USA, Sri Ramchandra University, Porur, India
102 - Resting Heart Rate Is an Independent Predictor of All-Cause Mortality
and Myocardial Infarction in the Middle-Aged General Population
Florian Custodis, Ulla Roggenbuck, Nils Lehmann, Susanne Moebus, Ulrich
Laufs, Amir A. Mahabadi, Gerd Heusch, Klaus Mann, Karl-Heinz Jöckel,
Raimund Erbel, Michael Böhm, Stefan Möhlenkamp, Department of
Cardiology, Universitätsklinik des Saarlandes, Homburg/Saar, Germany, Clinic
of Cardiology, West-German Heart Center Essen, University Clinic Essen,
Essen, Germany
103 - Impact of Age on the Cardiovascular Event Risk Conferred by HbA1c in
Patients with Established Coronary Artery Disease
Alexander Vonbank, Christoph Saely, Philipp Rein, Daniela Zanolin, Heinz
Drexel, VIVIT Institute, Feldkirch, Austria, Department of Internal Medicine
and Cardiology at the Academic Teaching Hospital Feldkirch, Feldkirch,
Austria
104 - Prediction of Racial Differences in Sub-Clinical Vascular Disease in
African Americans and Whites: Comparison of the Framingham and the
Atherosclerotic Cardiovascular Risk Scores
Jia Shen, Ibhar Al Mheid, Alanna Morris, Viola Vaccarino, Laurence Sperling,
Gary H. Gibbons, Arshed Quyyumi, Emory Clinical Cardiovascular Research
Institute, Atlanta, GA, USA
105 - Gender, Coronary Artery Calcium Score and Cardiovascular Risk
Reclassification
Devin K. Patel, Marat Fudim, Sandip Zalawadiya, Anupama Kottam, Issa
Alesh, Shaun Cardozo, Luis Afonso, Vanderbilt University, Nashville, TN, USA
106 - Gender Differences in Cardiovascular Risk by Two Different Scores: A
Five Years Follow up Analysis of a 1500-Patient Database
Ricardo G. Baeza, Victor Neira, Constanza Cea, Javier Revello Pedemonte,
Luigi Gabrielli, Samuel Zvaighaft, Alvaro Huete, Monica Acevedo, Catholic
University of Chile, Santiago, Chile, Clinica Las Condes, Santiago, Chile
107 - Ethnicity, Coronary Artery Calcium Score and Cardiovascular Risk
Reclassification
Marat Fudim, Devin K. Patel, Sandip Zalawadiya, Anupama Kottam, Issa
Alesh, Shaun Cardozo, Luis Afonso, Vanderbilt University, Nashville, TN, USA
108 - Impaired Kidney Function Is a Diabetes Risk Equivalent in Patients with
Established Coronary Artery Disease
Christoph Saely, Daniela Zanolin, Alexander Vonbank, Philipp Rein, Heinz
Drexel, VIVIT Institute, Feldkirch, Austria, Department of Internal Medicine
and Cardiology at the Academic Teaching Hospital Feldkirch, Feldkirch,
Austria
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 22 of 64
Program PDF
Updated: 2-23-15
109 - Prevalence of Electrocardiographic Patterns Associated with Sudden
Cardiac Death in General Population Older than Forty Years
Paula Awamleh, Catherine Graupner, Pedro Talavera, Jose Maria Serrano
Antolin, Juan Gomez-Doblas, Javier Muñiz, Joaquin Alonso, Eulalia Roig, Rosa
Jimenez, Carmen Cristóbal, Getafe University Hospital, Madrid, Spain,
Fuenlabrada University Hospital, Madrid, Spain
110 - Relation of Heart Rate Recovery After Exercise to Insulin Resistance and
Chronic Inflammation in Healthy Adolescents and Young Adults: Results from
the National Health And Nutrition Examination Survey (nhanes) 1999-2004
Hsu-Ko Kuo, Joel Gore, Division of Cardiology, University of Massachusetts,
Worcester, MA, USA
111 - Exercise Gas Exchange Phenotypes in a Population at Risk and Reduced
Heart Rate Recovery Post-Exercise: Findings from the EURO(Pean) EX(Ercise)
Population-Based Study
Marta Pellegrino, Greta Generati, Francesco Bandera, Valentina Labate,
Valeria Donghi, Eleonora Alfonzetti, Marco Guazzi, Heart Failure Unit, IRCCS
Policlinico San Donato, San Donato M.se, Italy
112 - Cardiac Structural and Functional Changes After Sustained High Aerobic
Exercise Training Stimulus
Satyam Sarma, William Dinsfriend, Erin Howden, William Cornwell, Kara
Boyd, Mitchel Samels, Sheryl Livingston, Dean Palmer, Benjamin Levine,
Institute for Exercise and Environmental Medicine, Dallas, TX, USA, University
of Texas Southwestern Medical Center, Dallas, TX, USA
113 - Internet Survey: Health Screening in Sports
Victor Chen, Vidhya Gunasekaran, Don Kim, Gloria Wu, UC San Diego, La
Jolla, CA, USA
114 - An Assessment of the Performance of Pre-Participation Guidelines
Applied to Novice Older Endurance Athletes
Martin E. Matsumura, Courtney Bennett, Justin Abbatamarco, Lehigh Valley
Health Network, Allentown, PA, USA
115 - Weight Loss but Not Exercise Lowers Glucagon Response and Improves
Glucagon-Like Peptide-1 to Insulin Ratio in Prediabetic Patients with
Coronary Artery Disease: The Randomized CUT-IT Trial
Lene Roerholm Pedersen, Rasmus Olsen, Jens Juul Holst, Steen Bendix
Haugaard, Eva Prescott, Department of Cardiology, Bispebjerg Hospital,
University of Copenhagen, Copenhagen, Denmark
116 - Early-Onset Menopausal Vasomotor Symptoms Are Associated with
Endothelial Dysfunction: The National Heart Lung and Blood InstituteSponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
Rebecca Thurston, B. Delia Johnson, Carl Pepine, Chrisandra Shufelt, Steven
Reis, Sheryl Kelsey, Vera Bittner, Frank Stanczyk, Glenn Braunstein, Sarah
Berga, George Sopko, C. Noel Bairey Merz, University of Pittsburgh,
Pittsburgh, PA, USA
117 - Physiologically-Assessed Hot Flashes Are Associated with Poorer
Endothelial Function Among Early Midlife Women
Rebecca Thurston, Emma Barinas-Mitchell, Nanette Santoro, J. Richard
Jennings, Roland vonKanel, Yuefang Chang, Karen Matthews, University of
Pittsburgh, Pittsburgh, PA, USA
Monday, March 16, 2015
118 - Serum Uric Acid Level and Prevalence of Atrial Fibrillation in 285,882
Japanese General Population
Shin Kawasoe, Shiro Yoshifuku, Takuro Kubozono, Hironori Miyahara, Naoya
Oketani, Masaaki Miyata, Shigeho Maenohara, Mitsuru Ohishi, Graduate
School of Medical and Dental Sciences, Kagoshima University, Kagoshima,
Japan
119 - Does Warfarin Time-in-Therapeutic Range Affect Healthcare Resource
Utilization and Costs Among Nonvalvular Atrial Fibrillation Patients in the
U.S.?
Steven Deitelzweig, Michael Evans, Eric Hillson, Jeffrey Trocio, Amanda
Bruno, Wilson Tan, Melissa Lingohr-Smith, Jay Lin, Bristol-Myers Squibb,
Plainsboro, NJ, USA, Pfizer, NewYork, NY, USA
120 - Comparison of Medical Costs Avoided Among Nonvalvular Atrial
Fibrillation Patients Treated with Dabigatran, Rivaroxaban, Apixaban, and
Edoxaban versus Warfarin
Alpesh N. Amin, Amanda Bruno, Jeffrey Trocio, Jay Lin, Melissa LingohrSmith, Bristol-Myers Squibb, Plainsboro, NJ, USA, Pfizer, New York, NY, USA
121 - Clinical Impact of Bradycardia on the Incidence of Atrial Fibrillation in a
Population-Based Cohort Study
Takashi Kobayashi, Yoshihiro Kokubo, Makoto Watanabe, Aya Higashiyama,
Yoko M. Nakao, Takuya Watanabe, Kunihiro Nishimura, Misa Takegami,
Michikazu Nakai, Shiro Kamakura, Kengo Kusano, Yoshihiro Miyamoto, Nat.
Cerebral & Cardio. Ctr., Suita Osaka, Japan
122 - Antithrombotic Treatment in Relation to Age in Patients with Newly
Diagnosed Atrial Fibrillation in North America (GLORIA-AF Phase II)
Jonathan L. Halperin, Menno Huisman, Hans-Christoph Diener, Sergio
Dubner, Changsheng Ma, Kenneth Rothman, Jeff Healey, Kristina Zint, Amelie
Elsaesser, Miney Paquette, Christine Teutsch, Gregory Lip, Mount Sinai
School of Medicine, New York, NY, USA
123 - How Much Do the New Atrial Fibrillation Guidelines Affect Stroke
Prevention Practice?
Enrique Padilla Campos, Eric R. Silverman, Nicole Pohlman, Benjamin
Gastevich, Lynne Braun, Youping Deng, Li Yan, Kousik Krishnan, Richard
Trohman, Annabelle Volgman, Rush University Medical Center, Chicago, IL,
USA
124 - Patterns of Newly Detected Atrial Fibrillation and Antithrombotic
Treatment in North America (GLORIA-AF Phase II)
Jonathan L. Halperin, Menno Huisman, Hans-Christoph Diener, Sergio J.
Dubner, Changsheng Ma, Kenneth Rothman, Jeff Healey, Kristina Zint, Amelie
Elsaesser, Miney Paquette, Christine Teutsch, Gregory Lip, Mount Sinai
School of Medicine, New York, NY, USA
Non-Certified Industry Events - Learning Destinations
Session #4103
Introducing Lumason™: An Echo-enhancing Agent Designed to
Improve Left Ventricular Opacification and Endocardial Border
Delineation
Monday, March 16, 2015, 10 a.m. - 1 p.m.
Expo Hall 2151
CME Hours: /CNE Hours:
Introducing Lumason™: An Echo-enhancing Agent Designed to Improve Left
Ventricular Opacification and Endocardial Border Delineation
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 23 of 64
Program PDF
Updated: 2-23-15
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2610
LAA Closure for Preventions Stroke
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 6F
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Jason H. Rogers
Co-Chair: Allan Schwartz
10:45 a.m.
Anatomy and Physiology of the Atrial Appendage
Renu Virmani
10:55 a.m.
Image Guidance of LAA closure using Endovascular Device: Transseptal
Puncture to Device Deployment
Saibal Kar
Los Angeles, CA
11:05 a.m.
Procedural Steps for Closure of the LAA using Epicardial Approach
Miguel Valderrabano
Houston, TX
11:15 a.m.
Complications of LAA Closure: Prevention and Management
Brijeshwar Singh Maini
Lemoyne, PA
11:25 a.m.
Endovascular Device LAA Closure is the Preferred Approach
Reda Ibrahim
Montreal, Canada
11:35 a.m.
Epicardial Ligation of the LAA is the Preferred Approach
Randall J. Lee
San Francisco, CA
11:45 a.m.
LAA Closure Should be one of the First in Line Treatment Options for Stroke
Prevention in Atrial Fibrillation
Horst Sievert
Frankfurt, Germany
11:55 a.m.
LAA Closure Should only be Reserved for Patients who Failed or Cannot take
Long Term Anticoagulants
Michael D. Ezekowitz
Wynnewood, PA
12:05 p.m.
Discussion
Monday, March 16, 2015
Prevention - Poster Contributions
Session #1247
Renal Nerve Denervation
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
125 - Renal Sympathetic Denervation for Treatment of Drug-Resistant
Hypertension in an Asian Population: Results from the Global SYMPLICITY
Registry in South Korea (GSR Korea) and Comparison to SYMPLICITY HTN-2
Byeong-Keuk Kim, Michael Boehm, Felix Mahfoud, Giuseppe Mancia, Sungha
Park, Myeong-Ki Hong, Hyo-Soo Kim, Seung-Jung Park, Chang Gyu Park, Ki
Bae Seung, Hyeon-Cheol Gwon, Dong-Ju Choi, Tae Hoon Ahn, Chong Jin Kim,
Hyuck Moon Kwon, Murray Esler, Yangsoo Jang, Severance Cardiovascular
Hospital, Yonsei University College of Medicine, Seoul, South Korea
126 - Chemical Denervation of the Renal Artery by Vincristine: The Role of
the Delivery Flow Rate
Andreas Synetos, Konstantinos Toutouzas, Georgios Benetos, Konstantinos
Stathogiannis, George Trantalis, George Agrogiannis, Christodoulos
Stefanadis, Dimitris Tousoulis, First Department of Cardiology, University of
Athens, Greece, Athens, Greece
127 - Neuropeptide Y As an Indicator of Successful Reduction of Sympathetic
Nervous Activity After Renal Sympathetic Denervation
Oliver Doerr, Christoph Liebetrau, Helge Mollmann, Luise Gaede, Christian
Troidl, Jens Wiebe, Jedrzej Hoffmann, Sandra Voss, Timm Bauer, Christian
Hamm, Holger Nef, University of Giessen, Dept. of Cardiology, Giessen,
Germany, Kerckhoff Heart Center, Bad Nauheim, Germany
128 - Home Blood Pressure Significantly Decreases Throughout the First Year
After Renal Denervation
Martine Beeftink, Willemien Verloop, Rosa L. de Jager, Margreet F. Sanders,
Michiel Voskuil, Peter J. Blankestijn, Wilko Spiering, UMC Utrecht, Utrecht,
The Netherlands
129 - Magnitude of Blood Pressure Reduction in the Placebo Arms of Modern
Hypertension Trials: Implications for Trials of Renal Denervation
Hitesh Patel, Carl Hayward, Baris Ata Ozdemir, Stuart Rosen, Henry Krum,
Alexander Lyon, Darrel Francis, Carlo Di Mario, NIHR Cardiovascular BRU,
Royal Brompton Hospital, London, United Kingdom, NHLI, Imperial College,
London, United Kingdom
130 - Impact of Multi-Electrode Renal Sympathetic Denervation on ShortTerm Blood Pressure Variability in Patients with Drug-Resistant
Hypertension: Insights from the EnligHTN I Study
Konstantinos P. Tsioufis, Vasilios Papademetriou, Dimitris Tsiachris,
Alexandros Kasiakogias, Athanasios Kordalis, Konstantinos Thomopoulos,
Kyriakos Dimitriadis, Dimitris Tousoulis, Christodoulos I Stefanadis,
Gianfranco Parati, Stephen Worthley, First Cardiology Clinic, University of
Athens, Hippokration Hospital, Athens, Greece, Cardiovascular Research
Centre, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia
131 - Reduced Blood Pressure Lowering Effect of Catheter-Based Renal
Denervation in Patients with Isolated Systolic Hypertension: Data from
Pooled Symplicity HTN Trials
Felix Mahfoud, George Bakris, Deepak L. Bhatt, Murray Esler, David Kandzari,
Kazuomi Kario, Henry Krum, Giuseppe Mancia, Ashok Seth, Michael Weber,
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 24 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Robert Whitbourn, Michael Boehm, Universitätskliniken des Saarlandes,
Homburg/Saar, Germany
Laura Doss, Tufik Assad, Eric Farber-Eger, Quinn Wells, Anna Hemnes, Evan
Brittain, Vanderbilt University Medical Center, Nashville, TN, USA
132 - Brain-Derived Neurotrophic Factor as a Marker for Immediate
Assessment of the Success of Renal Sympathetic Denervation
Oliver Doerr, Christoph Liebetrau, Helge Mollmann, Luise Gaede, Christian
Troidl, Vanessa Haidner, Jens Wiebe, Sandra Voss, Timm Bauer, Christian
Hamm, Holger Nef, University of Giessen, Dept. of Cardiology, Giessen,
Germany
Special Topics - Poster Contributions
Session #1248
FIT Clinical Decision Making: Arrhythmias and Pericardial Disease
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
133 - Acute Reduction of Aortic Stiffness in Patients with Resistant Arterial
Hypertension as a Marker of Efficacy of Renal Denervation Therapy
Filippo Scalise, Valentina Casali, Carla Auguadro, Eugenio Novelli, Giuseppe
Mancia, Policlinico di Monza, Monza, Italy, Università degli Studi Milano
Bicocca, Monza, Italy
135 - The Runaway Defibrillator... A Case of an Implantable Cardiac
Defibrillator That Failed Communication and Deactivation with a Magnet
Mahmoud Assaad, Ahmad Daraghmeh, Christian Machado, Providence
Hospital, Southfield, MI, USA
134 - Influence of Renal Sympathetic Denervation on Cardiac Extracellular
Matrix Turnover and Cardiac Fibrosis
Oliver Doerr, Christoph Liebetrau, Helge Mollmann, Luise Gaede, Christian
Troidl, Kareen Morczeck, Jens Wiebe, Jedrzej Hoffmann, Sandra Voss, Timm
Bauer, Christian Hamm, Holger Nef, University of Giessen, Dept. of
Cardiology, Giessen, Germany, Kerckhoff Heart Center, Bad Nauheim,
Germany
Pulmonary Hypertension and Venous Thrombo-embolic Disease Poster Contributions
Session #1249
Noninvasive and Invasive Assessment of Pulmonary Hypertension
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
171 - Echocardiographic Pulmonary/Left Atrial Ratio: A Novel and Robust
Non-Invasive Discriminator of Pre-Capillary versus Post-Capillary Pulmonary
Hypertension
Gregory M. Scalia, Rebecca Kierle, Rebekka Beaumont, John Feenstra, David
Cross, Heart Care Partners, Brisbane, CA, Australia
173 - Echocardiographic Predictors of Combined Pre and Post Capillary
Pulmonary Hypertension (PH) in a Population of Systolic Heart Failure with
WHO Group II Pulmonary Hypertension
Guha Ashrith, Nadia Fida, Andrea Cordero-Reyes, Javier Amione-Guerra,
Zahoor Khan, Arvind Bhimaraj, Barry Trachtenberg, Guillermo Torre-Amione,
Sherif Nagueh, Jerry Estep, Houston Methodist Hospital, Houston, TX, USA
174 - Electrocardiographic Characteristics of Pulmonary Hypertension in the
Setting of Hereditary Hemorrhagic Telangiectasia
Melissa Lyle, Eric Fenstad, Michael McGoon, Robert Frantz, Michael Krowka,
Garvan Kane, Karen Swanson, Mayo Clinic, Rochester, MN, USA
175 - Right Ventricular Fractional Area Change Predicts InvasivelyDetermined Hemodynamics in Patients with Pulmonary Arterial
Hypertension
Howard M. Julien, Arielle Fields, Henry Siu, Michael Scharf, Praveen
Mehrotra, Thomas Jefferson University Hospital, Philadelphia, PA, USA
176 - Discordance of Pulmoary Capillary Wedge Pressure and Left Ventricular
End Diastolic Pressure in Patients with Pulmonary Hypertension
137 - Complete Heart Block and Ventricular Tachycardia in Primary Cardiac
Sarcoidosis: A Diagnostic Dilemma
Ricardo Cardona Guarache, Virginia Commonwealth University, Richmond,
VA, USA
138 - Atrioventricular Heart Blocks in Thyrotoxicosis
Ankur Gupta, Sonali Arora, Baystate Medical Center, Springfield, MA, USA
139 - Dual Response Tachycardia Misdiagnosed as Atrial Fibrillation
Sonia G. Ponce, Mark Garcia, Michael West, University of New Mexico,
Albuquerque, NM, USA
140 - Complete Heart Block from Ischemia During Exercise Stress Testing
Allan Chen, Viviana Falco, Neeraj Jain, Louisiana State University Health
Sciences Center, New Orleans, LA, USA
141 - Ictal Asystole Captured on Continuous Telemetry and Video
Electroencephalography
Eveleen R. Randall, Sunil Iyer, Weeranun Bode, Jennifer Schwartz, University
of North Carolina, Chapel Hill, NC, USA
142 - Night of the Perfect Electrical Storm: Ischemia Induced Polymorphic
Ventricular Tachycardia or Torsades De Pointes
Nishant Patel, Dana Johnson, Stephen Smith, Advocate Lutheran General
Hospital, Park Ridge, IL, USA
143 - High-Grade AV Block as the Initial Finding in Isolated Cardiac
Sarcoidosis
Danesh Modi, Matthew Pierce, Hayan Al Maluli, Joshua Cooper, Temple
University Hospital, Philadelphia, PA, USA
144 - Conduction System Failure with Kidney Injury and Thrombocytopenia:
Should You Implant a Pacemaker?
Hayan Al Maluli, Andrew Peters, Mohammed Nayeemuddin, Arslan Mirza,
Jeffrey Arkles, Danesh Modi, Riyaz Bashir, Temple University Hospital,
Philadelphia, PA, USA
145 - Wide Complex Tachycardia After Exertion: Finding the Right Cause
Ryan T. Borne, Luisa Mestroni, Duy Nguyen, University of Colorado Anschutz
Medical Campus, Aurora, CO, USA
146 - Total Artificial Heart for Ventricular Tachycardia Storm
Aalok D. Patel, Abdallah El Sabbagh, Suraj Kapa, Mayo Clinic, Rochester, MN,
USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 25 of 64
Program PDF
Updated: 2-23-15
147 - A Shocking Revelation: A Case of Recurrent Twiddler's Syndrome
Presenting with Inappropriate Implantable Cardioverter Defibrillator
Discharge
Abhishek Kulkarni, Sendil Kumar Hari Prasad, Dwight Stapleton, Guthrie
Clinic/ Robert Packer Hospital, Sayre, PA, USA
148 - Transcoronary Ethanol Ablation for Ventricular Tachycardia
Kiran Mogali, Michael Kaufmann, Mario Pascual, Michael Jansen, Karen
Smith, William Miles, University of Florida, Gainesville, FL, USA
149 - Not All Left Ventricular Leads Created Equal
Muhammad Soubhi Azzouz, Aiman Smer, Arun Kanmanthareddy, Mohamed
Ayan, Hussam Abuissa, Creighton University, Omaha, NE, USA
150 - A Wide Complex Rhythm, Does It Tell the Whole Story?
Deepthi Vodnala, Howard Rosman, Ali Shakir, St John Hospital and Medical
Center, Detroit, MI, USA, Henry Ford Macomb Hospital, Charter Township of
Clinton, MI, USA
151 - Sudden Cardiac Death in Malignant Bileaflet Mitral Valve Prolapse
Swapna Kanuri, Pallavi Bellamkonda, Aryan Mooss, CHI health Creighton
University Medical Center, Omaha, NE, USA
152 - ICD Management During Pregnancy and Delivery
Lucius A. Howell, Jennifer Schwartz, UNC Hospitals, Chapel Hill, NC, USA
153 - Atrial Infarction Masquerading as Transient Atrial Lead Failure
P V Parekh, H k Teo, T s Lim, C k Ching, National Heart Centre Singapore,
Singapore, Singapore
154 - Idiopathic VT: Don't Forget Cardiac Sarcoid!
Hussein Othman, John Kalasky, Howard Rosman, Ali Shakir, St. John Hospital
and Medical Center, Detroit, MI, USA, Henry Ford Macomb Hospital, Charter
Township of Clinton, MI, USA
155 - Sudden Cardiac Arrest and Sixty-Three Shocks: An Elusive Diagnosis of
Brugada Syndrome in an African American Male
Khyati H. Baxi, Melissa Dakkak, Robert Kim, Ambar Patel, University of
Florida, Jacksonville, FL, USA
156 - Thanksgiving Meal Paralysis? A Rare Case of Thyrotoxic Periodic
Paralysis with Cardiac Arrest
Nikhil Vivek Ambulgekar, Sohail Hassan, St John Hospital & Medical Center,
Grosse Pointe, MI, USA
157 - An Unusual Cause of Constrictive Pericarditis After Coronary Bypass
Surgery
Allan Chen, Neeraj Jain, Frederick Helmcke, Frank Smart, Louisiana State
University Health Sciences Center, New Orleans, LA, USA
158 - Constrictive Pericarditis in a Patient with Long Standing Hypothyroidism
Gaurav Tyagi, Tanya Doctorian, David Rabkin, Anthony Hilliard, Loma Linda
University Medical Center, Loma Linda, CA, USA
159 - Effusive-Constrictive Pericarditis Secondary to Malignant Pericardial
Mesothelioma
Monday, March 16, 2015
Rajesh Tota-Maharaj, Salma Baksh, Amrit Thakoor, Vidarshi Muthukumarana,
Jessica Dodge, Amirhossein Mahfoozi, Ira Galin, Hal Wasserman, Danbury
Hospital, Danbury, CT, USA
160 - Embolization of Inferior Vena Cava Filter Strut to Right Ventricle
Leading to Cardiac Tamponade
Hirad Yarmohammadi, Wobo Bekwelem, Andrew Bunney, Karol Mudy, Suma
Konety, University of Minnesota, Minneapolis, MN, USA
161 - Drug Induced Pericardial Tamponade
Nitya Sthalekar, Nirmal Kaur, Vinod Chaubey, Richard Wholey, St.Vincent
Hospital, Worcester, MA, USA
162 - Killing Two Birds with One Stone: Management of Chronic Relapsing
Constrictive Pericarditis in the Setting of Rheumatoid Arthritis
Laprincess Brewer, Hector R Villarraga, Mayo Clinic College of Medicine,
Rochester, MN, USA
163 - Tuberculous Pericarditis with Disseminated Tuberculosis in an Adult
with Sickle Cell Disease and Massive Splenomegaly
Dharmaraj Karthikesan, Hospital Sultanah Bahiyah, Alor Setar, Kedah,
Malaysia
164 - Systemic Venous Congestion from Idiopathic Calcified Constrictive
Pericarditis
Mohammed Al-Hijji, Jae Yoon Park, Nandan Anavekar, Mayo Clinic,
Rochester, MN, USA
166 - Acute Kidney Injury Presenting with Cardiac Arrest, Widened QRS and
ST Elevation
Katherine Duello, Peter Pollack, Mayo Clinic Florida, Jacksonville, FL, USA
167 - Straightforward Ablation with an Anatomic Twist
Alan Sugrue, Samuel Asirvatham, Christopher McLeod, Mayo Clinic,
Rochester, MN, USA
168 - A Rare Cause of Complete Heart Block
Omar Abdul Ghani, David Singh, Queens Medical Center, University of Hawaii
John A Burns School of Medicine, Honolulu, HI, USA
169 - Fever-Induced Brugada Pattern Masquerading as Acute ST Elevation
Myocardial Infarction
Sushruth Edla, Katarzyna Hause-Wardega, Keyvan Ravakhah, St. Vincent
Charity Medical Center, Cleveland, OH, USA
170 - Andersen-Tawil Syndrome: A Novel Approach for the Management of
Ventricular Arrhythmias
Opeyemi Fadahunsi, Bilal Shaikh, David Scollan, Reading Health System, West
Reading, PA, USA
Stable Ischemic Heart Disease - Poster Contributions
Session #1263
Revascularization and Stable Ischemic Heart Disease
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
361 - Gender Differences in Coronary Revascularization Rates in the United
States: Insight from National Inpatient Sample
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 26 of 64
Program PDF
Updated: 2-23-15
Estefania Oliveros, Vladimir Lakhter, Chad Zack, Yevgeniy Brailovsky, Harish
Jarrett, Michael Lashner, Vikas Aggarwal, Brian O'Murchu, Brian O'Neill,
Howard Cohen, Alfred Bove, Riyaz Bashir, Temple University Hospital,
Philadelphia, PA, USA
362 - The Impact of Patient Distance from PCI Site on 30 Day Readmissions
and Mortality: Insights from the VA CART Program
Javier Valle, Thomas J. Glorioso, Evan Carey, Plomondon Meg, Baron Anna,
John Rumsfeld, Ehrin Armstrong, Steven Bradley, P. Ho, University of
Colorado, Aurora, CO, USA, VA Eastern Colorado Health Care System, Denver,
CO, USA
363 - Complete Coronary Revascularization in Some Clinical Settings Is Not
Enough: Comparison of Ivabradine, Ranolazine and Standard Medical
Therapy in Term of Efficacy and Tolerability
Simone Calcagno, Paolo Severino, Temistocle Taccheri, Filippo Placentino,
Andrea Ceccacci, Alessandra Cinque, Nicolo' Salvi, Pasqualina Bruno,
Massimo Mancone, Francesco Fedele, Umberto I Hospital, Sapienza
University of Rome, Rome, Italy
364 - Chronic Coronary Total Occlusions in Patients Undergoing AICD
Implantation
Marina Zakharova, Thomas Rector, Venkatakrishna Tholakanahalli, Demetris
Yannopoulos, Emmanouil Brilakis, Santiago Garcia, University of Minnesota,
Minneapolis, MN, USA
Stable Ischemic Heart Disease - Poster Contributions
Session #1264
Coronary Plaque, Macro- and Microvessels
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
365 - Detection of Ischemic Myocardial Segments Confirmed on Invasive
Fractional Flow Reserve Using the Time Interval Threshold Between Aortic
Valve Closure and Regional Peak Longitudinal Strain
Koya Ozawa, Nobusada Funabashi, Takeshi Nishi, Masayuki Takahara,
Hiroyuki Takaoka, Yoshihide Fujimoto, Yoshio Kobayashi, Chiba University
Graduate School of Medicine, Chiba, Japan
366 - Comparison of Protective Effect of Angiotensin II Receptor Blocker and
Calcium Channel Blocker for Endothelial Vasomotor Function After
Everolimus-Eluting Stent Implantation
Yasuhiro Aoki, Keishi Ishikawa, Keiichiro Miura, Kazumasa Sugimoto, Takashi
Nakayama, Yoshihide Fujimoto, Yoshio Kobayashi, Chiba University Graduate
School of Medicine, Chiba, Japan
367 - Association of Genotyping with Platelet Activation and Cardiovascular
Outcome in Patients After Percutaneous Coronary Intervention Receiving
Clopidogrel: Two Pieces of the Puzzle of Clopidogrel Resistance
Gerasimos Siasos, Stamatios Kioufis, Evangelos Oikonomou, Marina
Zaromitidou, Manolis Vavuranakis, Konstantinos Maniatis, Eleni Kokkou,
Nikolaos Gouliopoulos, Konstantinos Mourouzis, Sotirios Tsalamandris,
Athanasios Papavassiliou, Christodoulos I Stefanadis, Dimitris Tousoulis,
University of Athens Medical School, 1st Cardiology Department,
“Hippokration” Hospital, Athens, Greece
368 - Plaque Morphology Can be a Predictor of Future Coronary Events in
Relation to Lesions of Deferred Fractional Flow Reserve-Negative Stenosis
Monday, March 16, 2015
Daisuke Higashioka, Yoshiki Matsuo, Takashi Kubo, Yoshinori Asae, Hiroki
Emori, Yasunori Yamamoto, Tomoko Nakamura, Akira Taruya, Haruhi Nishio,
Tsuyoshi Nishiguchi, Ikuko Teraguchi, Yasutsugu Shiono, Makoto Orii, Takashi
Yamano, Yasushi Ino, Tomoyuki Yamaguchi, Kumiko Hirata, Atsushi Tanaka,
Takashi Akasaka, Wakayama Medical University, Wakayama, Japan
369 - Coronary Microvascular Dysfunction and Coronary Artery Calcification
in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, and
Rheumatoid Arthritis
Kentaro Kakuta, Kaoru Dohi, Yoshiko Sato, Takashi Yamanaka, Masaki
Kawamura, Shiro Nakamori, Ryuji Okamoto, Eitaro Fujii, Norikazu Yamada,
Masaaki Ito, Yokkaichi Hazu Medical Center, Department of Cardiology,
Yokkaichi, Japan
370 - Targeting Transgene to Heart and Liver with AAV9 by CMV and CBA
Promoters
Yi Tong Ma, Bang-Dang Chen, Chun-Hui He, Yi-Ning Yang, First Affiliated
Hospital of Xinjiang Medical University, Urumqi, People's Republic of China
371 - Higher Plasma Trimethylamine-N-Oxide Is Associated with Greater
Atherosclerotic Burden Quantified by the SYNTAX Score
Vichai Senthong, Xinmin Li, John Coughlin, Timothy Hudec, Sarah Neale, Lin
Li, Yuping Wu, Zeneng Wang, Stanley Hazen, Wai Hong Tang, Heart and
Vascular Institute, Cleveland Clinic, Cleveland, OH, USA
372 - Impact of Eicosapentaenoic Acid on Prognosis in Patients with Ischemic
Heart Disease and Optimally Controlled LDL-Cholesterol Level
Ryotaro Yamada, Teruyoshi Kume, Yoji Neishi, Ai Kawamura, Koichiro Imai,
Tomitaka Higa, Kenzo Fukuhara, Tomoko Tamada, Terumasa Koyama, Hiroshi
Okamoto, Kiyoshi Yoshida, Hiroyuki Okura, Kawasaki Medical School,
Kurashiki, Japan, The Sakakibara Heart Institute of Okayama, Okayama, Japan
373 - The Direct Effects of Nifedipine on Cholesterol Crystallization and
Vulnerable Plaque’s
Abrar R. Sayeed, Ehtesham Sayeed, Omair Ali, Abdul Wase, George Abela,
Wright State University, Dayton, OH, USA, Michigan State University, East
Lansing, MI, USA
374 - Coronary Microvascular Dysfunction: A Systematic Review of
Treatments
Mark Marinescu, Michelle Ouellette, Adrián Löffler, Lavone Smith, Jamieson
Bourque, University of Virginia, Charlottesville, VA, USA
375 - Vascular Healing Response of Calcified Coronary Lesions After
Everolimus Eluting Stent Implantation: Evaluation with Optical Coherence
Tomography
Yutaka Goryo, Shiro Uemura, Yoko Dote, Yu Sugawara, Tomoya Ueda,
Makoto Watanabe, Yoshihiko Saito, Nara Medical University, Kashihara,
Japan
376 - How to Make a Diagnosis of Microvascular Disease: The Diagnostic
Potency of Rest-Stress Myocardial Perfusion Magnetic Resonance Imaging
Takayuki Warisawa, Takeshi Nojo, Tatsuya Amano, Hiroto Yabushita, Yusuke
Watanabe, Satoru Mitomo, Kenichi Karube, Takahiro Matsumoto, Tomohiko
Sato, Toru Naganuma, Yusuke Fujino, Tsuyoshi Kobayashi, Kensuke Takagi,
Hisaaki Ishiguro, Satoko Tahara, Naoyuki Kurita, Koji Hozawa, Shotaro
Nakamura, Sunao Nakamura, New Tokyo Hospital, Matsudo, Chiba, Japan
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 27 of 64
Program PDF
Updated: 2-23-15
377 - High Levels of Fibrinogen, but Not Fibrinogen Genetic Variants Predict
Coronary Artery Disease in Subjects with Hypertension and Diabetes Mellitus
Type 2
Nikolaos Papageorgiou, Alexandros Briasoulis, George Hatzis, Maria
Kozanitou, Marietta Charakida, Antigoni Miliou, Emmanouel Androulakis,
Konstantinos Tsioufis, Gerasimos Siasos, Konstantinos Toutouzas, Spyridon
Papaioannou, George Latsios, Zoi Pallantza, Christodoulos I Stefanadis,
Dimitris Tousoulis, 1st Cardiology Department, Hippokration Hospital,
Athens, Greece
378 - Association of Serum Total Bilirubin Level with Severity of Coronary
Atherosclerosis Is Linked to Systemic Inflammation: Promising Results from a
Large Scale Cohort Study
Mehmet Kadri Akboga, Ugur Canpolat, Asife Sahinarslan, Yakup Alsancak,
Serdar Nurkoc, Dursun Aras, Sinan Aydogdu, Adnan Abaci, Turkiye Yuksek
Ihtisas Training and Research Hospital, Ankara, Turkey, Gazi University
Medical Faculty, Department of Cardiology, Ankara, Turkey
TCT@ACC-i2 (Interventional Cardiology)
Poster Contributions - Session #2104
Structural
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
269 - Novel High-Potency Oral Antiplatelet Drugs versus Clopidogrel in
Patients Undergoing Complex Percutaneous Coronary Intervention: Results
from a Large Single-Center All-Comers Registry
Gennaro Giustino, Usman Baber, Melissa Aquino, George Dangas, Jason
Kovacic, Pedro Moreno, Roy Swathi, Prakash Krishnan, Joseph Sweeny,
Roxana Mehran, Annapoorna Kini, Samin Sharma, The Mount Sinai Hospital,
New York City, NY, USA
270 - Pioglitazone Increased Circulating MicroRNA-24 with Decreases in
Coronary Neointimal Hyperplasia in Type 2 Diabetic Patients: Optical
Coherence Tomography Analysis
Soon Jun Hong, Jong-Ho Kim, Seung-Cheol Choi, Hyung Joon Joo, Jae Hyoung
Park, CheolWoong Yu, Do-Sun Lim, Korea University Anam Hospital, Seoul,
South Korea
271 - Transcatheter Aortic Valve Replacement in USA in 2012: Analysis of NIS
Data
Sourabh Aggarwal, Yashwant Agrawal, Western Michigan University Homer
Stryker School of Medicine, Kalamazoo, MI, USA
Monday, March 16, 2015
274 - Radial versus Femoral Access for Percutaneous Coronary Intervention
in Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of
38,587 Patients
Don Pham, Vu Hoang, Daniel Addison, Ameera Ahmed, Ravi Hira, Ihab
Hamzeh, Salim Virani, Nasser Lakkis, Mahboob Alam, Baylor College of
Medicine, Houston, TX, USA
275 - Impact of Cangrelor Overdosing on Bleeding Complications in Patients
Undergoing Percutaneous Coronary Intervention: Insights from the
CHAMPION Trials
Dominick J. Angiolillo, Deepak Bhatt, MD, Philippe Steg, Gregg Stone, Harvey
White, C. Michael Gibson, Christian Hamm, Matthew Price, Jayne Prats,
Tiepu Liu, Jonathan Day, Kenneth Mahaffey, Robert Harrington, University of
Florida, Jacksonville, FL, USA, Brigham and Women's Hospital - Harvard
Medical School, Boston, MA, USA
276 - GpIIb/IIIa Inhibitors Use Improves Outcomes After Aspiration
Thrombectomy in Patients with ST Elevation Myocardial Infarction: A
Metaregression Analysis
Sameer Ather, Navkaranbir Bajaj, Saurabh Gaba, Himanshu Aggarwal, Gopal
Ghimire, Vikas Bhatia, Akhil Parashar, Mustafa Ahmed, Charity Morgan,
Gregg Fonarow, Sumanth Prabhu, Prakash Deedwania, Wilbert Aronow,
Stefan D. Anker, Ali Ahmed, Massoud Leesar, University of Alabama at
Birmingham, Birmingham, AL, USA
277 - Early Clinical Experience with a Non-Vascular Treatment for Resistant
Hypertension
Richard Heuser, St. Luke's Medical Center, Phoenix, AZ, USA
278 - Bariatric Arterial Embolization as Treatment for Obesity: Mechanisms
Using Highly Calibrated 50 Micron Embolic Beads
Dara L. Kraitchman, Charles Hu, Robert Anders, Timothy Moran, Jaskaran
Singh, Paul DiCamillo, Eun Shin, Mao Hai-Quan, Tza-Huei Wang, Arepally
Aravind, Clifford Weiss, Johns Hopkins University School of Medicine,
Batlimore, MD, USA
280 - Cardiac Catheterization in Cancer Patients with Thrombocytopenia: 4Year Experience from a High Volume Cancer Center Cardiac Catheterization
Laboratory
Cezar Iliescu, Syed Yusuf, Gloria Iliescu, Pimprapa Vejpongsa, Jean-Bernard
Durand, Elie Mouhayar, Mehmet Cilingiroglu, Konstantinos Marmagkiolis,
MD Anderson Cancer Center, Houston, TX, USA, UT Health Science Center at
Houston, Houston, TX, USA
272 - The Use of Hemodynamic Indices as Predictors of Improvement in
Mitral Regurgitation after Transcatheter Aortic Valve Replacement (TAVR)
Rajiv Tayal, Martin Miguel Amor, Manjusha Anna, Cheng Chu, Alan Weinberg,
Afroditi Emporelli, Geru Wu, Patricia Panfile, Chunguang Chen, Bruce Haik,
Paul Burns, Mark Russo, Najam Wasty, David Baran, Marc Cohen, Newark
Beth Israel Medical Center, Newark, NJ, USA
281 - Non-Contrast Magnetic Resonance Angiography Can Accurately Define
Ileofemoral Arterial Access Size in Patients Referred for Transcatheter Aortic
Valve Replacement
Troy M. LaBounty, Nicole Bhave, Shivraman Giri, Jonathon Leipsic, Kevin
Packard, James Balter, Stanley Chetcuti, G. Michael Deeb, Paul Grossman,
Himanshu Patel, Smita Patel, Venkatesh Murthy, University of Michigan, Ann
Arbor, MI, USA
273 - Immediate Echocardiographic and Hemodynamic Results of
Percutaneous Transvenous Mitral Commissurotomy In Patients with
Symptomatic Mitral Restenosis After Closed Surgical Commissurotomy
Md.Toufiqur Rahman, Farazi Bakhtiar Ahmed, MD. Shahidul Islam, Abdullah
Majumder, Syed Haque, National Institute of Cardiovascular Diseases, Dhaka,
Dhaka, Bangladesh, Al-Helal Heart Institute, Dhaka, Bangladesh
282 - Fresh Adipose Tissue Derived Stem Cells Significantly Enhance
Ventricular Function in a Chronic Porcine Myocardial Infarction Model
Alexander Haenel, Mohamad Ghosn, Daryl G. Schulz, Jody Vykoukal, Dipan
Shah, Albert E. Raizner, Eckhard Alt, Tulane University School of Medicine,
New Orleans, LA, USA, Houston Methodist Hospital, Houston, TX, USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 28 of 64
Program PDF
Updated: 2-23-15
283 - Drug Release Profile of a Novel Sirolimus Eluting Bioresorbable Scaffold:
Implication on Neointimal Formation and Healing
Masahiko Shibuya, Kamal Ramzipoor, Chang Lee, Jennifer McGregor, Yanping
Cheng, Serge Rousselle, Alex Estrada, Greg Kaluza, Juan Granada, Skirball
Center for Innovation, Orangeburg, NY, USA
285 - A Systematic Review of Percutaneous Closure of Ruptured Sinus of
Valsalva Aneurysm in Adults
Abhishek Matta, Abhilash Akinapelli, Arun Nagabandi, Venkata Alla, Michael
Delcore, Creighton University Medical Center, Omaha, NE, USA
286 - Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug
Dosing Recommendations and Risk Stratification in Patients with Chronic
Kidney Disease Undergoing Percutaneous Coronary Interventions
Jessica Parsh, Milan Seth, Simon Dixon, Herbert Aronow, Hitinder Gurm,
University of Michigan Health System, Ann Arbor, MI, USA
287 - Reproducibility and Hemodynamic Dependence of Coronary Physiologic
Indices
Hyoung-Mo Yang, Marcel van't Veer, Martin K.C. Ng, Yuhei Kobayashi, Alan
Yeung, Nico Pijls, William Fearon, Stanford University Medical Center,
Stanford, CA, USA
288 - Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism on
Intra-Stent
Thrombi After Everolimus-Eluting Stent
Natsuko Tahara, Toshiro Shinke, Hiromasa Otake, Tomofumi Takaya,
Tsuyoshi Osue, Akihide Konishi, Hiroto Kinutani, Masaru Kuroda, Hachidai
Takahashi, Daisuke Terashita, Kenzo Uzu, Daiji Kashiwagi, Koji Kuroda, Yuto
Shinkura, Yoshinori Nagasawa, Ken-ichi Hirata, Kobe University Graduate
School of Medicine, Kobe, Japan
289 - The Impact of Lipid-Containing Plaque Composition Measured by NearInfrared Spectroscopy on Coronary Arterial Remodeling
Hideaki Ota, Marco Magalhaes Pereira, Smita Negi, Thibault Lhermusier,
Ricardo Escarcega Alarcon, Nevin Baker, Sarkis Kiramijyan, Edward Koifman,
Rebecca Torguson, Itsik Ben-Dor, Lowell Satler, William Suddath, Augusto
Pichard, Ron Waksman, MedStar Washington Hospital Center, Washington,
DC, USA
290 - Significance of Micro-Vessels Within Atherosclerotic Coronary Plaques:
A Study with Multiple Intravascular Imaging Modalities
Toshihiko Nishida, Takafumi Hiro, Tadateru Takayama, Mitsumasa Sudo,
Yoshiharu Higuchi, Atsushi Hirayama, Division of Cardiology, Department of
Mediciene Nihon University School of Medicine, Tokyo, Japan
291 - Culprit-Vessel versus Complete Revascularization During Primary
Angioplasty in ST-Segment Elevation Myocardial Infarction: An Updated
Meta-Analysis
Alexandros Briasoulis, Luis Afonso, Ashraf Mostafa, Sidakpal Panaich, Mohan
Palla, Ashok Kondur, Theodore Schreiber, Detroit Medical
Center/Cardiovascular Vascular Institute, Detroit, MI, USA
292 - Impact of Arterial Access Site on Risk for Acute Kidney Injury in Patients
Undergoing PCI: Results from a Large Single-Center PCI Registry
Avi Levine, Usman Baber, Melissa Aquino, Swathi Roy, Prakash Krishnan,
Pedro Moreno, Jason Kovacic, Roxana Mehran, Samin Sharma, Annapoorna
Kini, Mount Sinai Medical Center, New York, NY, USA
293 - A Different DES Should Be Implanted For DES-ISR
Monday, March 16, 2015
Takayuki Yabe, Mikihito Toda, Hideo Amano, Toho University Omori Medical
Center, Tokyo, Japan
294 - Impact of Left Ventricular Dysfunction on Outcomes in Patients with
Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights
from the AVIATOR Registry
Gennaro Giustino, Marco Mennuni, Jonathan Halperin, Omar Meelu,
Samantha Sartori, Usman Baber, George Dangas, Samin Sharma, Annapoorna
Kini, Corrado Tamburino, Alaide Chieffo, Antonio Colombo, Patrizia
Presbitero, Roxana Mehran, The Mount Sinai Hospital, New York City, NY,
USA
295 - How to Optimize Drug-Eluting Balloon Angioplasty For In-Stent
Restenosis: HOST-ISR DEB Registry
Kihyun Jeon, Sang Hyun Kim, Joo Myung Lee, Hack-Lyoung Kim, Jung-kyu
Han, Jae-Bin Seo, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, WooYoung Chung, Bon Kwon Koo, Myung-A Kim, Young-Bae Park, Hyo-Soo Kim,
Department of Internal Medicine and Cardiovascular Center, Seoul National
University Hospital, Seoul, South Korea, Division of Cardiology, Department
of Internal Medicine, Seoul National University Boramae Hospital, Seoul,
South Korea
296 - Bivalirudin versus Heparin Use in Primary Percutaneous Coronary
Intervention: An Updated Meta-Analysis of Randomized Controlled Trials
Rahman Shah, Adam Mizeracki, Kodangudi Ramanathan, Veterans Affairs
Medical Center, Memphis, TN, USA, University of Tennessee, Memphis, TN,
USA
297 - Late-Phase CRP Elevation and Long-Term Outcomes Among Patients
Who Underwent DES Implantation
Masanori Shiba, Masato Nakamura, Toho University Ohashi Medical Center,
Tokyo, Japan
298 - Differential Regulation of Inflammatory Adhesion Molecules During
Endothelial Regeneration After Permanent versus Bioresorbable Polymer DES
Implantation
Hiroyoshi Mori, Kazuyuki Yahagi, Tobias Koppara, Oscar Sanchez, Frank
Kolodgie, Qi Cheng, Eduardo Acampado, Renu Virmani, Michael Joner,
CVPath Institute, Gaithersburg, MD, USA
299 - Induction of Perturbed Shear Stress Leads to Focal Advanced
Atherosclerotic Plaque Formation in Transgenic Minipigs with
Hypercholesterolemia
Christian Bo Poulsen, Ryan M. Pedrigi, Vikram V. Mehta, Anouk Post, Nilesh
Pareek, Niels Ramsing Holm, Dogu Kilic, Mohammed El-Bahnasawi, Martin M.
Bjørklund, Niels Peter Andersen, Anne K. Grøndal, Arun Nachiappan, Nicolas
Foin, Justin E r Davies, Carlo Di Mario, Hans Erik Bøtker, Jacob F. Bentzon,
Erling Falk, Rob Krams, Ranil de Silva, Aarhus University Hospital, Aarhus,
Denmark, Imperial College London, London, United Kingdom
300 - Diagnostic Performance of iFR for Evaluation of Intermediate Left Main
Coronary Artery Stenoses
Ciro Indolfi, Annalisa Mongiardo, Carmen Spaccarotella, Daniele Torella,
Gianluca Caiazzo, Giovanni De Velli, Micaela Conte, Alberto Polimeni, Sabato
Sorrentino, Marco Contarini, Daniel Todaro, Salvatore De Rosa, Magna
Graecia University, Catanzaro, Italy
301 - Volume Reduction of Mitral Regurgitation Is Main Contributor to
Increase of Cardiac Forward Flow After Transcatheter Aortic Valve
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 29 of 64
Program PDF
Updated: 2-23-15
Replacement in Patients with Preprocedural Functional Mitral Regurgitation;
Hemodynamic Analysis Using Echocardiography
Yuji Itabashi, Kentaro Shibayama, Hirotsugu Mihara, Hiroto Utsunomiya,
Robert Siegel, Hasan Jilaihawi, Raj Makkar, Takahiro Shiota, Cedars-Sinai
Heart Institute, Los Angeles, CA, USA
302 - Acute Recoil Following Implantation of Everolimus-Eluting ABSORB
Biodegradable Vascular Scaffolds or Xience Metallic Stents: The ABSORB II
Trial
Bernard Chevalier, Yuki Ishibashi, Yoshinobu Onuma, Patrick W. Serruys, CA
Institut Jacques Cartier, Massy, France, Massy, France, Erasmus MC,
Rotterdam, The Netherlands
303 - Intravenous Adenosine Infusion Is Safe and Well Tolerated During
Coronary Fractional Flow Reserve Assessment in Severe Aortic Stenosis
Dusan A. Stanojevic, Prasad Gunasekaran, Micah Levine, Mark Reichuber,
Randall Genton, Ashwani Mehta, Matthew Earnest, Mark Wiley, Peter
Tadros, Buddhadeb Dawn, Kamal Gupta, Kansas University Medical Center,
Kansas City, KS, USA
304 - Initiation of Renal Replacement Therapy Following Transcatheter Aortic
Valve Replacement Is Associated with Dismal Outcomes
Jay Nitin Patel, Sonya Gadhvi, Michael Salama, Liliana Rios-Rojas, Joseph
Mattana, John Goncalves, Richard Schwartz, Kevin Marzo, Abdul Moiz Hafiz,
Winthrop-University Hospital, Mineola, NY, USA
305 - Requirement of Permanent Pacemaker Placement and Incidence of Left
Bundle Branch Block in Patients Undergoing Transcatheter Aoritc Valve
Implantation: A Meta-Analysis of Edwards SAPIEN Valve Versus Medtronic
CoreValve
Hemang B. Panchal, Neil Barry, Samit Bhatheja, Vijay Ramu, Timir Paul,
Steven Lavine, East Tennessee State University, Johnson City, TN, USA
Monday, March 16, 2015
University of Glasgow, Glasgow, United Kingdom, Golden Jubilee National
Hospital, Clydebank, United Kingdom
310 - The Effect Of Lumen Tortuosity And Guide Wire Stiffness On
Measurement Of Vessel Size Using Optical Coherence Tomography In A
Coronary Artery Model
Edward Danson, Peter Hansen, Ravinay Bhindi, Royal North Shore Hospital,
Sydney, Australia
311 - Beneficial Effect of Platelet Inhibition Against Peri-Procedural
Myocardial Infarction Due to Intra-Stent Thrombus Penetration: Optical
Coherence Tomography Sub-Analysis in Prasfit Elective
Kenzo Uzu, Toshiro Shinke, Hiromasa Otake, Tomofumi Takaya, Tsuyoshi
Osue, Masamichi Iwasaki, Akihide Konishi, Hiroto Kinutani, Masaru Kuroda,
Hachidai Takahashi, Daisuke Terashita, Ken-ichi Hirata, Shigeru Saito, Masato
Nakamura, Junya Shite, Takashi Akasaka, Kobe University Graduate School of
Medicine, Kobe, Japan
312 - Classifying Plaques According to Lipid Content As Assessed by Near
Infrared Spectroscopy: Implications for Plaque Vulnerability
Annapoorna Subhash Kini, Yuliya Vengrenyuk, Sadako Motoyama, Jacobo
Pena, Jonathan Feig, Usman Baber, Anitha Rajamanickam, Javed Suleman,
Joseph Sweeny, Jagat Narula, Samin Sharma, Pedro Moreno, Mount Sinai
Medical Center and Mount Sinai School of Medicine, New York, NY, USA
313 - Preclinical Safety Assessment of a Neointimal Suppressing CiglitazoneCoated Stent: Data from Scanning Electron and Confocal Microscopy in a
Rabbit Iliacal Artery Model
Sylvia Otto, Kristin Jaeger, Renu Virmani, Hans R. Figulla, Tudor Poerner, 1st
Medical Dept., Division of Cardiology, University Clinic Jena, Jena, Germany,
CV Path, Gaithersburg, MD, USA
306 - Index of Microcirculatory Resistance As an Early Predictive Factor of LV
Remodeling after Reperfused Myocardial Infarction
Marc Sirol, Arthur Cescau, Georogios Sideris, Damien Logeart, JeanGuillaume Dillinger, Jean-Jacques Mercadier, Patrick Henry, APHP-Lariboisire
University Hospital, Paris, France
314 - Coronary Aorta Diastolic Pressure Index: A New Novel Indicator for
Predicting Significant Coronary Stenosis. A Validation Against Fractional Flow
Reserve
Khawaja Afzal Ammar, Mirza Nubair Ahmad, Arsalan Riaz, Fatima A Husain,
Syed Shahab Kazmi, Haroon Yousaf, Imran Husain, Anjan Gupta, Aurora
Cardiovascular Services, Aurora Sinai/Aurora St. Luke’s Medical Centers,
Milwaukee, WI, USA
307 - The Impact of Inflammation on Reflected Waves After Transcatheter
Aortic Valve Implantation
Gerasimos Siasos, Manolis Vavuranakis, Eleni Kokkou, Maria Kariori, Mary
Lavda, Sophia Vaina, Carmen Moldovan, Konstantinos Kalogeras, Evangelia
Bei, Dimitrios Vrachatis, Konstantinos Mourouzis, Christodoulos I Stefanadis,
Dimitris Tousoulis, University of Athens Medical School, 1st Cardiology
Department, “Hippokration” Hospital, Athens, Greece
315 - Do We Need Systemic Anticoagulation and Dual Anti-Platelet Therapy
for Fractional Flow Reserve Calculation?
Mandeep Dhindsa, Fernando Boccalandro, Pro-Care Odessa Heart Institute,
Permian Research Foundation, Odessa, TX, USA, Texas Tech University Health
Science Center, Dept. of Internal Medicine, Odessa, TX, USA
308 - Mechanisms for False Thin-Cap Fibroatheromas Identified by Optical
Coherence Tomography
Taylor Hoyt, Jennifer Phipps, Deborah Vela, Maximillian Buja, Thomas Milner,
Marc Feldman, University of Texas Health Science Center-San Antonio, San
Antonio, TX, USA, Texas Heart Institute, Houston, TX, USA
316 - Long-Term Clinical Outcome of Patients with Acute Myocardial
Infarction Complicated by Cardiogenic Shock or Cardiac Arrest Who Received
Extracorporeal Membrane Oxygenation Assisted Primary Percutaneous
Coronary Intervention
Sung Won Cho, Jin Kun Jang, Sung Sik Kim, Seung Ho Kang, Cheju Halla
General Hospital, Jeju, South Korea
309 - Left Ventricular Outcomes Following Multivessel PCI versus Infarct-Only
PCI in Patients with Acute STEMI: The Glasgow PRAMI CMR Sub-Study
Kenneth Mangion, David Carrick, Alexander R. Payne, John McClure,
Maureen Mason, Mark Petrie, Margaret McEntegart, Hany Eteiba, Keith
Oldroyd, Colin Berry, BHF Glasgow Cardiovascular Research Centre,
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 30 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Valvular Heart Disease - Poster Contributions
Session #1261
The Stenotic Aortic Valve
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
Valvular Heart Disease - Poster Contributions
Session #1262
Prosthetic Valve Disease
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
347 - Effect of Beta-Blockade on Cardiovascular Event Rates in Patients with
Asymptomatic Aortic Stenosis
Casper N. Bang, Anders M. Greve, Anne B. Rossebø, Simon Ray, Kenneth
Egstrup, Kurt Boman, Christoph Nienaber, Peter Okin, Richard Devereux,
Kristian Wachtell, The New York Hosp. Cornell Med Ctr., New York, NY, USA,
Department of Medicine, Glostrup University Hospital, Copenhagen,
Denmark
353 - “Safe Period” of Anticoagulation Withdrawal in Patients with
Mechanical Heart Valve(s)
Rafael Cavalcanti, Benjamin Rosenbaum, Edward Benzel, Niraj Varma,
Cleveland Clinic Foundation, Cleveland, OH, USA, University of Kentucky,
Lexington, KY, USA
348 - National Utilization Patterns of Transcatheter Aortic Valve Replacement
Shortly After Device Approval
Michael Young, Kevin Kennedy, Robert Yeh, Vanderbilt University Medical
Center, Nashville, TN, USA, Massachusetts General Hospital, Boston, MA,
USA
349 - A Step Forward in the Minimalist Strategy for Transfemoral
Transcatheter Aortic Valve Implantation with the Edwards SAPIEN-XT
Prosthesis: Feasibility and Safety of Early Discharge
Guillaume Avinee, Carlos Rodriguez, Joseph Nader, Guillaume Viart,
Guillaume Cellier, Anaelle Abisror, Matthieu Godin, Christophe Tron, Eric
Durand, G. Alain Cribier, Helene Eltchaninoff, University Hospital of Rouen,
Cardiology Department, Inserm U1096, Rouen, France
350 - Accuracy of Preoperative Aortic Valve Annular Sizing Using Cardiac
Magnetic Resonance
Conor F. Hynes, Dominic A. Emerson, Michael D. Greenberg, Federico E.
Mordini, Gregory D. Trachiotis, Veterans Affairs Medical Center, Washington,
DC, USA, The George Washington University, Washington, DC, USA
351 - Major Vascular Complications After Transfemoral TAVI: Incidence and
Impact On 30-Day Mortality According to VARC-1 and VARC-2 Definitions
Joseph Nader, Eric Durand, Carlos Rodriguez, Guillaume Avinee, Guillaume
Cellier, Matthieu Godin, Christophe Tron, G. Alain Cribier, Helene
Eltchaninoff, Department of Cardiology, Rouen University Hospital, INSERM
U1096, Hospital Charles Nicolle, Rouen, France, Department of Cardiac
Surgery, Amiens Picardy University Hospital, Amiens, France
352 - Incidence of Pacemaker Implantation and Paravalvular Aortic
Insufficiency After Transcatheter Aortic Valve Replacement: A Comparison of
Three Generations of Edwards SAPIEN Valves
Paul Rogers, Ross Hoffman, Freddy Abi-samra, Michael Bernard, Sammy
Khatib, Glenn Polin, Tyrone Collins, Stephen Ramee, Daniel Morin, John
Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New
Orleans, LA, USA
354 - Mortality Predictors in Patients Referred for but Not Undergoing
Transcatheter Aortic Valve Replacement
Donna Kang, David Bach, Stanley Chetcuti, George M. Deeb, Paul Grossman,
Himanshu Patel, Daniel Menees, Matthew Romano, Troy LaBounty,
University of Michigan Health System, Ann Arbor, MI, USA
355 - Prognosis After Aortic Valve Replacement in Patients with Low Gradient
Severe Aortic Stenosis
Risa Fukumoto, Keitaro Mahara, Yuki Izumi, Ota Mitsuhiko, Kanako Kishiki,
Toshihiro Fukui, Jun Umemura, Shuichiro Takanashi, Tetsuya Sumiyoshi,
Hitonobu Tomoike, Sakakibara Heart Institute, Tokyo, Japan
356 - Von Willebrand Factor Activity Tests as Markers of Prosthesis
Dysfunction
Peter Pollak, Joseph Blackshear, Chad McRee, Mayo Clinic, Jacksonville, FL,
USA
357 - Heart Failure Readmission After Isolated Aortic Valve Replacement in
the Medicare Population: Role of Preoperative Heart Failure
Christina M. Vassileva, Tesfaye Telila, Stephen Hazelrigg, Stephen Markwell,
Southern Illinois University School of Medicine, Springfield, IL, USA
358 - Survival After Biological Aortic Root Replacement with a Xenobentall: A
Single Center Experience of 612 Consecutive Patients
Christian D. Etz, Alexandro Hoyer, Konstantin Von Aspern, Maximilian Luehr,
Farhad Bakhtiary, Martin Misfeld, Friedrich Mohr, Heart Center - University
of Leipzig, Leipzig, NM, Germany
359 - The Risk of Thromboembolic Complications Without Anticoagulation
After Surgical Aortic Valve Replacement With a Bioprosthesis
Peter B. Berger, Deepak Vedamurthy, Alfred Casale, Haiyan Sun, Charles
Benoit, Ashley Ferrari, Susan Trocciola, Ibrahim Ismail Sayed, Russell Carter,
Geisinger Health System, Danville, PA, USA
360 - Value of Neutrophil to Lymphocyte Ratio As a Predictor of Mortality in
Patients Undergoing Aortic Valve Replacement
Mirette Habib, Mohammad Thawabi, Amer Hawatmeh, Habib Habib, Walid
ElKhalili, Fayez Shamoon, Medhat Zaher, Saint Joseph Regional Medical
Center, Paterson, NJ, USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 31 of 64
Program PDF
Updated: 2-23-15
Vascular Medicine - Poster Contributions
Session #1257
Pulmonary Embolism
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
331 - Use of Advanced Therapies for Acute Pulmonary Embolism and Related
Outcomes Among Fee-for-Service Medicare Beneficiaries from 1999 to 2010
Behnood Bikdeli, Yun Wang, Karl Minges, Nihar Desai, Nancy Kim, Mayur
Desai, John Spertus, Frederick Masoudi, Brahmajee Nallamothu, Samuel
Goldhaber, Harlan Krumholz, Yale University School of Medicine, New Haven,
CT, USA
332 - Mortality, Expense and Length of Stay with Local versus Systemic
Thrombolysis in Pulmonary Embolism: An Analysis of Five Years of the
Nationwide Inpatient Sample Database
Saurav Chatterjee, Partha Sardar, Sahil Parikh, Anjali Vaidya, Anasua
Chakraborty, Debabrata Mukherjee, Jay Giri, Mount Sinai St Luke's-Roosevelt
Hospitals, New York City, NY, USA, University of Pennsylvania Perelman
School of Medicine, Philadelphia, PA, USA
Vascular Medicine - Poster Contributions
Session #1258
Advanced in Pharmacomechanical Therapy for Deep Vein
Thrombosis
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
333 - Percutaneous Endovenous Intervention Plus New Oral Anticoagulants
in Cancer Patients with Lower Extremity Deep Venous Thrombosis
Mohsen Sharifi, Wilbur Freeman, Curt Bay, Mirali Sharifi, Jean Chatham,
Frederic Schwartz, Arizona Cardiovascular Consultants & Vein Clinic, Mesa,
AZ, USA, A.T. Still University, Mesa, AZ, USA
334 - Sex Differences in Utilization and Outcomes of Catheter Directed
Thrombolysis in Patients with Proximal Lower Extremity Deep Venous
Thrombosis
Vladimir Lakhter, Chad Zack, Vikas Aggarwal, Yevgeniy Brailovsky, Harish
Jarrett, Estefania Oliveros, Michael Lashner, Grayson Wheatley, Alfred Bove,
Riyaz Bashir, Temple University Hospital, Philadelphia, PA, USA
Vascular Medicine - Poster Contributions
Session #1259
Vascular Medicine Potpourri
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
335 - Role of Angiopoetin-1, Angiopoietin-2, and Endothelial Function in HIV
Mark Joshua Dela Cruz, Y. Ma, Rebecca Scherzer, Alan Wu, Kristinalisa Maka,
Steven Deeks, Peter Ganz, Priscilla Hsue, University of California, San
Francisco, San Francisco, CA, USA
336 - Treatment with an Inorganic Nitric Oxide Donor Recapitulates the
Effects of Sarcolemmal Nnos on Muscle Blood Flow Regulation in Patients
with Becker Muscular Dystrophy
Monday, March 16, 2015
Michael D. Nelson, O'Neil Mason, Florian Rader, Ryan Rosenberry, Avery
Schwartz, Xiu Tang, Sarah Shidban, Neigena Mobaligh, Robert Elashoff,
Thomas Stabler, Jason Allen, Evgeny Tsmirinov, Rita Barresi, Ronald Victor,
Cedars-Sinai Heart Institute, Los Angeles, CA, USA
337 - Inflammation and Vascular Compliance Measurements: A Paradox? The
Bogalusa Heart Study
Camilo Fernandez - Alonso, Rupert Barshop, Roberto Blandon, Shengxu Li,
Wei Chen, Sathanur R. Srinivasan, Gerald S. Berenson, Tulane University
Health Sciences Center, New Orleans, LA, USA
338 - MicroRNA-483 Targeting Connective Tissue Growth Factor: Implication
in Kawasaki Disease
Ming He, Zhen Chen, Marcy Martin, Jin Zhang, Chisato Shimizu, Jane Burns,
John Y-J Shyy, University of California, San Diego, La Jolla, CA, USA
339 - Decreased Integrin α9 Expression Involves in the Pathogenesis of Acute
Aortic Dissection by Inducing Phenotype Transition of Smooth Muscle Cell
Bi Huang, Xiaojian Wang, Xiaohan Fan, Yanmin Yang, Rutai Hui, Shu Zhang,
State Key Laboratory of Cardiovascular Disease, Emergency and Critical Care
Center, National Center, Beijing, People's Republic of China
340 - Protein Kinase C-α Inhibits Angiogenesis Induced by Platelet-Derived
Growth Factor C In Hyperglycemic Endothelial Cells
Junji Moriya, Napoleone Ferrara, University of California, San Diego, La Jolla,
CA, USA
341 - Ticagrelor’s Antiplatelet Effect is Modified by Acidification and Nitrites,
and Readily Forms Nitrosothiol Compounds to Augment its Antiplatelet Effect
in Vitro
Laurence Thornhill, Philip E. James, Richard Anderson, Wales Heart Research
Institute, Cardiff, United Kingdom, University Hospital of Wales, Cardiff,
United Kingdom
342 - Eicosapentaenoic Acid Reduces Small Dense Low Density Lipoprotein
Oxidation and Improves Endothelial Function In Vitro as Compared to other
Triglyceride-Lowering Agents
Richard Preston Mason, Robert Jacob, J. Jose Corbalan, Tadeusz Malinski,
Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA,
Elucida Research LLC, Beverly, MA, USA
Vascular Medicine - Poster Contributions
Session #1260
Vascular Function: Emerging Concepts
Monday, March 16, 2015, 9:30 a.m. - 12:30 p.m.
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
343 - Transferrin Receptor 1 Is Involved in the Mechanism of Human Vascular
Remodeling in Atherosclerotic Lesions
Hisashi Sawada, Yoshiro Naito, Makiko Oboshi, Koichi Nishimura, Akiyo
Eguchi, Yoshitaka Okuhara, Daisuke Morisawa, Toshihiro Iwasaku, Shinichi
Hirotani, Toshiaki Mano, Masaharu Ishihara, Tohru Masuyama, Hyogo
College of Medicine, Nishinomiya, Japan
344 - Declined Visual Acuity Is Associated with Vascular Dysfunction in
Patients with Diabetes Mellitus
Gerasimos Siasos, Nikolaos Gouliopoulos, Marilita Moschos, Evangelos
Oikonomou, Georgia Siasou, Theodore Paraskevopoulos, Theodosia Konsola,
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 32 of 64
Program PDF
Updated: 2-23-15
Christina Kollia, Theodoros Zografos, Konstantinos Mourouzis, Marina
Zaromitidou, Athanasios Papavassiliou, Christodoulos I Stefanadis, Dimitris
Tousoulis, University of Athens Medical School, 1st Cardiology Department,
“Hippokration” Hospital, Athens, Greece
345 - Dietary Sodium and Arterial Function: The PURSE-HIS Study
Mohan Thanikachalam, Hari Vanzan, Vijay Nambi, Sadagopan Thanikachalam,
Tufts University School of Medicine, Boston, MA, USA, Sri Ramchandra
University, Porur, India
346 - Cardiovascular Effects of Carfilzomib, a New Proteasome Inhibitor, on
Coronary Resistencies, Vascular Tone and Vascular Reactivity
Tiziano M. Scarabelli, Carol Chen-Scarabelli, Mara Gavazzoni, Gagan Sahni,
Louis Saravolatz, Riccardo Raddino, Jagat Narula, Mount Sinai Hospital, New
York, NY, USA
Acute Coronary Syndromes - Moderated Poster Contributions
Session #1266M
What's New in ACS?
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Acute Coronary Syndromes Moderated Poster Theater, Poster Hall
B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Shaun G. Goodman
ACC Poster Moderator: Robert Roswell
9:45 a.m.
Acute Myocardial Infarction with Cardiogenic Shock Among Medicare
Beneficiaries: Do Reperfusion and Revascularization Matter?
Aaron D. Kugelmass, Phillip P. Brown, David Cohen, Matthew Reynolds,
Kimberly K. Wright, April W. Simon, Steven D. Culler, Baystate Medical
Center, Springfield, MA, USA, Clinical Data Solutions, Atlanta, GA, USA
9:55 a.m.
Question and Answer
10:00 a.m.
The Comparative Efficacy of Bivalirudin Is Markedly Attenuated by Use of
Radial Access: Insights from Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2)
Emily Perdoncin, Milan Seth, Hitinder Gurm, University of Michigan, Ann
Arbor, MI, USA
10:10 a.m.
Question and Answer
10:15 a.m.
Contemporary Trends of Pharmacoinvasive Strategy in Patients with STSegment Elevation Myocardial Infarction in Different Region of United States:
Insights from Nationwide Inpatient Sample
Nish Patel, Nileshkumar Patel, Badal Thakkar, Ankit Chothani, Nilay Patel,
Shilpkumar Arora, Vikas Singh, Sunny Jhamnani, Sidakpal Panaich, Abhishek
Deshmukh, Apurva Badheka, Carlos Alfonso, Mauricio Cohen, University of
Miami Miller School of Medicine, Miami, FL, USA
10:25 a.m.
Question and Answer
Monday, March 16, 2015
Arrhythmias and Clinical EP - Moderated Poster Contributions
Session #1270M
Risk Factor and Demographic Influences in Arrhythmias
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Arrhythmias and Clinical EP Moderated Poster Theater, Poster Hall
B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Jim W. Cheung
ACC Poster Moderator: Alexander Mazur
9:45 a.m.
Familial Clustering of Syncope in First-Degree Relatives: A Danish Nationwide
Study
Deewa Zahir, Louise E. Bruun, Anna-Karin Nume, Martin Ruwald, Gunnar
Gislason, Gentofte Hospital, Hellerup, Denmark
9:55 a.m.
Question and Answer
10:00 a.m.
Effect of Weight Loss on Ventricular Repolarization: A Meta-Analysis of
Clinical Studies
Jad Omran, Belal Firwana, Ashraf Al-Dadah, Martin Alpert, University of
Missouri Hospital and Clinics, Columbia, MO, USA
10:10 a.m.
Question and Answer
10:15 a.m.
Body Mass Index and Outcomes with Apixaban versus Warfarin in Patients
with Atrial Fibrillation in the ARISTOTLE (Apixaban for Reduction in Stroke
and Other Thromboembolic Events in Atrial Fibrillation) Trial
Roopinder K. Sandhu, Justin Ezekowitz, Ulrika Andersson, John Alexander,
Christopher Granger, Sigrun Halvorsen, Michael Hanna, Ziad Hijazi, Petr
Jansky, Renato Lopes, Lars Wallentin, University of Alberta, Edmonton,
Canada
10:25 a.m.
Question and Answer
Congenital Heart Disease - Moderated Poster Contributions
Session #1271M
Congenital Heart Disease: Anomalous Coronary Artery Origin
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Congenital Heart Disease Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
9:45 a.m.
Anomalous Origin of the Coronary Arteries: Incidence and Outcomes among
Patients Undergoing Coronary CTA
Michael Cheezum, Brian Ghoshhajra, Marcio Bittencourt, Edward Hulten,
Negareh Mousavi, Michael Steigner, Frank Rybicki, Nishant Shah, Thomas
MacGillivray, Ami Bhatt, Anne Marie Valente, Suhny Abbara, Udo Hoffmann,
Marcelo Di Carli, Doreen Yeh, Michael Landzberg, Richard Liberthson, Ron
Blankstein, Brigham and Women's Hospital, Boston, MA, USA, Massachusetts
General Hospital, Boston, MA, USA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 33 of 64
Program PDF
Updated: 2-23-15
9:55 a.m.
Question and Answer
10:00 a.m.
Prevalence and Long Term Follow-up of Anomalous Coronary Arteries
Originating from Opposite Sinus (ACAOS)
Negin Nezarat, Yanting Luo, Sirous Darabian, Rine Nakanishi, Anas Alani,
Suguru Matsumoto, Jeby Abraham, Fernandez Flores, Matthew Budoff,
LAbioMED, Torrance, CA, USA
Monday, March 16, 2015
10:15 a.m.
Paradigm Change in the Demographics of Mortality in Hypertrophic
Cardiomyopathy
Barry J. Maron, Ethan J. Rowin, Susan Casey, Mark Link, John R. Lesser,
Raymond H. M. Chan, Ross Garberich, James E. Udelson, Martin Maron,
Minneapolis Heart Institute Foundation, Minneapolis, MN, USA, Tufts
Medical Center, Boston, MA, USA
10:25 a.m.
Question and Answer
10:10 a.m.
Question and Answer
10:15 a.m.
Standardized Approach to Patients with Anomalous Aortic Origin of a
Coronary Artery: Results from the Coronary Anomalies Program at Texas
Children’s Hospital
Silvana Molossi, Carlos Mery, Rajesh Krishnamurthy, Kristen Sexson, Kathleen
Carberry, Carmen H. Watrin, Dana Reaves, Prakash Masand, Dean McKenzie,
Charles Fraser, Baylor College of Medicine, Houston, TX, USA, Texas
Children's Hospital, Houston, TX, USA
10:25 a.m.
Question and Answer
ACC Poster Moderator: Frank Cetta
ACC Poster Moderator: Lowell H. Frank
Heart Failure and Cardiomyopathies - Moderated Poster
Contributions
Session #1269M
New Insights in Hypertrophic Cardiomyopathy
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Heart Failure and Cardiomyopathies Moderated Poster Theater,
Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Barry J. Maron
ACC Poster Moderator: David Owens
9:45 a.m.
Serum Biomarkers of Early Stages of Hypertrophic Cardiomyopathy in a
Young Population
Eva I. Fernlund, Tom Gyllenhammar, Anders Larsson, Johan Arnlov, Marcus
Carlsson, Robert Jablonowski, Petru Liuba, Dept. of Pediatric Cardiology,
Lund, Sweden, Dept. of Pediatrics, Linkoping, Sweden
9:55 a.m.
Question and Answer
10:00 a.m.
Patients With Genotype-Positive Hypertrophic Cardiomyopathy Are at
Increased Risk of Heart Failure Related Death
H. G. van Velzen, P. A. Vriesendorp, R. A. Oldenburg, M. A. van Slegtenhorst,
A. F.L. Schinkel, M. Michels, Erasmus Medical Centre, Thoraxcentre,
Department of Cardiology, Rotterdam, The Netherlands
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Moderated Poster Contributions - Session #1265M
Fusion Imaging
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Non Invasive Imaging Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Zahi A. Fayad
ACC Poster Moderator: Ahmed A. Tawakol
9:45 a.m.
First in Man Observations with Simultaneous 18F-FDG PET and MR Imaging in
Peripheral Artery Disease Using a Whole-Body Integrated Scanner
Tobias Koppara, Isabel Dregely, Kristin Kuhs, Stephan Nekolla, Karl-Ludwig
Laugwitz, Markus Schwaiger, Renu Virmani, Tareq Ibrahim, Klinikum rechts
der Isar der Technischen Universität München, München, Germany, CV PATH
Institute, Inc., Gaithersburg, MD, USA
9:55 a.m.
Question and Answer
10:00 a.m.
PET/CTA Image Fusion for Noninvasive Absolute Myocardial Flow
Quantification Across Specific Coronary Lesions
Hee-Seung Bom, Marina Piccinelli, Ernest Garcia, John Votaw, C. David
Cooke, Russell Folks, Daya Manatunga, Habib Samady, Chonnam National
University, Gwangju, South Korea, Emory University, Atlanta, GA, USA
10:10 a.m.
Question and Answer
10:15 a.m.
Head to Head Comparison of Inflammation and Neovascularization in Human
Carotid Plaques
Fabian Demeure, Caroline Bouzin, Veronique Roelants, François-Xavier
Hanin, Anne Bol, Bernhard Gerber, Anne-Catherine Pouleur, Agnes Pasquet,
Jean-Louis J. Vanoverschelde, David Vancraeynest, Institut de Recherche
Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels,
Belgium
10:25 a.m.
Question and Answer
10:10 a.m.
Question and Answer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 34 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Non-Certified Industry Events - Learning Destinations
Session #4007
Same-Day Discharge Strategy for PCI – What are Key
Considerations?
Monday, March 16, 2015, 9:45 a.m. - 10:45 a.m.
Expo Hall 3545
CME Hours: /CNE Hours:
History or Prevalent Coronary Calcium in a Multi-Ethnic Population-Based
Study
Purav Mody, Andre Paixao, Amit Khera, Colby Ayers, James de Lemos, Anand
Rohatgi, University of Texas Southwestern Medical Center, Dallas, TX, USA
9:45 a.m.
Same-Day Discharge Strategy for PCI - What are Key Considerations?
Sunil V. Rao
Durham, NC
10:15 a.m.
Particulate Air Pollution and Carotid Artery Stenosis
Jonathan Newman, George D. Thurston, Kevin Cromar, Yu Guo, Jeffrey
Berger, Caron Rockman, Edward Fisher, New York University Medical School,
New York, NY, USA
9:45 a.m.
Same-Day Discharge Strategy for PCI - What are Key Considerations?
Ehtisham Mahmud
San Diego, CA
9:45 a.m.
Same-Day Discharge Strategy for PCI - What are Key Considerations?
Ian Gilchrist
Hershey, PA
9:45 a.m.
Same-Day Discharge Strategy for PCI - What are Key Considerations?
Khaldoon Alaswad
Appleton, WI
10:10 a.m.
Question and Answer
10:25 a.m.
Question and Answer
Special Topics - Moderated Poster Contributions
Session #1268M
FIT Clinical Decision Making: Moderated Poster Session IV
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Pulmonary Hypertension and FIT Clinical Decision Making
Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Suzanne Baron
ACC Poster Moderator: Chittur A. Sivaram
Non-Certified Industry Events - Learning Destinations
Session #4015
Industry-Expert Theater West Presentation
Monday, March 16, 2015, 9:45 a.m. - 10:45 a.m.
Expo Hall 145
CME Hours: /CNE Hours:
9:45 a.m.
Termination of a Left Atrial Tachycardia by Left Atrial Appendage Ligation
Moustapha Atoui, Sampath Gunda, Jayasree Pillarisetti, Muhammad Afzal,
Donita Atkins, Madhu Reddy, Dhanunjaya Lakkireddy, University of Kansas
Hospital, Kansas CIty, KS, USA
Industry-Expert Theater West Presentation
9:55 a.m.
Question and Answer
Prevention - Moderated Poster Contributions
Session #1267M
Biomarkers and Exposures: Linking to CVD
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Prevention Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
ACC Poster Moderator: Emil deGoma
ACC Poster Moderator: Donna M. Polk
9:45 a.m.
A Novel Biomarker of Circulating Glycoproteins and Cardiovascular and AllCause Mortality among 39,521 Initially Healthy Adults
Patrick R. Lawler, Akintunde Akinkuolie, Julie Buring, Paul Ridker, Robert
Glynn, Samia Mora, Brigham and Women's Hospital, Boston, MA, USA
9:55 a.m.
Question and Answer
10:00 a.m.
High Density Lipoprotein Cholesterol Efflux Capacity as a Novel Risk Marker
for Incident Atherosclerotic Cardiovascular Disease Independent of Family
10:00 a.m.
Platypnea-Orthodeoxia and Right Heart Failure from Iatrogenic Atrial Septal
Defect
Jaspreet Singh, Dan Inder Sraow, Rajiv Jauhar, S. Jacob Scheinerman, Rohan
Bhansali, Perwaiz Meraj, Hofstra North Shore-LIJ School of Medicine, New
Hyde Park, NY, USA
10:10 a.m.
Question and Answer
10:15 a.m.
Pheochromocytoma Associated Cardiomyopathy Mimicking Acute STElevation Myocardial Infarction
Shailendra Singh, John Makaryus, Shahryar Saba, Evelina Grayver, Leon
Bacchus, Loukas Boutis, Hofstra North Shore-LIJ School of Medicine,
Manhasset, NY, USA
10:25 a.m.
Question and Answer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 35 of 64
Program PDF
Updated: 2-23-15
Stable Ischemic Heart Disease - Moderated Poster Contributions
Session #1274M
Surgical Revascularization for Ischemic Heart Disease
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Stable Ischemic Heart Disease Moderated Poster Theater, Poster
Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
9:45 a.m.
Post Procedural Stroke in Coronary Artery Bypass Grafting and Percutaneous
Interventions: An 11 Year Statewide Analysis
Abel E. Moreyra, Gregory A. Maniatis, Hui Gu, William J. Kostis, Nora M.
Cosgrove, John Pantazopoulos, John B. Kostis, for the MIDAS Study Group,
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
9:55 a.m.
Question and Answer
10:00 a.m.
The Clinical and Angiographic Outcomes in Coronary Artery Bypass Surgery
Using Grafts with Multiple versus Single Distal Targets
Aws Alherbish, Colleen Norris, Jayan Najendran, Michelle Graham, Sean Van
Diepen, University of Alberta, Edmonton, Canada
10:10 a.m.
Question and Answer
10:15 a.m.
Routine Coronary Artery Bypass of Angiographically Borderline Coronary
Artery Stenoses is not Associated with Improved Survival
Janek Senaratne, Colleen Norris, Michelle Graham, Jayan Nagendran, Darren
Freed, Jonathan Afilalo, Sean Van Diepen, University of Alberta, Edmonton,
Canada
Monday, March 16, 2015
10:00 a.m.
Persistence of Iatrogenic Atrial Septal Defect After Interventional Mitral
Valve Repair with the Mitraclip System: A Note of Caution
Christoph Hammerstingl, Can Öztürk, Robert Schueler, Nikos Werner, Armin
Welz, Georg Nickenig, Heart Centre, University of Bonn, Bonn, Germany
10:10 a.m.
Question and Answer
10:15 a.m.
The Incidence of Paravalvular Regurgitation in Transthoracic
Echocardiography-Guided Deployment of Transcatheter Aortic Valve Is
Comparable to That of Transesophageal Echocardiography-Guided
Deployment
Salim Hayek, Arash Harzand, Hawkins Gay, Christina Chrysohoou, Jose
Condado Contreras, Vasilis Babaliaros, Vinod Thourani, Stamatios Lerakis,
Emory University School of Medicine, Atlanta, GA, USA
10:25 a.m.
Question and Answer
Valvular Heart Disease - Moderated Poster Contributions
Session #1273M
Multimodality Imaging for Prognosis in Aortic Stenosis
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Valvular Heart Disease Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
10:25 a.m.
Question and Answer
9:45 a.m.
Prognostic Value of Global Longitudinal Strain Assessed by 3D Speckle
Tracking Echocardiography in Asymptomatic Patients with Severe Aortic
Stenosis
Yasufumi Nagata, Masaaki Takeuchi, Victor Chien-Chia Wu, Masaki Izumo,
Kengo Suzuki, Kimi Sato, Yoshihiro Seo, Kyoko Otani, Yoshihiro Akashi,
Kazutaka Aonuma, Yutaka Otsuji, University of Occupational and
Environmental Health, Kitakyushu, Japan
ACC Poster Moderator: Robert A. Guyton
ACC Poster Moderator: Hiroo Takayama
9:55 a.m.
Question and Answer
TCT@ACC-i2 (Interventional Cardiology)
Moderated Poster Contributions - Session #2109M
TCT@ACC-i2: Interventional Cardiology V
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
TCT@ACC-i2 Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
10:00 a.m.
Assessment of Frailty Using Patient-Provided Information Independently
Predicts Outcome in Aortic Stenosis
Marie-Annick Clavel, Sheila M. Manemann, Youssef Maalouf, Hector
Michelena, Veronique Roger, Maurice Enriquez-Sarano, Mayo Clinic,
Rochester, MN, USA
ACC Poster Moderator: Philippe Genereux
10:10 a.m.
Question and Answer
9:45 a.m.
Largest Series of Completely Percutaneous Antegrade TransseptalTransapical Mitral Valve-in-Valve Implantation for Bioprosthetic Dysfunction
Sean R. Wilson, Chad Kliger, Sonnit Sharma, Weiss Dillon, Vladimir Jelnin,
Itzhak Kronzon, Gila Perk, Ahmed Al-Badri, Nirav Patel, Gregory Fontana,
Carlos Ruiz, Lenox Hill Hospital, New York, NY, USA
9:55 a.m.
Question and Answer
10:15 a.m.
Adverse Prognosis Associated with Asymmetric Myocardial Thickening in
Aortic Stenosis
Calvin Woon Loong Chin, Emily Yeung, Anoop Shah, Scott Semple, Maria Koo,
Nicholas Mills, David Newby, Marc Dweck, University of Edinburgh,
Edinburgh, United Kingdom, National Heart Center Singapore, Singapore,
Singapore
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 36 of 64
Program PDF
Updated: 2-23-15
10:25 a.m.
Question and Answer
ACC Poster Moderator: Bahar Pirat
Vascular Medicine - Moderated Poster Contributions
Session #1272M
Aortic Diseases: Keys for the Vascular Specialist
Monday, March 16, 2015, 9:45 a.m. - 10:30 a.m.
Vascular Medicine Moderated Poster Theater, Poster Hall B1
CME Hours: 0.75 /CNE Hours: 0.75
Monday, March 16, 2015
Arrhythmias and Clinical EP - Scientific Session
Session #686
Abnormal ECG? Asymptomatic? What Next?
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 1B
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Melvin M. Scheinman
Co-Chair: Brian Olshansky
Panelist: Michael J. Ackerman
Panelist: Andrew D. Krahn
9:45 a.m.
Mutations in Smooth Muscle Aortic Alpha-Actin Gene Are Associated with
Familial Thoracic Aortic Aneurysm and Dissection
Nupoor Narula, Eliana Disabella, Valentina Favalli, Alessandra Serio, Maurizia
Grasso, Carmelina Giorgianni, Tonia Fiantanese, Takahide Kodama, Eloisa
Arbustini, Center for Inherited Cardiovascular Diseases – IRCCS Policlinico San
Matteo, Pavia, Italy
10:45 a.m.
CASE PRESENTATION: A 27 Year Old Man With a Brugada Pattern ECG
Abigail Matos-Pagan
Mayaguez, PR
9:55 a.m.
Question and Answer
10:57 a.m.
Question and Answer
10:00 a.m.
Weekend Admissions for Acute Aortic Dissection Have a Higher Risk of InHospital Mortality Compared to Weekday Admissions
Nilay Kumar, Anand Venkatraman, Ambarish Pandey, Neetika Garg,
Cambridge Health Alliance/Harvard Medical School, Cambridge, MA, USA,
Beth Israel Deaconess Medical Center, Boston, MA, USA
11:07 a.m.
CASE PRESENTATION: A 46 Year Old Man With ST Segment Elevation in the
Inferior ECG Leads
Dan Hu
Utica, NY
10:50 a.m.
Panel Discussion
11:12 a.m.
Panel Discussion
10:10 a.m.
Question and Answer
10:15 a.m.
Impact of Type-II Endoleak on Aneurysm Sac Growth and Predictors of TypeII Endoleak After Endovascular Aneurysm Repair
Ren Kawaguchi, Yusuke Miyaishi, Hakuken Kan, Masahiko Ezure, Tatsuo
Kaneko, Shigeru Oshima, Gunma Prefectural Cardiovascular Center, Gunma,
Japan
11:19 a.m.
Question and Answer
11:30 a.m.
CASE PRESENTATION: A 36 Year Old Woman With a Prolonged QT
Sami Viskin
Tel Aviv, Israel
10:25 a.m.
Question and Answer
11:35 a.m.
Panel Discussion
ACC Poster Moderator: Cameron W. Donaldson
ACC Poster Moderator: John R. Laird
11:42 a.m.
Question and Answer
Non-Certified Industry Events - Learning Destinations
Session #4407
Cardiac Tamponade Simulation Training
Monday, March 16, 2015, 10 a.m. - 10:30 a.m.
Expo Hall 3932
CME Hours: /CNE Hours:
11:52 a.m.
CASE PRESENTATION: An 18 Year Old Brazilian Soccer Player With Frequent
PVCs
Mikhael El-Chami
Atlanta, GA
Cardiac Tamponade Simulation Training
11:57 a.m.
Panel Discussion
12:04 p.m.
Question and Answer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 37 of 64
Program PDF
Updated: 2-23-15
Congenital Heart Disease - Special Session
Session #411
2015 Dan G. McNamara Lecture: An Historical Perspective of
Pediatric Cardiology’s Quality and Registry Efforts
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 31C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Robert H. Beekman
Co-Chair: Kathy J. Jenkins
10:45 a.m.
Welcome and Reflecting on McNamara Lecture
Daniel J. Murphy
11:21 a.m.
Should MR Be Fixed in Heart Failure?
Steven F. Bolling
Ann Arbor, MI
11:36 a.m.
Question and Answer
11:39 a.m.
When to Consider Tricuspid Valve Repair
Valluvandam Jeevanandam
Chicago, IL
11:54 a.m.
Question and Answer
10:55 a.m.
Introduction of Dr. James Moller
Roberta G. Williams
Los Angeles, CA
11:05 a.m.
Using Data to Improve Quality: The Pediatric Cardiac Care Consortium
James H. Moller
Minneapolis, MN
11:35 a.m.
New Directions for Quality Improvement in Congenital Heart Disease
Jeffrey P. Jacobs
Saint Petersburg, FL
11:55 a.m.
Interview with Dr. James Moller
Hugh D. Allen
Houston, TX
11:57 a.m.
Aortic Valve Stenosis With Low EF: TAVR Versus Replacement
Joseph E. Bavaria
Philadelphia, PA
12:12 p.m.
Question and Answer
Heart Failure and Cardiomyopathies - Scientific Session
Session #688
Contemporary Controversies in Heart Failure: Arrhythmia
Management at the Extremes
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 5A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Mohammad Munawar
Heart Failure and Cardiomyopathies - Scientific Session
Session #687
Surgical Controversies in Heart Failure Management
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 6C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Michael A. Acker
Co-Chair: Christina M. Vassileva
10:45 a.m.
CAD and Low EF: Does Viability Assessment Matter?
Lyle Joyce
11:00 a.m.
Question and Answer
11:03 a.m.
When Is Less More? Minimally Invasive Surgery in Low EF
Michael J. Mack
Plano, TX
11:18 a.m.
Question and Answer
Monday, March 16, 2015
10:45 a.m.
Management of Ventricular Tachycardia in Advanced Heart Failure: ICD
Implantation in End Stage Heart Failure and LVAD Patients: Who Needs an
ICD?
Wayne C. Levy
11:00 a.m.
Management of PVCs and Ventricular Tachycardia in Advanced Heart Failure:
Therapeutic Options and Novel Approaches
Melissa R. Robinson
Seattle, WA
11:15 a.m.
Management of VT/VF Storm in Advanced Heart Failure: What to Think
About, What Works, What Doesn’t Work?
Owen Obel
Dallas, TX
11:30 a.m.
Identifying Super-Responders to Cardiac Resynchronization Therapy
Jonathan Hsu
La Jolla, CA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 38 of 64
Program PDF
Updated: 2-23-15
11:45 a.m.
Cardiac Resynchronization Therapy: Should Non-LBBB Patients or Patients
With Atrial Fibrillation Receive CRT?
Michael Robert Gold
Charleston, SC
12:00 p.m.
Atrial Fibrillation in Advanced Heart Failure: Role of Rate Control and
Antiarrhythmic Drugs
Sanjiv M. Narayan
Stanford, CA
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #689
Coronary Artery Disease: Non-Invasive Imaging
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 10
CME Hours: 1.5 /CNE Hours: 1.5
Monday, March 16, 2015
11:35 a.m.
Intraoperative TEE: How to Help Your Surgeon
Feroze Mahmood
Boston, MA
12:00 p.m.
Audience Question and Answer/Discussion
Pulmonary Hypertension and Venous Thrombo-embolic Disease Scientific Session
Session #690
Chronic Thromboembolic Pulmonary Hypertension: The UCSD
Experts Welcome the ACC
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 9
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: William R. Auger
Co-Chair: Nick Kim
Co-Chair: Matthew J. Budoff
Co-Chair: Jennifer H. Mieres
10:45 a.m.
From Acute to Chronic, or Not? The Epidemiology and Pathophysiology of
CTEPH
Peter Fedullo
10:45 a.m.
Nuclear Remains King
Leslee J. Shaw
11:00 a.m.
Does This Patient Have Operable Disease? Diagnostic Challenges and
Operability Assessment in CTEPH
William R. Auger
San Diego, CA
11:08 a.m.
New Horizons in CT
Richard T. George
Monkton, MD
11:30 a.m.
Novel CMR Approaches
Michael Salerno
Charlottesville, VA
11:15 a.m.
Pulmonary Endarterectomy - Advances in Surgical Techniques
Michael Madani
San Diego, CA
11:53 a.m.
Is There a Role for Echo?
Jonathan R. Lindner
Portland, OR
11:30 a.m.
Medical Therapy for CTEPH
Nick Kim
San Diego, CA
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Lifelong Learning (including MOC)
Session #820 - Core Curriculum: Echocardiography for the Boards
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 20C
CME Hours: 1.5 /CNE Hours: 1.5
Chair: Catherine M. Otto
10:45 a.m.
Quantitative Assessment of the Regurgitant Valve
Rosario Freeman
Seattle, WA
11:10 a.m.
Cardiac Manifestations of Systemic Disease
Sunil V. Mankad
Rochester, MN
11:45 a.m.
Future Directions in CTEPH
Kim M. Kerr
LaJolla, CA
12:00 p.m.
Assessing CTEPH From a Cardiologist's View -Importance of Hemodynamics
and Pulmonary Angiography
Kirk U. Knowlton
San Diego, CA
12:07 p.m.
Assessing CTEPH From a Cardiologist's View -Importance of Hemodynamics
and Pulmonary Angiography
Daniel Blanchard
San Diego, CA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 39 of 64
Program PDF
Updated: 2-23-15
Special Topics - Intensive
Session #53
Sports and Exercise Intensive
Monday, March 16, 2015, 10:45 a.m. - 3:30 p.m.
Room 3
CME Hours: 4.25 /CNE Hours: 4.25
10:45 a.m.
Program Co-Chair: Michael Emery
10:45 a.m.
Program Co-Chair: Silvana Molossi
Co-Chair: David Owens
Co-Chair: Christina Salazar
Panelist: Thomas G. Allison
Panelist: Robert W. Battle
Panelist: Michael Emery
Panelist: Matthew W. Martinez
Panelist: David Prior
12:42 p.m.
Stress Echo: Does Improvement in LV Function With Exercise Exclude
Pathology in the Athlete With Low Ejection Fraction?
Michael Emery
Greenville, SC
10:45 a.m.
Welcome & Introduction
Michael Emery
10:45 a.m.
Welcome & Introduction
Silvana Molossi
Houston, TX
10:50 a.m.
ACC Talk: Reflections on Thirty-Five Years of Sports Cardiology
Paul D. Thompson
Hartford, CT
Co-Chair: Michelle Grenier
Co-Chair: Robert Vogel
Panelist: Richard J. Kovacs
Panelist: Barry J. Maron
Panelist: Paul D. Thompson
Panelist: Douglas P. Zipes
12:54 p.m.
Evaluation of the Exercising Congenital Heart Disease Patient: Does Imaging
Impact Decision Making?
Robert W. Battle
Charlottesville, VA
1:06 p.m.
LV Cardiomyopathy: Which Imaging Study to Best Make the Diagnosis?
Matthew W. Martinez
Allentown, PA
1:18 p.m.
Evaluation of the RV: How to Image and What are the Important Features?
David Prior
Melbourne, Australia
11:10 a.m.
History of the Bethesda Guidelines: How Far Have We Come?
Barry J. Maron
Minneapolis, MN
11:25 a.m.
Darwinian or Lemarkian Evolution - Why the Change?
Richard J. Kovacs
Indianapolis, IN
11:40 a.m.
The Azimuth - A 30,000 ft View of the Guidelines
Douglas P. Zipes
Indianapolis, IN
12:15 p.m.
Break
12:30 p.m.
Part Two: Novel Approach to Imaging the Athlete
12:30 p.m.
Cardiopulmonary Stress Testing is the First and Best Test for the Athlete
Thomas G. Allison
Rochester, MN
10:45 a.m.
Part One
11:55 a.m.
Panel Discussion/ Question & Answer
Monday, March 16, 2015
1:30 p.m.
Panel Discussion/ Question & Answer
1:45 p.m.
Break
2:00 p.m.
Part Three: Challenging Cases for the Athlete
Co-Chair: Mark S. Link
Co-Chair: Silvana Molossi
Panelist: Aaron L. Baggish
Panelist: Eugene H. Chung
Panelist: Martin S. Maron
Panelist: Todd D. Miller
Panelist: Paul D. Thompson
2:00 p.m.
CASE PRESENTATION: Left Ventricular Non-Compaction
Jonathan Kim
Atlanta, GA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 40 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
3:25 p.m.
Table Discussion
2:05 p.m.
Panel Discussion
2:10 p.m.
Table Discussion
2:15 p.m.
CASE PRESENTATION: Anomalous Coronary Artery
Kristen Sexson
Houston, TX
2:20 p.m.
Panel Discussion
Special Topics - Symposium
Session #113
Cardiovascular Translational Research Symposium (ISCTR)
Monday, March 16, 2015, 10:45 a.m. - 5:15 p.m.
Room 6A
CME Hours: 5.5 /CNE Hours: 5.5
10:45 a.m.
Session 1: ISCTR Overview
Co-Chair: Anthony N. DeMaria
Co-Chair: Robert Roberts
2:25 p.m.
Table Discussion
2:30 p.m.
CASE PRESENTATION: Aysmptomatic Athlete with Abnormal ECG
Peter N. Dean
Charlottesville, VA
2:35 p.m.
Panel Discussion
10:45 a.m.
Welcome Statement
Anthony N. DeMaria
10:50 a.m.
Statement from CEO of ACC
Shalom Jacobovitz
Washington, DC
2:40 p.m.
Table Discussion
11:00 a.m.
Overview of Cardiovascular Translational Research
Nabil Dib
Gilbert, AZ
2:45 p.m.
CASE PRESENTATION: Congenital Heart Disease
Wayne J. Franklin
Houston, TX
11:15 a.m.
Session II: Cardiovascular Translational Research Pathway for Devices
Co-Chair: Blase A. Carabello
2:50 p.m.
Panel Discussion
Co-Chair: Magdi H. Yacoub, United Kingdom
2:55 p.m.
Table Discussion
11:15 a.m.
US Regulatory Pathway for Medical Devices
Bram D. Zuckerman
3:00 p.m.
CASE PRESENTATION: Channelopathy
Jennifer Michaud Finch
Burlington, MA
11:30 a.m.
Large Animal Model for Heart Failure, Valvular Disease, Coronary Artery
Disease, and Device Testing
Daniel Burkhoff
New York, NY
3:05 p.m.
Panel Discussion
11:45 a.m.
Translational Pathway for Percutaneous Mitral Valve Repair/Replacement
Ted Feldman
Evanston, IL
3:10 p.m.
Table Discussion
3:15 p.m.
CASE PRESENTATION: Athlete with Impaired Performance
Jeffrey Lin
Boston, MA
3:20 p.m.
Panel Discussion
12:00 p.m.
Translational Pathway for Percutaneous Aortic Valve Replacement
Stanton Rowe
Irvine, CA
12:15 p.m.
Break
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 41 of 64
Program PDF
Updated: 2-23-15
12:30 p.m.
Translational Pathway for BVA (Bio-absorbable Stent)
Patrick W. Serruys
Rotterdam, Netherlands
Monday, March 16, 2015
Panelist: Nabil Dib
Panelist: Stefanie Dimmeler
Panelist: Didier Locca
Panelist: Steven Oh
Panelist: Andreas M. Zeiher
12:45 p.m.
Panel Discussion
2:55 p.m.
Session IV: Cardiovascular Translational Pathways for Drugs
Panelist: Daniel Burkhoff
Panelist: Nabil Dib
Panelist: Ted Feldman
Panelist: Richard M. Rapoza
Panelist: Stanton Rowe
Panelist: Patrick W. Serruys
Panelist: Bram D. Zuckerman
Co-Chair: Robert Roberts
Co-Chair: Hendrik Tevaearai
2:55 p.m.
Cardiovascular Translational Pathways for Drugs
Hendrik Tevaearai
1:00 p.m.
Session III: Cardiovascular Translational Research Pathway for Biologics
Co-Chair: Nabil Dib
Co-Chair: Stefanie Dimmeler
1:00 p.m.
US Regulatory Requirement for Bioloigcs
Steven Oh
1:15 p.m.
Animal Model of MI, CHF, and Coronary Ischemia for Biologic Evaluation
Steven Chamuleau
Amsterdam, Netherlands
3:10 p.m.
Personalized Medicine
Robert Roberts
Ottawa, Canada
3:20 p.m.
Panel Discussion
3:30 p.m.
Break
3:45 p.m.
Session V: Translational Research Scholarship Curriculum and Educational
Program
1:30 p.m.
Methods of Delivery for Biologics
Nabil Dib
Gilbert, AZ
Co-Chair: Daniel Burkhoff
Co-Chair: Spencer B. King
1:45 p.m.
Break
3:45 p.m.
Status and Future Plans of the Overall ISCTR Educational Program and
Curriculum
Spencer B. King
2:00 p.m.
Translational Pathway for Cellular Therapy
Andreas M. Zeiher
Frankfurt, Germany
2:15 p.m.
Pre-Clinical and Clinical Imaging for Biologics Outcome
Didier Locca
Geneva, Switzerland
2:30 p.m.
Pathology Evaluation for Regenerative Therapy
Stefanie Dimmeler
Frankfurt, Germany
2:45 p.m.
Panel Discussion
Panelist: Steven Chamuleau
4:00 p.m.
ISCTR Scholar Point of View
Zain Khalpey
Tucson, AZ
4:10 p.m.
Panel Discussion
4:15 p.m.
Session VI: Opportunities for Translational Research and Unmet Needs for
Industry
Co-Chair: Charles A. Simonton
Co-Chair: Mark Toland
4:15 p.m.
Abbott Laboratories
Charles A. Simonton
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 42 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2635
Integrating Device and Drug Care in STEMI
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 6D
CME Hours: 1.5 /CNE Hours: 1.5
4:25 p.m.
Boston Scientific
Craig M. Stolen
St Paul, MN
4:35 p.m.
Boston Scientific
Mark Toland
Natick, MA
Co-Chair: Cindy L. Grines
Co-Chair: Gregg W. Stone
10:45 a.m.
Prolonged Transfer for PCI in STEMI: When to Add a Lytic
Michel R. Le May
4:45 p.m.
Cardiovascular Systems, Inc
Robert Thatcher
St Paul, MN
10:55 a.m.
Discussion and Q&A
4:55 p.m.
Edwards Life Sciences
Stanton Rowe
Irvine, CA
11:00 a.m.
Cangrelor vs. GPI - What Does the Future Hold?
Robert A. Harrington
Stanford, CA
5:05 p.m.
Panel Discussion
Special Topics - Future of CV Medicine
Session #1009
Physician Competence: Future of Cardiovascular Medicine X
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 20D
CME Hours: 1.5 /CNE Hours: 1.5
11:10 a.m.
Discussion and Q&A
11:15 a.m.
Is There a Role for a Mesh Covered or a Self-Expanding Stent?
Roxana Mehran
New York, NY
Co-Chair: Eric S. Williams
Co-Chair: Richard J. Baron
11:25 a.m.
Discussion and Q&A
10:45 a.m.
Statement of Key Issues
Eric S. Williams
11:30 a.m.
Second or Third Generation DES Should be the Default Strategy for Primary
PCI
Sripal Bangalore
New York, NY
10:55 a.m.
Panel Discussion: Do we Really Know the Best way to Confirm On-going
Competency? (And, is it Time to Overhaul or Retire the Secure High-stakes
MOC Examination?)
11:40 a.m.
Discussion and Q&A
Panelist: Richard J. Baron
Panelist: Eric R. Bates
Panelist: Mariell Jessup
Panelist: David C. May
11:45 a.m.
Deciding among Clopidogrel, Prasugrel, or Ticagrelor
Erik Magnus Ohman
Durham, NC
11:35 a.m.
Panel Discussion: "Punching the Ticket” During Fellowship: What are the
Expected Competencies of a General Clinical Cardiologist?
11:55 a.m.
Discussion and Q&A
Panelist: James A. Arrighi
Panelist: Jonathan L. Halperin
Panelist: Lisa A. Mendes
Panelist: C. Michael Valentine
Panelist: John Paul Vavalle
12:00 p.m.
Case Presentation: The Challenges of Primary PCI
Manesh R. Patel
Durham, NC
12:10 p.m.
Discussion and Q&A
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 43 of 64
Program PDF
Updated: 2-23-15
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2636
Future of TAVR Including Emerging Technology
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 6E
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Howard C. Herrmann
Co-Chair: David R. Holmes
Monday, March 16, 2015
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2637
CTO Case Review: How to Accomplish Final Success, How to Bail Out
Complications?
Monday, March 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 8
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Jeffrey W. Moses
Co-Chair: Emmanouil S. Brilakis
Debate #1: The Best TAVR Prosthesis in 2016 Will Be:
10:45 a.m.
Case Presentation: Antegrade IVUS Gided Re-entry
Masahisa Yamane
10:45 a.m.
Balloon-Expandable
Susheel K. Kodali
10:55 a.m.
Discussion and Q&A
10:55 a.m.
Self-Expanding
James Bernard Hermiller
Indianapolis, IN
11:00 a.m.
Case Presentation: Antegrade Dissection Re-entry after Failed Retrograde
Approach
William L. Lombardi
Bellingham, WA
11:05 a.m.
Discussion
11:15 a.m.
NewValve Platforms - Are they Really Better?
Horst Sievert
Frankfurt, Germany
11:25 a.m.
Cerebral Protection - Is it Necessary?
Eberhard Grube
Siegburg, Germany
11:10 a.m.
Discussion and Q&A
11:15 a.m.
Case Presentation: Complex Reverse CART Only with Angio Guidance
George Sianos
Thessaloniki, Greece
11:25 a.m.
Discussion and Q&A
11:35 a.m.
Vascular Access: Cut-down, Percutaneous, Trans-apical Closure Devices
David Xiao-Ming Zhao
Nashville, TN
11:30 a.m.
Case Presentation: Complex Reverse CART with IVUS Guidance
Satoru Sumitsuji
Suita, Osaka, Japan
Debate #2: Conscious Sedation is Better than General Anesthesia
11:45 a.m.
Pro
Itsik Ben-Dor
Rockville, MD
11:55 a.m.
Con
Prakash Patel
Philadelphia, PA
12:05 p.m.
Discussion
11:40 a.m.
Discussion and Q&A
11:45 a.m.
Case Presentation: Collateral Channel Perforation during Retrograde
Approach
Dimitrios Karmpaliotis
Atlanta, GA
11:55 a.m.
Discussion and Q&A
Case Presenter: non role Non Role 16, 2015, 10:45 a.m. - 12:15 p.m.
Room 11A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: James B. McClurken
Co-Chair: Amy E. Simone
Panelist: Tiffani Gray
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 44 of 64
Program PDF
Updated: 2-23-15
Panelist: Katherine J. Hoercher
Panelist: Mathew S. Maurer
Panelist: Vinod H. Thourani
10:45 a.m.
CASE PRESENTATION: 89 Year-old, 'Intact,' AS, MR, CAD, PVD, New Dental
Implants - INTRODUCTION
Jennifer Harrar
Doylestown, PA
10:50 a.m.
How Does the Heart Team Collate the Data - and Still See the Patient?
Barbara Todd
Philadelphia, PA
11:00 a.m.
Advancing Age, Worsening CHF, Progressing Valvular +/- Coronary Lesions How Do You Apply Guidelines?
Alaide Chieffo
Milan, Italy
11:10 a.m.
Frailty Assessment in the Complex Cardiac Patient - Correlation With
Functional Outcomes
Jonathan Afilalo
Montreal, Canada
11:20 a.m.
Surgeon's Perspective: Nuanced Evaluation and Care Improve SAVR Patient
Selection and Outcomes in the Older Adult
David A. Fullerton
CO
11:30 a.m.
Brazilian Society of Cardiology Geriatric Cardiology Guidelines - Help in the
Complex Valve Patients?
Claudia F. Gravina
São Paulo, Brazil
11:40 a.m.
Next Generation TAVR - Are Improvements Causing Indication 'Creep' for
Older Patients, Too?
Martin B. Leon
New York, NY
11:50 a.m.
CASE PRESENTATION: 89 Yo, 'intact,' AS, MR, CAD, PVD, New Dental Implants
- CONCLUSION
Jennifer Harrar
Doylestown, PA
12:00 p.m.
Panel Discussion
Monday, March 16, 2015
Special Topics (including MOC)
Session #821
ACCF Study Session for Maintenance of Certification: ABIM
Recertification Made Easy: ACC General Cardiology Module 12
Monday, March 16, 2015, 12:15 p.m. - 2:45 p.m.
29B
CME Hours: 2.5 /CNE Hours: 0
Chair: Douglas E. Drachman
MOC Faculty: Joseph Edward Marine
MOC Faculty: Julie Damp
TCT@ACC-i2 (Interventional Cardiology)
Lifelong Learning (including MOC)
Session #822 - ACCF Study Session for Maintenance of Certification:
ABIM Recertification Made Easy: Interventional Module 5
Monday, March 16, 2015, 12:15 p.m. - 2:45 p.m.
30B
CME Hours: 2.5 /CNE Hours: 0
Chair: Charles E. Chambers
MOC Faculty: Jeffrey J. Cavendish
MOC Faculty: Paul Sorajja
Acute Coronary Syndromes - Scientific Session
Session #692
Logistical Challenges in STEMI
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 20A
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Daniel Kolansky
Co-Chair: Sameer Mehta
12:30 p.m.
Creating a Referral Network
Alice K. Jacobs
12:35 p.m.
Question and Answer
12:42 p.m.
PCI in Hospitals Without Surgical Back Up
Eric R. Bates
Ann Arbor, MI
12:47 p.m.
Question and Answer
12:54 p.m.
Ship and Drip (Facilitated Transfer to PCI Hospital)
Shaun G. Goodman
Toronto, Canada
12:59 p.m.
Question and Answer
1:06 p.m.
Timing of Urgent CABG
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 45 of 64
Program PDF
Updated: 2-23-15
Jack Boyd
Stanford, CA
Monday, March 16, 2015
1:05 p.m.
DEBATE: AF: Lenient Versus Strict Rate Control? Strict: A 65 Year Old Man has
Permanent AF and 24 hr Holter Shows Average Heart Rate 100 bpm, Range
80-140 bpm. He Feels Well. Is this Rate Control Good Enough? (CON)
Albert L. Waldo
Cleveland, OH
1:13 p.m.
Question and Answer
1:18 p.m.
Out of Hospital Identification of STEMI
Christopher B. Granger
Durham, NC
1:15 p.m.
Question and Answer
1:20 p.m.
DEBATE: Cardioversion of AF With or Without Anticoagulation? A 67 Year Old
Woman Presents to the ER in AF That Began 24 Hours Ago. She Has No Past
Medical History. Can She Be Cardioverted Without Anticoagulation on
Board? (PRO)
Bulent Gorenek
Eskisehir, Turkey
1:23 p.m.
Question and Answer
1:30 p.m.
Upstream Management in the ER
Deborah Diercks
Roseville, CA
1:35 p.m.
Question and Answer
Arrhythmias and Clinical EP - Scientific Session
Session #693
Did the Guidelines Get It Right? A Series of Debates
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 1B
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Julia H. Indik
Co-Chair: Fred M. Kusumoto
Panelist: Geerhardt Hindricks
Panelist: Richard L. Page
12:30 p.m.
DEBATE: Timing of ICD Implant After Revascularization. Always 90 Days? A 60
Year Old Woman With Heart Failure, Remote Anterior Wall MI and LVEF 25%,
Recent Angina and Stent to Obtuse Marginal Artery (PRO)
Andrea M. Russo
Moorestown, NJ
1:30 p.m.
DEBATE: Cardioversion of AF With or Without Anticoagulation? A 67 Year Old
Woman Presents to the ER in AF that Began 24 Hours Ago. She Has No Past
Medical History. Can She Be Cardioverted Without Anticoagulation on
Board? (CON)
Mina K. Chung
Cleveland, OH
1:40 p.m.
Question and Answer
Congenital Heart Disease - Scientific Session
Session #694
What’s New in Pediatric Electrophysiology?
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 31C
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Charles I. Berul
Co-Chair: Suzanne M. Shepard
Panelist: Richard J. Czosek
Panelist: Christina Miyake
Panelist: Elizabeth V. Saarel
12:40 p.m.
Timing of ICD Implant After Revascularization. Always 90 Days? CON? A 60
Year Old Woman With Heart Failure, Remote Anterior Wall MI and LVEF 25%,
Recent Angina and Stent to Obtuse Marginal Artery.
Julia H. Indik
Tucson, AZ
12:30 p.m.
When to Place a Defibrillator in Children and ACHD Patients: Indications
Besides the Obvious
Maully J. Shah
Philadelphia, PA
12:50 p.m.
Question and Answer
12:39 p.m.
Question and Answer
12:55 p.m.
DEBATE: AF: Lenient Versus Strict Rate Control? Lenient: A 65 Year Old Man
has Permanent AF and 24 hour Holter Shows Average Heart Rate 100 bpm,
Range 80-140 bpm. He Feels Well. Is this Rate Control Good Enough? (PRO)
Isabelle Van Gelder
Groningen, Netherlands
12:44 p.m.
Is Exercise Okay: With Arrhythmia; With ICD/Pacemaker; With No Device?
Reviewing the New Bethesda 36 Guidelines and Medicolegal Implications of
Bending the Rules
Mitchell Cohen
Phoenix, AZ
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 46 of 64
Program PDF
Updated: 2-23-15
12:53 p.m.
Question and Answer
12:58 p.m.
Coming Soon: Rhythm Management Devices of the Near Future-Leadless
Devices, Remote Monitoring and Other New Technologies
Joseph Atallah
Edmonton, Canada
1:07 p.m.
Question and Answer
1:12 p.m.
Has Equipoise Shifted? Safer Ablation for Children: Low/No Fluoroscopy,
Cryoablation - Is Ablation Now Better then Drugs for WPW/SVT?
Kathryn Collins
Aurora, CO
1:21 p.m.
Question and Answer
1:26 p.m.
Updated Recommendations for EP Interventions in ACHD
Paul Khairy
Montreal, Canada
1:35 p.m.
Question and Answer
Heart Failure and Cardiomyopathies - Scientific Session
Session #695
Long Term Care of LVAD Patients
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 6C
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Loren Semones
Co-Chair: Mark Slaughter
12:30 p.m.
Financial Challenges or Destination Therapy
Francis D. Pagani
12:42 p.m.
Long Term Surveillance in LVAD Patients
John B. O'Connell
GA
12:55 p.m.
Discharge Planning for Destination Therapy
Peter Hoagland
San Diego, CA
1:07 p.m.
End of Life Issues in LVAD Patients
Katrina Bramstedt
Gold Coast, Australia
Monday, March 16, 2015
1:20 p.m.
Building Networks in LVAD Care
Douglas Horstmanshof
Oklahoma City, OK
1:33 p.m.
What to Do With the LVAD Patient Requiring Renal Replacement Therapy
Jeffrey Teuteberg
Pittsburgh, PA
Heart Failure and Cardiomyopathies - Scientific Session
Session #696
Treatment Strategies for Hospitalized Heart Failure Patients
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 5A
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Meredith Ann Brisco
Co-Chair: Uri Elkayam
12:30 p.m.
Who Needs a Swan?
Monica Shah
12:45 p.m.
Diuretic Strategies in Acute Heart Failure: Does DOSE Matter?
Michael Felker
Durham, NC
1:00 p.m.
Which IV Therapies work?
Gerasimos S. Filippatos
GR-115 23 Athens, Greece
1:15 p.m.
Should We All RELAX?
John R. Teerlink
San Francisco, CA
1:30 p.m.
It's Not Just About the Heart: Assessing Depression in Heart Failure
Debra Moser
Lexington, KY
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #697
Integrated Imaging of Heart Valve Disease: A Clinical Guide
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 2
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Paaladinesh Thavendiranathan
Co-Chair: Nozomi Watanabe
12:30 p.m.
Imaging The Aortic Root in Severe AS: Role of Echo Versus CT
Sarah Rinehart
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 47 of 64
Program PDF
Updated: 2-23-15
12:43 p.m.
Question and Answer
12:45 p.m.
Imaging the Mitral Valve: Role of Echo and CMR
Erwan Donal
Rennes, France
12:58 p.m.
Question and Answer
1:00 p.m.
Quantification of Chronic MR: How do Echo and CMR compare?
Seth Uretsky
New York, NY
1:13 p.m.
Question and Answer
1:15 p.m.
Echocardiography of the Tricuspid Valve and TR: When Is CMR Needed?
GEU-RU Hong
Daegu, Korea, Republic of
1:28 p.m.
Question and Answer
1:30 p.m.
Imaging Prosthetic Valve Dysfunction: Role of Echo and CT
Hugo Moreno Velazquez
Mexico City, Mexico
1:43 p.m.
Question and Answer
Non-Certified Industry Events - Learning Destinations
Session #4008
To sleep, perchance to breathe ... How the treatment of sleep apnea
can improve cardiovascular health
Monday, March 16, 2015, 11:30 a.m. - 12:30 p.m.
Expo Hall 3545
CME Hours: /CNE Hours:
11:30 a.m.
Current Clinical Practice
Alan S. Maisel
San Diego, CA
Monday, March 16, 2015
Non-Certified Industry Events - Learning Destinations
Session #4016
Understanding Risk Beyond the Culprit Lesion
Monday, March 16, 2015, 11:30 a.m. - 12:30 p.m.
Expo Hall 145
CME Hours: /CNE Hours:
11:30 a.m.
Understanding Risk Beyond the Culprit Lesion
Marc Cohen
Newark, NJ
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #698
Case Based Echo
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 10
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Athena Poppas
Co-Chair: Susan E. Wiegers
12:30 p.m.
LV Non-Compaction
Susan E. Wiegers
12:35 p.m.
Panel Discussion
12:42 p.m.
Question and Answer
12:55 p.m.
HIV Cardiomyopathy
Kirsten E. Fleischmann
San Francisco, CA
1:00 p.m.
Panel Discussion
1:07 p.m.
Question and Answer
1:20 p.m.
Arrhythmogenic RV Cardiomyopathy
Francois Haddad
Palo Alto, CA
11:40 a.m.
Outcomes in Cardiovascular Disease
Ian Wilcox
Newtown, Australia
1:25 p.m.
Panel Discussion
12:00 p.m.
Emerging Evidence in the Treatment of Heart Failure
Olaf Oldenburg
Bad Oeynhausen, Germany
1:32 p.m.
Question and Answer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 48 of 64
Program PDF
Updated: 2-23-15
Prevention - Scientific Session
Session #700
Anti-Hypertensive Therapy Update; Established and Emerging Drugs
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 6B
CME Hours: 1.25 /CNE Hours: 1.25
Monday, March 16, 2015
12:42 p.m.
Newly FDA Approved Ultrasound-Assisted Low-Dose Thrombolysis: Minimize
Intracranial Hemorrhage
Gregory Piazza
Boston, MA
12:51 p.m.
Discussion/Question and Answer
Co-Chair: Michael H. Crawford
Co-Chair: Tiny Nair
12:30 p.m.
Emerging Molecules to Lower the Blood Pressure: The Next Pharmacological
Frontier in Hypertension
John C. Burnett
12:40 p.m.
RAAS Blockers: Differences in Efficacy and Clinical Outcomes. Time to be
Realistic!
Addison Taylor
Houston, TX
12:50 p.m.
The "Beta-Blocker" Controversy: Is It a Class Effect?
Thomas D. Giles
Metairie, LA
1:00 p.m.
Diuretics--As Good as Advertised?
William C. Cushman
Memphis, TN
12:54 p.m.
3 Newly FDA Approved (Within the Past Year) Oral Anticoagulants to Treat
Acute PE and DVT
Samuel Z. Goldhaber
Boston, MA
1:03 p.m.
Discussion/Question and Answer
1:06 p.m.
Lab Tests to Measure Levels of New Oral Anticoagulants and Strategies for
Reversibility: Replacement, Antibodies, and Decoy Molecules
Robert D. McBane
Rochester, MN
1:15 p.m.
Discussion/Question and Answer
1:18 p.m.
CASE PRESENTATION: IVC Filter Saves a Life
Soo Hyun Kim
Avon, OH
1:10 p.m.
Role of Direct Vasodilators in the Treatment of Severe Hypertension
Vito Campese
Los Angeles, CA
1:20 p.m.
Question and Answer
Pulmonary Hypertension and Venous Thrombo-embolic Disease Scientific Session
Session #699
Advanced Therapy for Pulmonary Embolism: ECMO, Thrombolysis,
Filters, and Novel Anticoagulants
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 9
CME Hours: 1.25 /CNE Hours: 1.25
1:22 p.m.
DEBATE: Resolved: IVC Filter Criteria Should be Liberalized Based Upon
Observational Data From U.S. Registries
Victor F. Tapson
Beverly Hills, CA
1:29 p.m.
DEBATE: Resolved: IVC Filters Are a Runaway Technology; Their Use Needs to
be Curbed and Restricted
Joshua A. Beckman
Boston, MA
1:36 p.m.
Rebuttal
1:38 p.m.
Rebuttal
Co-Chair: Samuel Z. Goldhaber
Co-Chair: Kristen Pogue
12:30 p.m.
ECMO to Salvage Patients With Otherwise Fatal Massive PE
Matthew Bacchetta
1:40 p.m.
Questions for the Debaters
12:39 p.m.
Discussion/Question and Answer
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 49 of 64
Program PDF
Updated: 2-23-15
Special Topics - Special Session
Session #413
Best of JACC 2014: Practice Changing Research Published in the JACC
Journals and the Eugene Braunwald Lecture on Future Directions in
Cardiovascular Medicine
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 33C
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Valentin Fuster
Monday, March 16, 2015
12:41 p.m.
Re-thinking the Academic Medical Center Structure
Robert A. Harrington
Stanford, CA
12:49 p.m.
Re-thinking Graduate Medical Education
James A. Arrighi
Providence, RI
12:30 p.m.
Introduction
Valentin Fuster
12:57 p.m.
Table Discussions - audience at tables/rows will be assigned one of the 3
topics that were discussed by the speakers; they will be asked to affirm or
modify the proposed ideas
12:35 p.m.
Highlights from JACC
Valentin Fuster
New York, NY
1:12 p.m.
Panel/Audience Discussion - primarily calling upon representatives from
(some of the) various tables/rows to discuss results of their deliberations
12:50 p.m.
Highlights from JACC: Cardiovascular Interventions
Spencer B. King
Atlanta, GA
1:00 p.m.
Highlights from JACC: Cardiovascular Imaging
Jagat Narula
New York, NY
1:12 p.m.
Panel Moderator
Joseph A. Hill
Dallas, TX
1:12 p.m.
Panel Moderator
Marvin A. Konstam
Boston, MA
Panelist: James A. Arrighi
Panelist: Robert A. Harrington
Panelist: Amit Khera
Panelist: Richard J. Kovacs
1:10 p.m.
Highlights from JACC: Heart Failure
Christopher M. O'Connor
Durham, NC
1:15 p.m.
Eugene Braunwald Lecture: The Global Epidemic of Cardiovascular Disease
Salim Yusuf
Hamilton, Canada
Special Topics - Future of CV Medicine
Session #1010
Academic Medical Centers of the Future: Future of Cardiovascular
Medicine XI
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 20D
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Joseph A. Hill
Co-Chair: Marvin A. Konstam
12:30 p.m.
Welcome and Introduction
1:42 p.m.
Summary, Conclusion, Next Steps
Joseph A. Hill
Dallas, TX
1:42 p.m.
Summary, Conclusion, Next Steps
Marvin A. Konstam
Boston, MA
TCT@ACC-i2 (Interventional Cardiology)
Lifelong Learning (including MOC)
Session #823 - Core Curriculum: Cardiac
Catheterization/Hemodynamics
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 20C
CME Hours: 1.25 /CNE Hours: 1.25
Chair: Rick A. Nishimura
12:33 p.m.
Re-thinking the Academic Medical Enterprise
Richard J. Kovacs
12:30 p.m.
Pressure-Volume Loops are the Key (to Understanding) the Heart
Morton J. Kern
Orange, CA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 50 of 64
Program PDF
Updated: 2-23-15
12:50 p.m.
Pitfalls in Assessing Valvular Disease in the Cath Lab
Richard G. Bach
St. Louis, MO
1:10 p.m.
Don’t Misinterpret your Swan-Ganz Findings: Cases that will Guide You
Anjan K. Sinha
Indianapolis, IN
1:30 p.m.
Audience Question and Answer/Discussion
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2638
Multi-Modality for Structural Heart Disease Interventions
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 6F
CME Hours: 1.25 /CNE Hours: 1.25
Monday, March 16, 2015
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2639
DAPT in 2015: Focus on DAPT Trial
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 6D
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Laura Mauri
Co-Chair: Martin B. Leon
12:30 p.m.
Dilemmas in DAPT Duration: Case Based Examples of My Current Practice
Recommendations
James Bernard Hermiller
12:40 p.m.
Discussion
Mini-Focus on DAPT Trial
Co-Chair: Rebecca T. Hahn
Co-Chair: Mark Reisman
12:30 p.m.
Understanding Cardiac Anatomy and How Best to Image It
Nicolo Piazza
12:40 p.m.
Device-specific Imaging for Left Atrial Appendage Closure
Brian K. Whisenant
Salt Lake City, UT
12:49 p.m.
Multi-modality Imaging Pre-TAVR: Not a Luxury but a Necessity
Victoria Delgado
Leiden, Netherlands
12:59 p.m.
Can Imaging Help Determine Appropriateness of Transcatheter vs Surgical
Mitral Valve Repair?
D. Scott Lim
Charlottesville, VA
1:08 p.m.
Intra-Cardiac Imaging for Structural Heart Disease Interventions
Thomas Bartel
Innsbruck, Austria
1:18 p.m.
Multi-modality Imaging for Assessment of Valve Function Post-Intervention
Paul A. Grayburn
Dallas, TX
12:45 p.m.
DES: The DAPT Trial Results
Laura Mauri
Boston, MA
12:55 p.m.
Discussion
1:00 p.m.
DES vs. BMS: The DAPT Trial Results
Dean J. Kereiakes
Cincinnati, OH
1:10 p.m.
Discussion
1:15 p.m.
DAPT in Diabetic Patients: The DAPT Trial Results
Ian T. Meredith
Clayton, VIC 3168, Australia
1:25 p.m.
Discussion
1:30 p.m.
DAPT in Acute Coronary Syndromes: The DAPT Trial Results
Robert W. Yeh
Boston, MA
1:40 p.m.
Discussion
1:36 p.m.
Tissue Characterization, Molecular Imaging, and Flow Visualization: A
Window Into the Mechanobiology of the Valve
Philippe Pibarot
Quebec, Canada
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 51 of 64
Program PDF
Updated: 2-23-15
Valvular Heart Disease - Scientific Session
Session #701
Experts Debate: Challenges in Heart Valve Disease
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 11A
CME Hours: 1.25 /CNE Hours: 1.25
Co-Chair: Salvatore Costa
Co-Chair: Neal S. Kleiman
Monday, March 16, 2015
Vascular Medicine - Scientific Session
Session #702
Vascular Team Based Care: What Are the Essential Components for
Success?
Monday, March 16, 2015, 12:30 p.m. - 1:45 p.m.
Room 4
CME Hours: 1.25 /CNE Hours: 1.25
12:30 p.m.
CASE PRESENTATION: 75 Yr Old Woman With Flail Mitral Valve and Dyspnea.
Colin M. Barker
Co-Chair: Michele L. Yeadon
Co-Chair: George Adams
Panelist: Mark C. Bates
Panelist: Larry J. Diaz
Panelist: Dmitriy N. Feldman
12:35 p.m.
Protagonist: Transcatheter MV Repair Will Replace Most MV Surgery Within
the Next 5 Years
Saibal Kar
Los Angeles, CA
12:30 p.m.
Do Patients Actually Benefit From Multispecialty Vascular Care: What Really
Happens at the Cleveland Clinic?
Mehdi H. Shishehbor
Cleveland, OH
12:45 p.m.
Antagonist: Transcatheter MV Repair Will Replace Most MV Surgery Within
the Next 5 Years
Patrick M. McCarthy
Chicago, IL
12:44 p.m.
Will Team Based Care Impact the Minorities With Vascular Disease?
Joseph Atiah Akamah
Nashville, TN
12:58 p.m.
The 3 C's: Collaborate, Communicate, Coordinate: Efficient Team Based Care
Rajeev L. Narayan
Hackensack, NJ
12:55 p.m.
Protagonist, Rebuttal
1:00 p.m.
Rebuttal, Antagonist
1:05 p.m.
CASE PRESENTATION: 82 Year Old Female With Severe AS (AS jet > 4.5 m/s).
No Dyspnea But Limited Mobility Due to Knee Pain
Tiffani Gray
Houston, TX
1:10 p.m.
Protagonist: Most Asymptomatic Patients With Severe AS Should Undergo
Valve Replacement
Blase A. Carabello
New York, NY
1:20 p.m.
Antagonist: Most Asymptomatic Patients with Severe AS Should Undergo
Valve Replacement
Patricia A. Pellikka
Rochester, MN
1:30 p.m.
Rebuttal, Protagonist
1:37 p.m.
Rebuttal, Antagonist
1:12 p.m.
One Team, Two Feet: Providing High Value Care
John P. Reilly
New Orleans, LA
1:26 p.m.
Panel Discussion: How Do You Build a Cardiovascular Team?
Non-Certified Industry Events - Learning Destinations
Session #4408
Monomorphic Ventricular Tachycardia Simulation Training
Monday, March 16, 2015, 1 p.m. - 1:30 p.m.
Expo Hall 3932
CME Hours: /CNE Hours:
Monomorphic Ventricular Tachycardia Simulation Training
Acute Coronary Syndromes - Scientific Session
Session #703
Acute Coronary Syndromes Guidelines Controversies
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 20A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Jonathan L. Halperin
Co-Chair: Sanjay Kaul
Panelist: Jeffrey L. Anderson
Panelist: Christian W. Hamm
Panelist: Alice K. Jacobs
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 52 of 64
Program PDF
Updated: 2-23-15
2:00 p.m.
Evidence Justifies Adoption of Early Invasive Strategy in Most Patients With
ACS
Hani Jneid
Houston, TX
2:08 p.m.
Evidence Dictates Thoughtful and Selective Application of Early Invasive
Strategy
Scott Wright
Rochester, MN
2:16 p.m.
Protagonist, Rebuttal
2:20 p.m.
Panel Discussion/Question and Answer
2:30 p.m.
Strong Evidence Warrants Universal Adoption of Clopidogrel Pretreatment
A. Michael Lincoff
Cleveland, OH
2:38 p.m.
Evidence From Randomized Controlled Trials on Clopidogrel Pretreatment Is
Lacking, So Pretreatment Decision Should Be Individualized.
Peter B. Berger
Danville, PA
Acute Coronary Syndromes - Scientific Session
Session #722
Appropriate Utilization of Cardiac Imaging and Other Methods for
Chest Pain in the ED
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 33C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Raymond J. Gibbons
Co-Chair: Matthew J. Budoff
2:10 p.m.
Echocardiography in the ED for Chest Pain Patients
Sanjiv Kaul
Portland, OR
2:20 p.m.
Utility of Myocardial Perfusion Imaging in the ED
James E. Udelson
Boston, MA
2:30 p.m.
Coronary Computed Tomography Angiography in the ED: Current Status
Udo Hoffmann
Boston, MA
2:40 p.m.
CCTA in the ED: Upstream and Downstream Implications
Raymond J. Gibbons
Rochester, MN
2:46 p.m.
Protagonist, Rebuttal
2:48 p.m.
Antagonist, Rebuttal
2:50 p.m.
Panel Discussion/Question and Answer
3:00 p.m.
Still a Role For Gpiib/IIIa in the Contemporary Era: Guidelines Need Not Be
Revised
Venu Menon
Cleveland, OH
3:08 p.m.
No role for GPIIB/IIIa in the Contemporary Era: Guidelines Should Be Revised.
Sigmund Silber
Munich, Germany
3:18 p.m.
Antagonist, Rebuttal
3:18 p.m.
Panel Discussion/Question and Answer
2:00 p.m.
Evolution of Testing Methods for Low-Intermediate Risk Chest Pain in the ED
Ezra A. Amsterdam
2:18 p.m.
Antagonist, Rebuttal
3:16 p.m.
Protagonist, Rebuttal
Monday, March 16, 2015
2:50 p.m.
High Sensitivity Troponin: The Holy Grail for Assessment of Chest Pain in the
ED?
Robert H. Christenson
Baltimore, MD
3:00 p.m.
Panel Discussion
Arrhythmias and Clinical EP - Scientific Session
Session #704
Stroke Prevention in Atrial Fibrillation: Drugs, Devices, and Debate
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 1B
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Marye J. Gleva
Co-Chair: Kenneth W. Mahaffey
2:00 p.m.
Fellow-In-Training Panelist: Tina Baykaner
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 53 of 64
Program PDF
Updated: 2-23-15
2:00 p.m.
Fellow-In-Training Panelist: Gautam G. Lalani
2:00 p.m.
NOACs: Management Dilemmas. Choice, Monitoring, Reversal.
Peter Kowey
Wynnewood, PA
2:10 p.m.
Identification of Patients at Risk for Stroke From Atrial Fibrillation
Emile G. Daoud
Columbus, OH
2:20 p.m.
Debate 1: AF Ablation Eliminates the Need for Anticoagulation (PRO)
Andrea Natale
Austin, TX
2:30 p.m.
Debate 1: AF Ablation Eliminates the Need for Anticoagulation (CON)
Jeff S. Healey
Hamilton, Canada
2:40 p.m.
Rebuttal 1: PRO
2:50 p.m.
Question and Answer
2:55 p.m.
Debate 2: OAC Is a Better Option for AF-Related Stroke Prevention Than
Device Therapy (Appendage Occlusion) (PRO)
Michael D. Ezekowitz
Wynnewood, PA
3:05 p.m.
Debate 2: OAC Is a Better Option for AF-Related Stroke Prevention Than
Device Therapy (Appendage Occlusion) (CON)
Vivek Yerrapu Reddy
New York, NY
3:20 p.m.
Rebuttal 2: CON
3:25 p.m.
Question and Answer
Congenital Heart Disease - Scientific Session
Session #705
When Is a Dilated Root Important?
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 31C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Michelle Grenier
Co-Chair: Anitha S. John
Panelist: Erle Austin
Panelist: Peter Bartz
2:00 p.m.
Connective Tissue Disorders in Children and Young Adults
Angela T. Yetman
Salt Lake City, UT
2:10 p.m.
Panel Discussion
2:15 p.m.
Aortic Z Scores, Changing Standards, What Is Acceptable in the Pediatric
Population?
Steven D. Colan
Boston, MA
2:25 p.m.
Panel Discussion
2:45 p.m.
Rebuttal 1: CON
3:15 p.m.
Rebuttal 2: PRO
Monday, March 16, 2015
2:30 p.m.
Surgical Indications and Approaches to the Dilated Root in Congenital Heart
Disease
James S. Tweddell
Milwaukee, WI
2:40 p.m.
Panel Discussion
2:45 p.m.
What Are You Too Big For? Activity and Management of the Child With a
Dilated Aortic Root
Michael Earing
Milwaukee, WI
2:55 p.m.
Panel Discussion
3:00 p.m.
Genetics and Aortopathies in Children: What Do We Know and Where Are
We Going?
Stephanie Ware
Indianapolis, IN
3:10 p.m.
Panel Discussion
3:15 p.m.
The Dilated Root and Heart Block
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 54 of 64
Program PDF
Updated: 2-23-15
Andrew Radbill
Nashville, TN
3:25 p.m.
Audience Question and Answer/Panel Discussion
Heart Failure and Cardiomyopathies - Scientific Session
Session #706
New Pharmacologic Therapies for Heart Failure
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 6C
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: William Robb MacLellan
Co-Chair: Ronald Witteles
Monday, March 16, 2015
2:15 p.m.
When Is Biventricular Support Needed?
Jack Copeland
San Diego, CA
2:30 p.m.
Role of Tricuspid Repair in LVAD Implantation
Shahab Akhter
Madison, WI
2:45 p.m.
Early Postoperative Management of the Right Ventricle
Claudius Mahr
Seattle, WA
2:00 p.m.
Protein Misfolding
Jonathan Schisler
3:00 p.m.
Plan B: Mechanical Circulatory support Options for the Right Ventricle
Mark Slaughter
Louisville, KY
2:15 p.m.
NEP Inhibitors
Scott D. Solomon
Boston, MA
3:15 p.m.
Long-Term Management of Right Ventricular Failure After LVAD
Michael M. Givertz
Boston, MA
2:30 p.m.
Protein Silencing
Mazen Hanna
University Heights, OH
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #708
Myocardial Tissue Characterization by CMR
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 2
CME Hours: 1.5 /CNE Hours: 1.5
2:45 p.m.
Dietary Therapies: Are We DASHing to the Finish Line?
Scott L. Hummel
Ann Arbor, MI
Co-Chair: Subha V. Raman
Co-Chair: Erik B. Schelbert
2:00 p.m.
Replacement Fibrosis/Scar Imaging
Igor Klem
3:00 p.m.
Matrix Metalloproteinase 9 Inhibitors
Peter P. Liu
Toronto, Canada
2:18 p.m.
Interstitial Fibrosis/T1 Mapping
Erik B. Schelbert
Pittsburgh, PA
3:15 p.m.
Nitroxyl Donors
Barry Borlaug
Rochester, MN
Heart Failure and Cardiomyopathies - Scientific Session
Session #707
Right Ventricular Failure With LVAD
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 5A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Keith D. Aaronson
Co-Chair: Nahush Mokadam
2:00 p.m.
Risk Models for Predicting Right Ventricle Failure Post-LVAD
Richard Kar-Hang Cheng
2:36 p.m.
Edema Imaging/T2
Matthias Friedrich
Calgary, Canada
2:54 p.m.
Iron Imaging/T2*
John Wood
LA, CA
3:12 p.m.
Fiber Orientation/Diffusion Tensor Imaging
Victor A. Ferrari
Philadelphia, PA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 55 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #709
Real World Echocardiography: Case Based Learning With Experts
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 10
CME Hours: 1.5 /CNE Hours: 1.5
2:34 p.m.
Do Diabetes and Chronic Kidney Disease Warrant a Special Status and
Different Targets?
Ernesto Schiffrin
Montreal, Canada
Co-Chair: Randolph P. Martin
2:46 p.m.
Panel Discussion
2:00 p.m.
A Leaky Valve and the Fix
Bijoy K. Khandheria
2:56 p.m.
Hypertension Management: Need for a Simpler and Practical Global View.
Rajeev Gupta
Jaipur Rajasthan 302001, India
2:05 p.m.
Panel Discussion
3:10 p.m.
A System Based Approach to Implementing Hypertension Guidelines
Eileen M. Handberg
Gainesville, FL
2:20 p.m.
Question and Answer
2:30 p.m.
A Not-So-Right Right Heart
Ajit Raisinghani
CA
3:20 p.m.
Panel Discussion
Prevention - Scientific Session
Session #725
Emerging Science Supporting the 2013 ACC-AHA Cholesterol
Guidelines: How Does it Relate to Patient Care?
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 6E
CME Hours: 1.5 /CNE Hours: 1.5
2:35 p.m.
Panel Discussion
2:50 p.m.
Question and Answer
3:00 p.m.
Joint Pains, Rash and A Sick Myocardium
Cheuk-man Yu
Hong Kong, China
Co-Chair: Sidney Smith, Jr.
Chapel Hill, NC
Co-Chair: Neil J. Stone
3:05 p.m.
Panel Discussion
2:00 p.m.
Risk Estimation: What Does the Science Tell Us in 2015?
David C. Goff
3:20 p.m.
Question and Answer
2:10 p.m.
Question and Answer
Prevention - Scientific Session
Session #711
A Guide for the Hypertension Guidelines: Too Many Cooks or Too
Much to Cook?
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 6B
CME Hours: 1.5 /CNE Hours: 1.5
2:15 p.m.
The Risk Discussion - A Focus on Shared Decision Making
Victor Montori
Rochester, MN
Co-Chair: Prakash C. Deedwania
Co-Chair: C. Venkata S. Ram
2:30 p.m.
DEABTE: Arbitrary LDL-C, Non HDL Cutoffs Are Needed
Christie M. Ballantyne
Houston, TX
2:12 p.m.
Panel Discussion
2:22 p.m.
Blood Pressure Targets: What Is Age Got to Do With It?
Jackson T. Wright
2:25 p.m.
Question and Answer
2:40 p.m.
DEBATE:Arbitrary LDL-C, Non HDL-C Cutoffs Not Needed
Karol E. Watson
Los Angeles, CA
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 56 of 64
Program PDF
Updated: 2-23-15
2:50 p.m.
Rebuttal, Protagonist
Monday, March 16, 2015
2:30 p.m.
Appropriate Statistical Application & Presentation
Stuart Pocock
London, United Kingdom
2:55 p.m.
Rebuttal, Antagonist
3:00 p.m.
Understanding the Guidelines Through Interactive Case Presentations
3:00 p.m.
CASE PRESENTATION: Secondary Prevention Case of 62 Year Old Man on a
High Intensity Statin Who Has Another Event One Year After Angioplasty
C. Noel Bairey Merz
Los Angeles, CA
3:05 p.m.
Question and Answer
2:40 p.m.
Question and Answer
Special Topics - Future of CV Medicine
Session #1011
Population Global Health - Combating CV Diseases/NonCommunicable Diseases Globally: Future of Cardiovascular Medicine
XII
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 20D
CME Hours: 1.5 /CNE Hours: 1.5
Chair: John Gordon Harold
3:10 p.m.
CASE PRESENTATION: Familial Hypercholesterolemia
Jennifer Robinson
Iowa City, IA
3:15 p.m.
Question and Answer
3:20 p.m.
CASE PRESENTATION: Primary Prevention
Neil J. Stone
Winnetka, IL
3:25 p.m.
Question and Answer
Special Topics - Special Session
Session #723
The New JACC Insight into Criteria for Submitting Good Scientific
Papers
Monday, March 16, 2015, 2 p.m. - 2:55 p.m.
Room 7B
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Valentin Fuster
Co-Chair: Spencer B. King
2:00 p.m.
Introduction of Session
John Gordon Harold
Los Angeles, CA
2:10 p.m.
Challenges for Global Health: NCD's- The Next 5 Years
Harlan M. Krumholz
New Haven, CT
2:30 p.m.
Prologue to 25 by 25: A WHF Perspective
Salim Yusuf
Hamilton, Canada
2:40 p.m.
NCD: A PAHO Perspective
Anselm Hennis
Washington, DC
2:50 p.m.
NCDs and Health in the Post-2015 Development Agenda
Johanna Ralston
Geneva, Switzerland
3:00 p.m.
NCD's Past is Prologue
Daniel Jose Pineiro
Buenos Aires, Argentina
2:00 p.m.
JACC: New Vision and Features
Valentin Fuster
2:10 p.m.
How Do Editors of NEJM Select the Best Manuscripts?
John A. Jarcho
Boston, MA
2:20 p.m.
How Do Editors of JACC Select the Best Manuscripts?
Jagat Narula
New York, NY
3:10 p.m.
Panel Discussion
Panelist: Anselm Hennis
Panelist: John Gordon Harold
Panelist: Harlan M. Krumholz
Panelist: Daniel Jose Pineiro
Panelist: Johanna Ralston
Panelist: Salim Yusuf
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 57 of 64
Program PDF
Updated: 2-23-15
Stable Ischemic Heart Disease - Scientific Session
Session #710
AUC: It's Not Just for PCI! Appropriate Use of Stress Testing
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 6D
CME Hours: 1.5 /CNE Hours: 1.5
Monday, March 16, 2015
Pre-procedure Strategies
2:00 p.m.
The Modern Era of Consents: From Studies of Sudden Death to STEMI
Bernard J. Gersh
2:09 p.m.
Pre-procedure Assessment of Bleeding Risk: Can we Discriminate who is at
High Risk?
Roxana Mehran
New York, NY
Co-Chair: Martha Gulati
Co-Chair: Leslee J. Shaw
2:00 p.m.
Use and Abuse of Stress Testing
Stephen D. Wiviott
2:18 p.m.
Pre-procedure Assessment of Post-procedure Acute Kidney Injury: Promises
and Pitfalls
Hitinder S. Gurm
Ann Arbor, MI
2:10 p.m.
Question and Answer
2:15 p.m.
Prognostic Utility of Treadmill Test Vs Stress Imaging
George A. Beller
Charlottesville, VA
2:25 p.m.
Question and Answer
2:27 p.m.
Eliminating Guesswork: Using Available Tools to Gauge Procedural Risk
John A. Spertus
Kansas City, MO
2:36 p.m.
Discussion
2:30 p.m.
Treadmill Test: Do the Non-ECG Variables Trump the ST-Segment?
Jerome L. Fleg
Bethesda, MD
Procedural and Post-procedural Strategies
2:40 p.m.
Question and Answer
2:45 p.m.
The Modern Cath Lab: Understanding Appropriate Use Criteria
Jeffrey Marshall
Gainesville, GA
2:45 p.m.
Stress Testing in Women: Gender Based Test Selection?
Leslee J. Shaw
Atlanta, GA
2:54 p.m.
The Modern Cath Lab: Implementation of a “Radial First” Strategy
Rajiv Gulati
Rochester, MN
2:55 p.m.
Question and Answer
3:03 p.m.
The Modern Cath Lab: Starting a Same-day Discharge Program
Ian Gilchrist
Hershey, PA
3:10 p.m.
Coronary Microvascular Disease: Noninvasive/Invasive Testing
Marcelo F. Di Carli
Boston, MA
3:12 p.m.
Robotic PCI
3:00 p.m.
Question and Answer
3:21 p.m.
Discussion
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2634
Optimizing PCI Care Processes
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 6F
CME Hours: 1.5 /CNE Hours: 1.5
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2640
Critical Limb Ischemia
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 8
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Sunil V. Rao
Co-Chair: Ajay J. Kirtane
Co-Chair: Kenneth Rosenfield
Co-Chair: Mehdi H. Shishehbor
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 58 of 64
Program PDF
Updated: 2-23-15
2:00 p.m.
Endovascular versus Open Surgery: The "BEST" approach to CLI
Kenneth Rosenfield
2:11 p.m.
Angiosome Concept and Perfusion Assessment
Mehdi H. Shishehbor
Cleveland, OH
2:22 p.m.
Retrograde Tibiopedal Access: When, Why, and How
Larry J. Diaz
Grand Rapids, MI
2:33 p.m.
Crossing Total Below Knee Occlusions: My Approach
John R. Laird
El Macero, CA
2:44 p.m.
When and Why: DES and DEB for Below Knee Arteries
Subhash Banerjee
Dallas, TX
2:55 p.m.
My Worst Complications and How I Managed Them
D. Christopher Metzger
Kingsport, TN
3:06 p.m.
Non-Invasive Follow-up and Medical Treatment after Intervention
Michael R. Jaff
Boston, MA
3:17 p.m.
Discussion
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2641
The Heart Team Approach to Identifying the TAVR Patient
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 9
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Theodore L. Schreiber
Co-Chair: Raj R. Makkar
2:00 p.m.
Assessment of AS: Invasive and Non-invasive Pitfalls
Zachary Gertz
2:10 p.m.
Preparing the Patient: Clinic Coordinator's Perspective
David Jones
Philadelphia, PA
2:20 p.m.
PLACEHOLDER: Anesthesia Considerations
Monday, March 16, 2015
2:30 p.m.
A Virtual Heart Team Meeting
Howard C. Herrmann
Philadelphia, PA
2:40 p.m.
PLACEHOLDER: Post-TAVR Pathway and Nursing Considerations
2:50 p.m.
How to Start a Valve Program
James E. Harvey
Cleveland, OH
3:00 p.m.
From Intermediate Risk to Cohort C
Molly Szerlip
Tucson, AZ
3:10 p.m.
Discussion
Valvular Heart Disease - Scientific Session
Session #713
2014 AHA/ACC Valvular Heart Disease Guidelines: The Impact on
Clinical Practice
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 11A
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Robert O. Bonow
Co-Chair: Carlos E. Ruiz
Panelist: John P. Erwin
Panelist: Robert A. Guyton
Panelist: Thoralf M. Sundt
Panelist: William A. Zoghbi
2:00 p.m.
ACC Talk: The Valve Guidelines
Rick A. Nishimura
Rochester, MN
2:12 p.m.
Aortic Valve: How the Guidelines Address Asymptomatic Disease and LowFlow Aortic Stenosis
Catherine M. Otto
Seattle, WA
2:24 p.m.
Mitral Valve: Differences in Approach to Diagnosis and Management for
Primary and Secondary Regurgitation
Blase A. Carabello
New York, NY
2:36 p.m.
The Multidisciplinary Heart Valve Team: Is It Necessary for Optimal Care?
Michael J. Mack
Plano, TX
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 59 of 64
Program PDF
Updated: 2-23-15
2:48 p.m.
Indications and Timing of Surgical and Transcatheter Valve Intervention
Vinod H. Thourani
Atlanta, GA
3:00 p.m.
CASE PRESENTATION: Asymptomatic AS Case
Patricia A. Pellikka
Rochester, MN
MOC Faculty: Oussama M. Wazni
Special Topics (including MOC)
Session #826
ACCF Study Session for Maintenance of Certification: ABIM
Recertification Made Easy: ACC General Cardiology Module 12
Monday, March 16, 2015, 3 p.m. - 5:30 p.m.
30B
CME Hours: 2.5 /CNE Hours: 0
Chair: John A. McPherson
MOC Faculty: Mina K. Chung
MOC Faculty: Laxmi S. Mehta
3:05 p.m.
Panel Discussion
3:15 p.m.
CASE PRESENTATION: Case of Severe Functional Mitral Regurgitation
Rebecca T. Hahn
New York, NY
3:20 p.m.
Panel Discussion
Vascular Medicine (including MOC)
Session #824
Core Curriculum: Evidence Based Evaluation and Management of the
Vascular Medicine Patient
Monday, March 16, 2015, 2 p.m. - 3:30 p.m.
Room 20C
CME Hours: 1.5 /CNE Hours: 1.5
Chair: Emile R. Mohler
2:00 p.m.
Management of Carotid Disease
Sahil A. Parikh
Cleveland, OH
Acute Coronary Syndromes - Scientific Session
Session #714
Cardiogenic Shock: Progress, Paradigms, and Unresolved Problems
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 20A
CME Hours: 1.5 /CNE Hours: 1.25
Co-Chair: Peter B. Berger
Co-Chair: Navin Kapur
3:45 p.m.
CASE PRESENTATION: Case Presenter: Marwan F. Jumean
3:50 p.m.
From Killip to NYHA to INTERMACS: The Evolving Spectrum of Cardiogenic
Shock
Navin Kapur
4:05 p.m.
Supporting the Unsupported: The Role of Circulatory Support in ACS/Shock
Ajay J. Kirtane
New York, NY
2:25 p.m.
Battling Limb Loss and Claudication
John P. Reilly
New Orleans, LA
4:20 p.m.
Calcification, Multivessel Disease, and the Left Main: Complex PCI in
ACS/Shock
Jeffrey W. Moses
New York, NY
2:50 p.m.
Imaging Essentials
Daniella Kadian-Dodov
New York, NY
3:15 p.m.
Audience Question and Answer/Discussion
Special Topics (including MOC)
Session #825
ACCF Study Session for Maintenance of Certification: ABIM
Recertification Made Easy: ACC General Cardiology Module 13
Monday, March 16, 2015, 3 p.m. - 5:30 p.m.
29B
CME Hours: 2.5 /CNE Hours: 0
Chair: Kim A. Eagle
MOC Faculty: Anthony Hilliard
Monday, March 16, 2015
4:35 p.m.
Inotropes and Vasopressors in Cardiogenic Shock: What's a Cardiologist to
Do?
Vladimir Dzavik
Toronto, Canada
4:50 p.m.
The Right Stuff: Targeting RV Dysfunction in ACS/Shock
Sandeep Nathan
Chicago, IL
5:05 p.m.
Case Review and Panel Discussion
Theodore A. Bass
Jacksonville, FL
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 60 of 64
Program PDF
Updated: 2-23-15
Arrhythmias and Clinical EP - Scientific Session
Session #715
Difficult Surgical Scenarios: LVAD, TAVR, Hybrid AF Ablation and
Preventing Post-Operative AF
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 1B
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Eugene H. Chung
Co-Chair: Jodie L. Hurwitz
Panelist: Srinivas Dukkipati
Panelist: Matthew Wright Kingdom
Panelist: Gregory K. Feld
Monday, March 16, 2015
5:00 p.m.
Novel Strategies to Prevent Post-Operative Atrial Fibrillation. Drugs, Fat Pad
Resection and Botox!
Dhanunjaya R. Lakkireddy
Overland Park, KS
Arrhythmias and Clinical EP (including MOC)
Session #827
Core Curriculum: Atrial Fibrillation - The Essentials
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 20C
CME Hours: 1.5 /CNE Hours: 1.5
Chair: Mitchell N. Faddis
3:45 p.m.
Debate 1: ICD Therapy Should be Utilized in LVAD Patients (PRO)
Hasan Garan
New York, NY
3:55 p.m.
Debate 1: ICD Therapy Should be Utilized in LVAD Patients (CON)
Alan Enriquez
Brookline, MA
4:05 p.m.
Rebuttal 1: PRO
3:45 p.m.
Strategies for Rate and Rhythm Control
Kristen K. Patton
Seattle, WA
4:10 p.m.
Stroke Prevention in AFib: In With the New, Out With the Old?
Ralph J. Verdino
Philadelphia, PA
4:10 p.m.
Rebuttal 1: CON
4:35 p.m.
Invasive Approaches to AFib
Michael Glikson
Tel Hashomer, Israel
3:55 p.m.
Question and Answer
5:00 p.m.
Audience Question and Answer/Discussion
4:05 p.m.
Debate 2: All Persistent AF Patients Should be Offered a Hybrid AF Ablation
PRO
John Paul Mounsey
Chapel Hill, NC
Congenital Heart Disease - Scientific Session
Session #716
Heart Failure: Controversies in Management
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 31C
CME Hours: 1.5 /CNE Hours: 1.5
4:15 p.m.
Debate 2: All Persistent AF Patients Should be Offered a Hybrid AF Ablation
(CON)
Vinod H. Thourani
Atlanta, GA
Co-Chair: Beth Dawn Kaufman
Co-Chair: Janet N. Scheel
Panelist: Kirk Kanter
Panelist: Steven D. Zangwill
3:45 p.m.
Cardiomyopathies: Can We Manage Without Device or Transplant?
Melanie Everitt
Salt Lake City, UT
4:25 p.m.
Rebuttal 2: PRO
4:30 p.m.
Rebuttal 2: CON
3:55 p.m.
Question and Answer
4:35 p.m.
Question and Answer
4:45 p.m.
Evaluation and Prevention of Heart Block in Patients Undergoing TAVR
Daniel L. Lustgarten
Burlington, VT
4:00 p.m.
State of the Art in Surgical Management of Cardiomyopathies: What Are the
Options?
Michael E. Mitchell
Milwaukee, WI
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 61 of 64
Program PDF
Updated: 2-23-15
4:10 p.m.
Question and Answer
4:15 p.m.
Managing Heart Failure After Repair of Congenital Heart Disease
David N. Rosenthal
Palo Alto, CA
4:25 p.m.
Question and Answer
Monday, March 16, 2015
4:39 p.m.
Exercise Training in Low EF Patients
Christopher M. O'Connor
Durham, NC
4:57 p.m.
When Should We Refer Heart Failure Patients to Cardiac Rehab: A Primer of
CMS Policy?
Ileana L. Pina
Bronx, NY
Heart Failure and Cardiomyopathies - Scientific Session
Session #718
Diagnosing Unexplained Nonischemic Cardiomyopathies
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 5A
CME Hours: 1.5 /CNE Hours: 1.5
4:30 p.m.
Living With a VAD: My Perspective
Jackson Radandt
Valders, WI
4:40 p.m.
Question and Answer
4:45 p.m.
Controversies in Pediatric Heart Transplantation
Janet N. Scheel
Washington, DC
4:55 p.m.
Question and Answer
5:00 p.m.
How Can We Support the Failing Single Ventricle?
Ronald Woods
Milwaukee, WI
Co-Chair: Sharmila Dorbala
Co-Chair: David Owens
3:45 p.m.
What Should Be the Standard Laboratory Workup for Cardiomyopathy in
2015?
Andre Keren
4:03 p.m.
How Useful Are Biomarkers for Diagnosing Rare Cardiomyopathy?
Peter P. Liu
Toronto, Canada
5:10 p.m.
Question and Answer
4:21 p.m.
Roles for Advanced Imaging in Unexplained Cardiomyopathy
David A. Bluemke
Bethesda, MD
Heart Failure and Cardiomyopathies - Scientific Session
Session #717
Exercise in Cardiomyopathy and Heart Failure
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 6C
CME Hours: 1.5 /CNE Hours: 1.5
4:39 p.m.
Nuclear Imaging Modalities for Assessment of Cardiomyopathy
Sharmila Dorbala
Boston, MA
4:57 p.m.
Genetics as Diagnostic Tool: What Tests? What Is the Cost? How Should
Results Be Communicated?
Euan A. Ashley
Palo Alto, CA
Co-Chair: Martin J. O'Riordan
Co-Chair: Ileana L. Pina
3:45 p.m.
Can Athletes With HCM Compete?
Sharlene M. Day
4:03 p.m.
Does Endurance Training Cause Cardiomyopathy?
Aaron L. Baggish
Boston, MA
4:21 p.m.
Differentiating Cardiomyopathy From the Athletic Heart
Michael Emery
Greenville, SC
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
Scientific Session - Session #719
Risk Stratification in CAD: Is CMR the Gold Standard?
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 2
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Robert O. Bonow
Co-Chair: Milind Y. Desai
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 62 of 64
Program PDF
Updated: 2-23-15
3:45 p.m.
Post-MI
Vicente Bodi
4:45 p.m.
CASE PRESENTATION: Case Presenter: I Am Taking My Statin, But My
Numbers Still Aren’t Pretty. Now What?
Parag Joshi
4:03 p.m.
Ischemia
Eike C. Nagel
London, United Kingdom
4:50 p.m.
Panel Discussion
4:21 p.m.
Chronic Scar
Raymond J. Kim
Durham, NC
4:57 p.m.
Question and Answer
Special Topics - Future of CV Medicine
Session #1012
Beyond Medicine - Impact of Climate Change, Pollution, Population
Migration, War: Future of Cardiovascular Medicine XIII
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 20D
CME Hours: 1.5 /CNE Hours: 1.5
4:39 p.m.
Diabetes
Raymond Y. K. Kwong
Boston, MA
4:57 p.m.
Ventricular Arrhythmia
Saman Nazarian
Baltimore, MD
Chair: Ralph G. Brindis
3:45 p.m.
Introduction to the Session
Prevention - Scientific Session
Session #721
Tight Corners/ Tough Cases: When the Guidelines Don’t Guide You
What Should I Do?
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 6B
CME Hours: 1.5 /CNE Hours: 1.5
3:45 p.m.
CASE PRESENTATION: Case Presenter: Ah, Ouch, Stop My Statins Stat! Life on
Statins Is Not Worth It!
Monika Sanghavi
3:50 p.m.
Panel Discussion
3:57 p.m.
Question and Answer
4:20 p.m.
CASE PRESENTATION: Case Presenter: They Say I Am Too Young for a Statin
But People My Father’s Age Can’t Avoid One. What Gives?
Danny J. Eapen
4:32 p.m.
Question and Answer
3:50 p.m.
Impact of Climate Change and Pollution - The Health of the Earth and its
Inhabitants
Michael Jerrett
Berkeley, CA
4:15 p.m.
Impact of Population, Immigration and War - The Health of the Earth and its
Inhabitants
M. Zaher Sahloul
Chicago, IL
Co-Chair: Amit Khera
Co-Chair: Samia Mora
Panelist: C. Noel Bairey Merz
Panelist: Neil J. Stone
Panelist: Paula J. Mooney
4:25 p.m.
Panel Discussion
Monday, March 16, 2015
4:40 p.m.
Panel Discussion with Audience Participation
Panelist: Sidney Smith, Jr.
Chapel Hill, NC
Panelist: Salim Yusuf
Panelist: William A. Zoghbi
Stable Ischemic Heart Disease - Scientific Session
Session #720
Medical, Interventional and Surgical Treatment of Coronary Artery
Disease: A Case Based Discussion With the Experts
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 6D
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Mathew Williams
Co-Chair: Susan Jane Zieman
Panelist: William E. Boden
Panelist: David J. Cohen
Panelist: David A. Fullerton
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 63 of 64
Program PDF
Updated: 2-23-15
Monday, March 16, 2015
3:45 p.m.
CASE PRESENTATION: An Incidental, Asymptomatic 90% Ostial LAD
Puja Parikh
New York, NY
G. Michael Deeb
Ann Arbor, MI
3:49 p.m.
Panel Discussion
4:15 p.m.
What Have we Learned so Far?
Michael J. Mack
Plano, TX
4:07 p.m.
CASE PRESENTATION: Asymptomatic MVD With Focal Lesions and Normal
Ventricular Function.
Matthew Cavender
Wellesley, MA
4:11 p.m.
Panel Discussion
4:30 p.m.
CASE PRESENTATION: Symptomatic Non-LAD Disease With Mildly Reduced
LVEF.
Gagan Deep Singh
Sacramento, CA
4:34 p.m.
Panel Discussion
4:52 p.m.
CASE PRESENTATION: MVD in an Asymptomatic Diabetic Patient With
Preserved LVEF.
Pawan Hari
NY
TVT Registry
4:25 p.m.
What Does it Mean?
David R. Holmes
Rochester, MN
4:35 p.m.
What Will We Learn?
John D. Carroll
Aurora, CO
4:45 p.m.
Will the Heart Team Approach Continue, Expand, or Dissolve?
Martin B. Leon
New York, NY
4:55 p.m.
Discussion
4:56 p.m.
Panel Discussion
TCT@ACC-i2 (Interventional Cardiology)
Scientific Session - Session #2642
Heart Team 2: Working Together
Monday, March 16, 2015, 3:45 p.m. - 5:15 p.m.
Room 9
CME Hours: 1.5 /CNE Hours: 1.5
Co-Chair: Theodore L. Schreiber
Co-Chair: Howard C. Herrmann
Financial Considerations
3:45 p.m.
Cost Effectiveness - the Payor's Perspective
Matthew R. Reynolds
3:55 p.m.
Global Payment Perspective
Nicolo Piazza
Montreal, Canada
4:05 p.m.
Hospital Perspective
ACC.15 | Program PDF | Monday, March 16, 2015 | Page 64 of 64